{
  "meta": {
    "id": "test3",
    "title": "Carbohydrate Metabolism",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 6-month-old boy begins experiencing vomiting, night sweats, and tremors after the introduction of fruit juices into his diet during weaning. Physical examination reveals significant hepatomegaly. Urine tests are positive for reducing sugars but negative for glucose. Which enzyme deficiency is most likely responsible for these symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Galactokinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fructokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aldolase B",
          "correct": true
        },
        {
          "label": "D",
          "text": "\u03b2-galactosidase",
          "correct": false
        }
      ],
      "correct_answer": "C. Aldolase B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Aldolase B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Galactokinase: Deficiency in galactokinase leads to galactosemia type 2, which primarily results in cataract formation but does not typically cause severe hypoglycemia or hepatomegaly in response to fructose ingestion.</li><li>\u2022 Option A.  Galactokinase:</li><li>\u2022 Deficiency</li><li>\u2022 galactokinase</li><li>\u2022 galactosemia type 2,</li><li>\u2022 cataract formation</li><li>\u2022 does not</li><li>\u2022 severe hypoglycemia or hepatomegaly</li><li>\u2022 Option B. Fructokinase: Fructokinase deficiency leads to essential fructosuria, a benign condition characterized by the excretion of fructose in the urine without serious metabolic disturbances or clinical symptoms.</li><li>\u2022 Option B. Fructokinase:</li><li>\u2022 Fructokinase deficiency</li><li>\u2022 fructosuria,</li><li>\u2022 benign</li><li>\u2022 excretion of</li><li>\u2022 fructose</li><li>\u2022 urine</li><li>\u2022 without</li><li>\u2022 Option D. \u03b2-Galactosidase: Deficiency in \u03b2-galactosidase leads to GM1 gangliosidosis or galactosialidosis , which involve neurological symptoms and developmental delays , but not the specific reaction to fructose ingestion as described.</li><li>\u2022 Option D. \u03b2-Galactosidase:</li><li>\u2022 Deficiency in \u03b2-galactosidase</li><li>\u2022 GM1 gangliosidosis or galactosialidosis</li><li>\u2022 neurological symptoms</li><li>\u2022 developmental delays</li><li>\u2022 not</li><li>\u2022 fructose ingestion</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hereditary Fructose Intolerance (HFI) is a condition resulting from aldolase B deficiency , characterized by adverse reactions to fructose ingestion, such as hypoglycemia, hepatomegaly, and metabolic disturbances.</li><li>\u27a4 Hereditary Fructose Intolerance (HFI)</li><li>\u27a4 aldolase B deficiency</li><li>\u27a4 adverse reactions</li><li>\u27a4 fructose ingestion,</li><li>\u27a4 hypoglycemia, hepatomegaly, and metabolic disturbances.</li><li>\u27a4 Ref : Harper 30/e: p 155, 202, 205.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 155, 202, 205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "12c6f5aa",
      "audio": ""
    },
    {
      "text": "There are one specific vitamins, which is involved in the TCA cycle as key for comprehending its biochemical intricacies and the nutritional requirements that support this fundamental metabolic pathway. Which of the following vitamins are involved in the TCA cycle?",
      "options": [
        {
          "label": "A",
          "text": "Pantothenic Acid as a part of CoA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Riboflavin as FAD",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thiamine",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pantothenic Acid: It is a component of Coenzyme A (CoA) , essential for the formation of Acetyl- CoA, a substrate entering the TCA cycle.</li><li>\u2022 Option A. Pantothenic Acid:</li><li>\u2022 Coenzyme A (CoA)</li><li>\u2022 CoA,</li><li>\u2022 substrate</li><li>\u2022 TCA cycle.</li><li>\u2022 Option B. Riboflavin: It is converted into Flavin Adenine Dinucleotide (FAD), a coenzyme used by succinate dehydrogenase in the TCA cycle.</li><li>\u2022 Option B. Riboflavin:</li><li>\u2022 converted into Flavin Adenine Dinucleotide (FAD),</li><li>\u2022 coenzyme</li><li>\u2022 succinate</li><li>\u2022 dehydrogenase</li><li>\u2022 Option C. Thiamine: As thiamine pyrophosphate (TPP) , it is a coenzyme for the pyruvate dehydrogenase complex that converts pyruvate into Acetyl-CoA, linking glycolysis with the TCA cycle.</li><li>\u2022 Option C. Thiamine:</li><li>\u2022 thiamine pyrophosphate (TPP)</li><li>\u2022 coenzyme</li><li>\u2022 pyruvate dehydrogenase</li><li>\u2022 complex</li><li>\u2022 pyruvate into Acetyl-CoA,</li><li>\u2022 glycolysis with the TCA cycle.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vitamins in TCA Cycle:</li><li>\u27a4 Vitamins in TCA Cycle:</li><li>\u27a4 Pantothenic Acid as a part of CoA Riboflavin as FAD Thiamine Niacin as NAD+</li><li>\u27a4 Pantothenic Acid as a part of CoA</li><li>\u27a4 Pantothenic Acid</li><li>\u27a4 Riboflavin as FAD</li><li>\u27a4 Riboflavin</li><li>\u27a4 Thiamine</li><li>\u27a4 Thiamine</li><li>\u27a4 Niacin as NAD+</li><li>\u27a4 Niacin</li><li>\u27a4 Ref : Vasudevan 9/e: 251.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 251.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "17b2507f",
      "audio": ""
    },
    {
      "text": "A research team is exploring the metabolic adaptations of cancer cells and how these cells meet their increased energy demands. In most cancer cells, the predominant metabolic pathway for generating the necessary energy is distinct from that of normal, non-cancerous cells. Which metabolic process do cancer cells primarily exploit to derive the energy needed for their rapid growth and proliferation?",
      "options": [
        {
          "label": "A",
          "text": "Glycolysis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Oxidative phosphorylation",
          "correct": false
        },
        {
          "label": "C",
          "text": "TCA in mitochondria",
          "correct": false
        },
        {
          "label": "D",
          "text": "From beta-oxidation",
          "correct": false
        }
      ],
      "correct_answer": "A. Glycolysis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Glycolysis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Oxidative phosphorylation : While important in many tissues, cancer cells rely less on oxidative phosphorylation compared to normal cells , partially because it is less efficient under hypoxic conditions, which are common in tumors.</li><li>\u2022 Option B. Oxidative phosphorylation</li><li>\u2022 cancer cells</li><li>\u2022 less</li><li>\u2022 oxidative phosphorylation</li><li>\u2022 normal cells</li><li>\u2022 less efficient under hypoxic conditions,</li><li>\u2022 common in tumors.</li><li>\u2022 Option C. TCA cycle in mitochondria : The TCA cycle is used by all cells , but cancer cells often have mitochondrial defects that reduce their reliance on this pathway.</li><li>\u2022 Option C. TCA cycle in mitochondria</li><li>\u2022 TCA cycle</li><li>\u2022 all cells</li><li>\u2022 cancer cells</li><li>\u2022 mitochondrial defects</li><li>\u2022 reduce</li><li>\u2022 reliance</li><li>\u2022 pathway.</li><li>\u2022 Option D. Beta-oxidation : This pathway oxidizes fatty acids to generate acetyl-CoA for energy ; however, cancer cells typically rely on this less than on glycolysis.</li><li>\u2022 Option D. Beta-oxidation</li><li>\u2022 oxidizes fatty acids</li><li>\u2022 acetyl-CoA for energy</li><li>\u2022 cancer cells</li><li>\u2022 rely on</li><li>\u2022 less</li><li>\u2022 glycolysis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cancer cells predominantly use glycolysis for energy production, even in the presence of oxygen, a phenomenon known as the Warburg effect. This metabolic adaptation allows cancer cells to thrive even under hypoxic conditions and contributes to the acidic microenvironment often seen in tumors due to lactate production.</li><li>\u27a4 Cancer cells</li><li>\u27a4 glycolysis for energy production,</li><li>\u27a4 presence of oxygen,</li><li>\u27a4 Warburg effect.</li><li>\u27a4 adaptation allows cancer cells to thrive</li><li>\u27a4 hypoxic conditions</li><li>\u27a4 acidic</li><li>\u27a4 microenvironment</li><li>\u27a4 tumors</li><li>\u27a4 lactate production.</li><li>\u27a4 Ref : Harper 30/e p738.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p738.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8457d9d",
      "audio": ""
    },
    {
      "text": "During fasting, the body employs various mechanisms to maintain blood glucose levels. Which of the following sequences correctly represents the order in which these mechanisms are activated to ensure blood glucose homeostasis in the fasting state?",
      "options": [
        {
          "label": "A",
          "text": "Glucose from diet > glycogenolysis > gluconeogenesis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glucose from diet > gluconeogenesis > glycogenolysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucose from diet > gluconeogenesis > proteolysis)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glucose from diet > lipolysis > gluconeogenesis",
          "correct": false
        }
      ],
      "correct_answer": "A. Glucose from diet > glycogenolysis > gluconeogenesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Glucose from diet > glycogenolysis > gluconeogenesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Glucose from diet > gluconeogenesis > glycogenolysis: This sequence is incorrect because glycogenolysis typically precede s gluconeogenesis in the fasting state as the body utilizes stored glycogen before synthesizing glucose from non-carbohydrate sources.</li><li>\u2022 Option B. Glucose from diet > gluconeogenesis > glycogenolysis:</li><li>\u2022 incorrect</li><li>\u2022 glycogenolysis</li><li>\u2022 s gluconeogenesis</li><li>\u2022 fasting state</li><li>\u2022 body utilizes stored glycogen</li><li>\u2022 synthesizing glucose</li><li>\u2022 non-carbohydrate sources.</li><li>\u2022 Option C. Glucose from diet > gluconeogenesis > proteolysis: While proteolysis (the breakdown of proteins ) does contribute substrates for gluconeogenesis , it is not a direct mechanism for maintaining blood glucose levels but rather provides amino acids that can be used in gluconeogenesis.</li><li>\u2022 Option C. Glucose from diet > gluconeogenesis > proteolysis:</li><li>\u2022 proteolysis</li><li>\u2022 breakdown of proteins</li><li>\u2022 gluconeogenesis</li><li>\u2022 not</li><li>\u2022 direct</li><li>\u2022 blood glucose levels</li><li>\u2022 amino acids</li><li>\u2022 gluconeogenesis.</li><li>\u2022 Option D. Glucose from diet > lipolysis > gluconeogenesis: Lipolysis, the breakdown of triglycerides into free fatty acids and glycerol , does provide substrates for gluconeogenesis (specifically glycerol), but it primarily serves as a mechanism for providing energy through fatty acid oxidation rather than directly contributing to maintaining blood glucose levels.</li><li>\u2022 Option D. Glucose from diet > lipolysis > gluconeogenesis:</li><li>\u2022 Lipolysis,</li><li>\u2022 triglycerides into free fatty acids</li><li>\u2022 glycerol</li><li>\u2022 substrates</li><li>\u2022 gluconeogenesis (specifically glycerol),</li><li>\u2022 mechanism</li><li>\u2022 energy through fatty acid oxidation</li><li>\u2022 directly</li><li>\u2022 blood glucose levels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 During starvation:</li><li>\u27a4 Liver produces glucose by glycogenolysis and later by gluconeogenesis so that the obligatory requirements of the brain are met. Liver also produces the ketone bodies , an alternate source of fuel. But the liver cannot use ketone bodies as its own fuel In the fasting state 2-2 1/2 hours \u2013 glucose from meals Next 3 hour s \u2013 from glycogenolysis Later from gluconeogenesis (proteolysis & lipolysis) Hyperglycemic hormones are secreted</li><li>\u27a4 Liver produces glucose by glycogenolysis and later by gluconeogenesis so that the obligatory requirements of the brain are met.</li><li>\u27a4 Liver</li><li>\u27a4 glucose</li><li>\u27a4 glycogenolysis</li><li>\u27a4 gluconeogenesis</li><li>\u27a4 brain</li><li>\u27a4 Liver also produces the ketone bodies , an alternate source of fuel. But the liver cannot use ketone bodies as its own fuel</li><li>\u27a4 Liver</li><li>\u27a4 ketone bodies</li><li>\u27a4 alternate source of fuel.</li><li>\u27a4 liver cannot</li><li>\u27a4 ketone bodies</li><li>\u27a4 fuel</li><li>\u27a4 In the fasting state</li><li>\u27a4 fasting state</li><li>\u27a4 2-2 1/2 hours \u2013 glucose from meals</li><li>\u27a4 2-2 1/2 hours</li><li>\u27a4 glucose</li><li>\u27a4 meals</li><li>\u27a4 Next 3 hour s \u2013 from glycogenolysis</li><li>\u27a4 3 hour</li><li>\u27a4 glycogenolysis</li><li>\u27a4 Later from gluconeogenesis (proteolysis & lipolysis)</li><li>\u27a4 Later</li><li>\u27a4 gluconeogenesis</li><li>\u27a4 Hyperglycemic hormones are secreted</li><li>\u27a4 Hyperglycemic</li><li>\u27a4 secreted</li><li>\u27a4 Liver is the net producer of glucose in the fasting state</li><li>\u27a4 Liver</li><li>\u27a4 net</li><li>\u27a4 glucose in the fasting state</li><li>\u27a4 Ref : Vasudevan 9/e: p 319-325.</li><li>\u27a4 Ref : Vasudevan 9/e: p 319-325.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3f71c47",
      "audio": ""
    },
    {
      "text": "A medical student is reviewing the glycolytic pathway and is attempting to identify the points of regulation within the process. She notes that certain steps are irreversible and thus play a key role in the regulation of glycolysis. Which of the following enzymes catalyzes a reaction in glycolysis that is not considered irreversible and therefore not a major regulatory point?",
      "options": [
        {
          "label": "A",
          "text": "Enolase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Phosphofructokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pyruvate Kinase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hexokinase",
          "correct": false
        }
      ],
      "correct_answer": "A. Enolase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Enolase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Phosphofructokinase : Catalyzes an irreversible step by converting fructose-6-phosphate to fructose-1,6-bisphosphate and is a major regulatory point of glycolysis.</li><li>\u2022 Option B. Phosphofructokinase</li><li>\u2022 Option C. Pyruvate Kinase : Irreversibly Catalyzes the conversion of phosphoenolpyruvate to pyruvate, another regulatory step in glycolysis.</li><li>\u2022 Option C. Pyruvate Kinase</li><li>\u2022 Option D. Hexokinase : Irreversibly phosphorylates glucose to glucose-6-phosphate at the start of the glycolytic pathway and is allosterically inhibited by its product, making it a key regulatory enzyme.</li><li>\u2022 Option D. Hexokinase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Irreversible Steps of Glycolysis:</li><li>\u27a4 Hexokinase Phosphofructokinase Pyruvate Kinase</li><li>\u27a4 Hexokinase</li><li>\u27a4 Phosphofructokinase</li><li>\u27a4 Pyruvate Kinase</li><li>\u27a4 Ref : Harper 30/e p170-172.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a0e76aec",
      "audio": ""
    },
    {
      "text": "A 55-year-old man presents with fatigue, abdominal pain, and hepatomegaly, with abnormal liver function tests suggesting ethanol toxicity. What could be the underlying biochemical change associated with ethanol toxicity in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Decreased lactate/Pyruvate ratio",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased NADH/NAD+ ratio",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stimulation of Gluconeogenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stimulation of fatty acid oxidation",
          "correct": false
        }
      ],
      "correct_answer": "B. Increased NADH/NAD+ ratio",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Increased NADH/NAD+ ratio</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Decreased lactate/pyruvate ratio: Ethanol metabolism actually leads to an increased lactate/pyruvate ratio due to the conversion of pyruvate to lactate in the presence of excess NADH.</li><li>\u2022 Option A. Decreased lactate/pyruvate ratio:</li><li>\u2022 Ethanol</li><li>\u2022 increased lactate/pyruvate ratio</li><li>\u2022 pyruvate to lactate</li><li>\u2022 NADH.</li><li>\u2022 Option C. Stimulation of gluconeogenesis: Ethanol metabolism inhibits gluconeogenesis due to the increased NADH/NAD+ ratio and the subsequent diversion of substrates like pyruvate and oxaloacetate to lactate and malate , respectively.</li><li>\u2022 Option C. Stimulation of gluconeogenesis: Ethanol</li><li>\u2022 inhibits gluconeogenesis</li><li>\u2022 increased NADH/NAD+ ratio</li><li>\u2022 diversion</li><li>\u2022 pyruvate and oxaloacetate</li><li>\u2022 lactate and malate</li><li>\u2022 Option D. Stimulation of fatty acid oxidation: Ethanol metabolism inhibits fatty acid oxidation , again due to the increased NADH/NAD+ ratio. Instead, there is an accumulation of fatty acids leading to fatty liver.</li><li>\u2022 Option D. Stimulation of fatty acid oxidation:</li><li>\u2022 Ethanol</li><li>\u2022 inhibits fatty acid oxidation</li><li>\u2022 increased</li><li>\u2022 NADH/NAD+ ratio.</li><li>\u2022 accumulation of fatty acids</li><li>\u2022 fatty liver.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Both the oxidation steps in alcohol metabolism produce NADH, resulting in a high NADH/NAD+ ratio. As a result, the following metabolic adaptations occur:</li><li>\u27a4 Both the oxidation steps</li><li>\u27a4 alcohol metabolism produce NADH,</li><li>\u27a4 high NADH/NAD+ ratio.</li><li>\u27a4 metabolic adaptations occur:</li><li>\u27a4 Lactic acidosis. Hypoglycemia. Ketogenesis. Fatty liver and steatosis. Mitochondrial damage and apoptosis. CNS depression</li><li>\u27a4 Lactic acidosis.</li><li>\u27a4 Hypoglycemia.</li><li>\u27a4 Ketogenesis.</li><li>\u27a4 Fatty liver and steatosis.</li><li>\u27a4 Mitochondrial damage and apoptosis.</li><li>\u27a4 CNS depression</li><li>\u27a4 Ref : Lippincott 7/e:317, DM Vasudevan  9/e: p 140-141</li><li>\u27a4 Ref</li><li>\u27a4 : Lippincott 7/e:317, DM Vasudevan  9/e: p 140-141</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf9e9de3",
      "audio": ""
    },
    {
      "text": "A teenager is brought to the ER with symptoms of increased confusion and lethargy. Lab tests reveal abnormal liver function and significantly elevated serum ammonia levels. His parents note his recent high protein intake, attributed to his athletic activities. Hyperammonemia can disrupt the TCA cycle by depleting a specific intermediate, leading to impaired energy metabolism. Which TCA cycle intermediate is most likely depleted in this scenario, contributing to the cycle's inhibition?",
      "options": [
        {
          "label": "A",
          "text": "Aspartate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Malate",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u03b1-ketoglutarate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fumarate",
          "correct": false
        }
      ],
      "correct_answer": "C. \u03b1-ketoglutarate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture27.jpg"
      ],
      "explanation": "<p><strong>Ans. C) \u03b1-ketoglutarate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hyperammonemia can i nhibit the TCA cycle by depleting \u03b1-ketoglutarate . Ammonia is detoxified in the liver by the urea cycle, which consumes \u03b1-ketoglutarate as it combines with ammonia to form glutamate. This process depletes \u03b1-ketoglutarate , a critical intermediate in the TCA cycle , leading to impaired energy metabolism and contributing to the symptoms observed.</li><li>\u27a4 Hyperammonemia</li><li>\u27a4 nhibit</li><li>\u27a4 TCA cycle</li><li>\u27a4 depleting \u03b1-ketoglutarate</li><li>\u27a4 Ammonia</li><li>\u27a4 detoxified</li><li>\u27a4 liver</li><li>\u27a4 urea cycle,</li><li>\u27a4 \u03b1-ketoglutarate</li><li>\u27a4 ammonia to form glutamate.</li><li>\u27a4 depletes \u03b1-ketoglutarate</li><li>\u27a4 intermediate</li><li>\u27a4 TCA cycle</li><li>\u27a4 impaired energy metabolism</li><li>\u27a4 symptoms observed.</li><li>\u27a4 Ref: Harper 30/e:  p 291, 292, Lippincott: P 253.</li><li>\u27a4 Ref: Harper 30/e:  p 291, 292, Lippincott: P 253.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d90afa3",
      "audio": ""
    },
    {
      "text": "Garrod's tetrad refers to a group of four metabolic disorders. Which of the following options correctly lists these disorders?",
      "options": [
        {
          "label": "A",
          "text": "Alkaptonuria, Pentosuria, Cystinuria, Albinism",
          "correct": true
        },
        {
          "label": "B",
          "text": "Alkaptonuria, Pentosuria, galactosemia, Albinism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fructosuria, Pentosuria, Cystinuria, Albinism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alkaptonuria, Pentosuria, Cystinuria, Mucopolysaccharidosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Alkaptonuria, Pentosuria, Cystinuria, Albinism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)\u00a0 Alkaptonuria, Pentosuria, Cystinuria, Albinism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Alkaptonuria, Pentos Uria, Galactosemia, Albinism: While galactosemia is a well-known metabolic disorder, it is not part of Garrod's original tetrad.</li><li>\u2022 Option B. Alkaptonuria, Pentos Uria, Galactosemia, Albinism:</li><li>\u2022 Option C. Fructosuria, Pentosuria, Cystinuria, Albinism: Fructosuria is another metabolic condition but was not included in Garrod's tetrad.</li><li>\u2022 Option C. Fructosuria, Pentosuria, Cystinuria, Albinism:</li><li>\u2022 Option D. Alkaptonuria, Pentos Uria, Cystinuria, Mucopolysaccharidosis: Mucopolysaccharidosis refers to a group of lysosomal storage diseases and is not part of Garrod's tetrad.</li><li>\u2022 Option D. Alkaptonuria, Pentos Uria, Cystinuria, Mucopolysaccharidosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Garrod\u2019s tetrad includes</li><li>\u27a4 Cystinuria Alkaptonuria Albinism Pentosuria</li><li>\u27a4 (Mnemonic- CAAP)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4feb71f5",
      "audio": ""
    },
    {
      "text": "Regarding the metabolic effects of insulin, which of the following statements is INCORRECT?",
      "options": [
        {
          "label": "A",
          "text": "It prevents lipolysis by inhibiting the activity of hormone sensitive lipase",
          "correct": false
        },
        {
          "label": "B",
          "text": "It stimulates glycogenolysis",
          "correct": true
        },
        {
          "label": "C",
          "text": "It increases proteins synthesis and prevents protein breakdown",
          "correct": false
        },
        {
          "label": "D",
          "text": "It decreases gluconeogenesis in cells",
          "correct": false
        }
      ],
      "correct_answer": "B. It stimulates glycogenolysis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) It stimulates glycogenolysis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glucose Uptake</li><li>\u27a4 Glucose Uptake</li><li>\u27a4 Insulin facilitates diffusion of glucose in muscle. Transporter, GLUT-4 is insulin dependent</li><li>\u27a4 Insulin facilitates diffusion of glucose in muscle.</li><li>\u27a4 Insulin</li><li>\u27a4 glucose in muscle.</li><li>\u27a4 Transporter, GLUT-4 is insulin dependent</li><li>\u27a4 GLUT-4 is insulin dependent</li><li>\u27a4 Utilization of Glucose : Glycolysis increased (key glycolytic enzymes: glucokinase, phosphofructokinase & pyruvate kinase) Insulin favors storage of glucose: Glycogen synthesis increased (Glycogen synthase) (option B) Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate   dehydrogenase (NADPH) activity is enhanced by insulin. Anti-lipolytic effect: Hormone sensitive lipase is decreased (option A). Gluconeogenesis Decreased (Key gluconeogenic enzymes: Pyruvate carboxylase, Phosphoenolpyruvate carboxykinase, Fructose 1,6-bisphosphatase and Glucose 6-phosphatase are inhibited by insulin. (option D) Anti-ketogenic Effect : HMG CoA synthase is decreased It increases proteins synthesis and prevents protein breakdown</li><li>\u27a4 Utilization of Glucose : Glycolysis increased (key glycolytic enzymes: glucokinase, phosphofructokinase & pyruvate kinase)</li><li>\u27a4 Utilization of Glucose</li><li>\u27a4 Glycolysis increased</li><li>\u27a4 Insulin favors storage of glucose: Glycogen synthesis increased (Glycogen synthase) (option B)</li><li>\u27a4 Insulin</li><li>\u27a4 storage of glucose:</li><li>\u27a4 Glycogen synthesis increased</li><li>\u27a4 Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate   dehydrogenase (NADPH) activity is enhanced by insulin.</li><li>\u27a4 Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate   dehydrogenase</li><li>\u27a4 Anti-lipolytic effect: Hormone sensitive lipase is decreased (option A).</li><li>\u27a4 Anti-lipolytic effect: Hormone sensitive lipase</li><li>\u27a4 decreased</li><li>\u27a4 Gluconeogenesis Decreased (Key gluconeogenic enzymes: Pyruvate carboxylase, Phosphoenolpyruvate carboxykinase, Fructose 1,6-bisphosphatase and Glucose 6-phosphatase are inhibited by insulin. (option D)</li><li>\u27a4 Gluconeogenesis Decreased</li><li>\u27a4 Anti-ketogenic Effect : HMG CoA synthase is decreased</li><li>\u27a4 Anti-ketogenic Effect</li><li>\u27a4 HMG CoA synthase</li><li>\u27a4 decreased</li><li>\u27a4 It increases proteins synthesis and prevents protein breakdown</li><li>\u27a4 increases proteins synthesis</li><li>\u27a4 prevents protein breakdown</li><li>\u27a4 Ref : Vasudevan 9/e p319-322.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e p319-322.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "05d14440",
      "audio": ""
    },
    {
      "text": "Identify which of the following pathways does not produce high-energy phosphate compounds directly helps in comprehending the energy dynamics within the cell.",
      "options": [
        {
          "label": "A",
          "text": "TCA cycle",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hexose Mono Phosphate pathway",
          "correct": true
        },
        {
          "label": "C",
          "text": "Glycolysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Beta Oxidation of Fatty Acid",
          "correct": false
        }
      ],
      "correct_answer": "B. Hexose Mono Phosphate pathway",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) HMP Pathway.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pathways which do not synthesize ATP are</li><li>\u27a4 Pathways which do not synthesize ATP are</li><li>\u27a4 HMP Pathway Rapaport Luebering Cycle Uronic acid pathway Alpha oxidation of Fatty acid Omega Oxidation of fatty acid</li><li>\u27a4 HMP Pathway</li><li>\u27a4 Rapaport Luebering Cycle</li><li>\u27a4 Uronic acid pathway</li><li>\u27a4 Alpha oxidation of Fatty acid</li><li>\u27a4 Omega Oxidation of fatty acid</li><li>\u27a4 Ref : Vasudevan 9/e: 253.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 253.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f4c36c5",
      "audio": ""
    },
    {
      "text": "Assertion (A): Piericidin and rotenone are inhibitors of (ETC) electron transport chain. Reasoning \u00ae: Piericidin and rotenone inhibits the flow of electron between the complex II and ubiquinone (coenzyme Q)",
      "options": [
        {
          "label": "A",
          "text": "A and R both are right but R is not the Correct explanation of A",
          "correct": false
        },
        {
          "label": "B",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": false
        },
        {
          "label": "C",
          "text": "A and R both are wrong",
          "correct": false
        },
        {
          "label": "D",
          "text": "A is true but R is false",
          "correct": true
        }
      ],
      "correct_answer": "D. A is true but R is false",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture2.jpg"
      ],
      "explanation": "<p><strong>Ans. D) A is right statement but R is not a correct explanation of statement A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Piericidin and rotenone are indeed inhibitors of the electron transport chain (ETC), specifically affecting the function of Complex I ( NADH dehydrogenase ). They block the transfer of electrons from NADH to ubiquinone ( coenzyme Q ), no t from Complex II . This action inhibits the electron transport chain early in its sequence, preventing the establishment of the proton gradient necessary for ATP synthesis via oxidative phosphorylation . The assertion is correct in stating that these compounds are inhibitors of the ETC , but the reasoning is incorrect as it misidentifies the site of inhibition .</li><li>\u2022 Piericidin</li><li>\u2022 rotenone</li><li>\u2022 inhibitors</li><li>\u2022 electron transport chain (ETC),</li><li>\u2022 Complex I</li><li>\u2022 NADH dehydrogenase</li><li>\u2022 block</li><li>\u2022 electrons</li><li>\u2022 NADH to ubiquinone</li><li>\u2022 coenzyme Q</li><li>\u2022 no</li><li>\u2022 Complex II</li><li>\u2022 inhibits the electron transport chain</li><li>\u2022 preventing</li><li>\u2022 proton gradient</li><li>\u2022 ATP synthesis</li><li>\u2022 oxidative phosphorylation</li><li>\u2022 assertion is correct</li><li>\u2022 inhibitors of the ETC</li><li>\u2022 reasoning is incorrect</li><li>\u2022 misidentifies the site of inhibition</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Harper 30/e: p 129-134.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 129-134.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "644a3550",
      "audio": ""
    },
    {
      "text": "In the context of glucose metabolism and insulin action, GLUT4 is characterized as a glucose transporter. Is it accurate to state that GLUT4's activity is regulated by insulin?",
      "options": [
        {
          "label": "A",
          "text": "True",
          "correct": true
        },
        {
          "label": "B",
          "text": "False",
          "correct": false
        },
        {
          "label": "C",
          "text": "None of above",
          "correct": false
        },
        {
          "label": "D",
          "text": "Not sure",
          "correct": false
        }
      ],
      "correct_answer": "A. True",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture2_iVZYTTa.jpg"
      ],
      "explanation": "<p><strong>Ans. A) True.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 GLUT4 is the major glucose transporter seen in skeletal muscle and adipose tissue . GLUT4 is under the control of insulin . Insulin promotes the translocation of intracellular GLUT4 molecules to the cell surface and thus increases glucose uptake. In Type 2 diabetes mellitus , membrane GLUT4 is reduced causing insulin resistance in muscle and fat cells. In diabetes, entry of glucose into muscle is only half of normal cells.</li><li>\u2022 GLUT4 is the major glucose transporter seen in skeletal muscle and adipose tissue .</li><li>\u2022 GLUT4</li><li>\u2022 major glucose transporter</li><li>\u2022 skeletal muscle and adipose tissue</li><li>\u2022 GLUT4 is under the control of insulin .</li><li>\u2022 GLUT4</li><li>\u2022 control</li><li>\u2022 insulin</li><li>\u2022 Insulin promotes the translocation of intracellular GLUT4 molecules to the cell surface and thus increases glucose uptake.</li><li>\u2022 Insulin</li><li>\u2022 promotes</li><li>\u2022 GLUT4</li><li>\u2022 cell surface</li><li>\u2022 increases glucose</li><li>\u2022 uptake.</li><li>\u2022 In Type 2 diabetes mellitus , membrane GLUT4 is reduced causing insulin resistance in muscle and fat cells.</li><li>\u2022 Type 2</li><li>\u2022 diabetes mellitus</li><li>\u2022 GLUT4 is reduced</li><li>\u2022 insulin resistance</li><li>\u2022 muscle and fat cells.</li><li>\u2022 In diabetes, entry of glucose into muscle is only half of normal cells.</li><li>\u2022 diabetes,</li><li>\u2022 glucose into muscle</li><li>\u2022 half of normal cells.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Vasudevan 9/ed: p 107.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/ed: p 107.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e61aadcf",
      "audio": ""
    },
    {
      "text": "A 5-months-old baby girl was given cow\u2019s milk at her 5 weeks and after 3 weeks she was admitted with a history of screaming after feeding and was discharged on advice to avoid cow\u2019s milk. Again, worsening of symptoms such as screaming, gas formation and distended abdomen occurred after she drank juice. Blood investigations, liver biopsy and physical examination were all normal. If an intestinal tissue biopsy is done and analyzed from the patient, which of the following would be deficient or defective?",
      "options": [
        {
          "label": "A",
          "text": "SGLT1",
          "correct": false
        },
        {
          "label": "B",
          "text": "GLUT 5",
          "correct": true
        },
        {
          "label": "C",
          "text": "Isomaltase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lactase",
          "correct": false
        }
      ],
      "correct_answer": "B. GLUT 5",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) GLUT 5</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. SGLT: Sodium Dependent Glucose Transporter-1 (SGLT-1) is the transporter in the intestine involved in glucose-galactose malabsorption . For diarrhoea , ORS is given which contains both glucose and sodium \u2192 allows absorption of sodium to replenish body sodium chloride levels and glucose to provide energy.</li><li>\u2022 Option A. SGLT:</li><li>\u2022 transporter</li><li>\u2022 intestine</li><li>\u2022 glucose-galactose</li><li>\u2022 malabsorption</li><li>\u2022 diarrhoea</li><li>\u2022 ORS</li><li>\u2022 both glucose and sodium</li><li>\u2022 absorption of sodium</li><li>\u2022 replenish</li><li>\u2022 body sodium chloride</li><li>\u2022 glucose to provide energy.</li><li>\u2022 Option C. Isomaltose: he cells of brush border of intestine contain sucrase, maltase, Isomaltose and lactase \u2192 which hydrolyze the corresponding disaccharides into monosaccharides , which are then absorbed.</li><li>\u2022 Option C. Isomaltose:</li><li>\u2022 cells of brush border</li><li>\u2022 sucrase, maltase, Isomaltose and lactase</li><li>\u2022 hydrolyze</li><li>\u2022 disaccharides into monosaccharides</li><li>\u2022 absorbed.</li><li>\u2022 Option D.  Lactase: Deficiency of lactase leads to lactose intolerance \u2192 accumulation of lactose in the gut \u2192 Irritant diarrhoea and flatulence. Treatment- withdrawn milk temporarily.</li><li>\u2022 Option D.  Lactase:</li><li>\u2022 Deficiency of lactase</li><li>\u2022 lactose intolerance</li><li>\u2022 accumulation of lactose</li><li>\u2022 Irritant diarrhoea</li><li>\u2022 flatulence.</li><li>\u2022 withdrawn milk temporarily.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 GLUT 5 is a fructose transporter expressed in the intestinal mucosa. A deficiency or defect in GLUT 5 would lead to fructose malabsorption , presenting with symptoms such as abdominal pain, distension, and gas formation after consuming fructose.</li><li>\u27a4 GLUT 5</li><li>\u27a4 fructose</li><li>\u27a4 intestinal mucosa.</li><li>\u27a4 deficiency or defect in GLUT 5</li><li>\u27a4 fructose</li><li>\u27a4 malabsorption</li><li>\u27a4 abdominal pain, distension, and gas formation</li><li>\u27a4 consuming fructose.</li><li>\u27a4 Ref : Vasudevan 9/e: 106-107.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 106-107.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9bf163bf",
      "audio": ""
    },
    {
      "text": "A 58-year-old male with type 2 diabetes starts a new oral hypoglycemic regimen. Soon after, he presents with anxiety, diaphoresis, and hunger, which quickly resolves upon consuming glucose. This clinical scenario underscores the importance of the initial enzymatic step in glycolysis following glucose ingestion. In the context of glycolytic pathway activation for immediate energy production, which enzyme is responsible for catalyzing the first reaction that glucose undergoes in this metabolic pathway?",
      "options": [
        {
          "label": "A",
          "text": "Aldolase and Pyruvate kinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phosphofructokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hexokinase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phosphoglucose isomerase",
          "correct": false
        }
      ],
      "correct_answer": "C. Hexokinase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hexokinase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Aldolase and Pyruvate kinase : These enzymes function in the intermediate to later stages of glycolysis and are not involved in the initial phosphorylation of glucose.</li><li>\u2022 Option A. Aldolase and Pyruvate kinase</li><li>\u2022 intermediate to later stages of glycolysis</li><li>\u2022 not</li><li>\u2022 initial phosphorylation of glucose.</li><li>\u2022 Option B. Phosphofructokinase : This enzyme plays a key regulatory role in glycolysis by converting fructose-6-phosphate to fructose-1,6-bisphosphate , but it is not the first enzyme in the pathway.</li><li>\u2022 Option B. Phosphofructokinase</li><li>\u2022 key</li><li>\u2022 glycolysis</li><li>\u2022 fructose-6-phosphate to fructose-1,6-bisphosphate</li><li>\u2022 not</li><li>\u2022 Option D. Phosphoglucose isomerase : This enzyme acts second in the glycolytic pathway , converting glucose-6-phosphate to fructose-6-phosphate , following the action of hexokinase.</li><li>\u2022 Option D. Phosphoglucose isomerase</li><li>\u2022 enzyme acts</li><li>\u2022 glycolytic pathway</li><li>\u2022 glucose-6-phosphate</li><li>\u2022 to</li><li>\u2022 fructose-6-phosphate</li><li>\u2022 hexokinase.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hexokinase catalyzes the first critical step in the glycolytic pathway by phosphorylating glucose to form glucose-6-phosphate . This reaction is essential for trapping glucose within the cell, enabling its subsequent metabolism in the glycolytic pathway to produce energy, particularly important in the context of restoring normal blood glucose levels after hypoglycemic episodes in diabetic patients.</li><li>\u27a4 Hexokinase catalyzes</li><li>\u27a4 first</li><li>\u27a4 glycolytic pathway</li><li>\u27a4 phosphorylating glucose</li><li>\u27a4 glucose-6-phosphate</li><li>\u27a4 trapping glucose</li><li>\u27a4 enabling</li><li>\u27a4 glycolytic pathway</li><li>\u27a4 energy,</li><li>\u27a4 restoring normal blood glucose levels</li><li>\u27a4 hypoglycemic</li><li>\u27a4 diabetic</li><li>\u27a4 patients.</li><li>\u27a4 Ref : Harper 30/e: p 168-172</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 168-172</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "17526e6a",
      "audio": ""
    },
    {
      "text": "A 42-year-old marathon runner experiences muscle fatigue and laboured breathing post-race. Upon evaluation, a metabolic cycle is considered in understanding her physiological state, as shown below. Which statement is correct regarding the metabolic cycle illustrated?",
      "options": [
        {
          "label": "A",
          "text": "Cahill\u2019s cycle",
          "correct": false
        },
        {
          "label": "B",
          "text": "Location: not seen in RBCs",
          "correct": false
        },
        {
          "label": "C",
          "text": "No re-utilization of lactate for gluconeogenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Energy need explains the oxygen debt after exercise",
          "correct": true
        }
      ],
      "correct_answer": "D. Energy need explains the oxygen debt after exercise",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture1_XU5jYM8.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Energy need explains the oxygen debt after exercise</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cahill\u2019s cycle : It is also know n as glucose-alanine cycle and occurs in fasting muscles .</li><li>\u2022 Option A. Cahill\u2019s cycle</li><li>\u2022 glucose-alanine cycle</li><li>\u2022 fasting muscles .</li><li>\u2022 Option B. Location not seen in RBCs : Lactate is released by exercising skeletal muscle and by cells that lack mitochondria such as RBCs into the blood.</li><li>\u2022 Option B. Location not seen in RBCs</li><li>\u2022 Lactate</li><li>\u2022 exercising skeletal muscle</li><li>\u2022 lack mitochondria</li><li>\u2022 RBCs</li><li>\u2022 blood.</li><li>\u2022 Option C. No re-utilization of lactate for gluconeogenesis : Glucose is converted to lactate in the muscle and in the liver this lactate is re-converted into glucose.</li><li>\u2022 Option C. No re-utilization of lactate for gluconeogenesis</li><li>\u2022 Glucose</li><li>\u2022 lactate in the muscle</li><li>\u2022 liver this lactate</li><li>\u2022 re-converted into glucose.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Cori cycle is energy-intensive, costing 6 ATPs in the liver to resynthesize glucose from 2 lactate molecules . During exercise , the body incurs an \" oxygen debt ,\" as it uses more oxygen to replenish ATP stores and clear the lactate produced, explaining the labored breathing post-exercise.</li><li>\u27a4 Cori cycle</li><li>\u27a4 energy-intensive,</li><li>\u27a4 6 ATPs</li><li>\u27a4 liver</li><li>\u27a4 resynthesize glucose</li><li>\u27a4 2 lactate molecules</li><li>\u27a4 exercise</li><li>\u27a4 oxygen debt</li><li>\u27a4 more oxygen to replenish ATP stores</li><li>\u27a4 clear</li><li>\u27a4 lactate</li><li>\u27a4 labored</li><li>\u27a4 breathing post-exercise.</li><li>\u27a4 Ref : Harper30/e: p 556, Vasudevan 9/ed: p 114</li><li>\u27a4 Ref</li><li>\u27a4 : Harper30/e: p 556, Vasudevan 9/ed: p 114</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "512f16b9",
      "audio": ""
    },
    {
      "text": "In the context of infantile conditions, hypoglycemia is observed in which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Glycogen storage disease type I",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hereditary Fructose intolerance",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both a and b",
          "correct": true
        },
        {
          "label": "D",
          "text": "Only b",
          "correct": false
        }
      ],
      "correct_answer": "C. Both a and b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Both a and b</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Both Glycogen Storage Disease Type I (GSD I) and Hereditary Fructose Intolerance (HFI) can lead to hypoglycemia , particularly in infants.</li><li>\u2022 Glycogen Storage Disease Type I (GSD I)</li><li>\u2022 Hereditary Fructose Intolerance (HFI)</li><li>\u2022 hypoglycemia</li><li>\u2022 Option A:</li><li>\u2022 Option A:</li><li>\u2022 Glycogen Storage Disease Type I (Von Gierke Disease)</li><li>\u2022 Glycogen Storage Disease Type I (Von Gierke Disease)</li><li>\u2022 Caused by a deficiency of glucose-6-phosphatase . This enzyme is crucial for the final step of gluconeogenesis and glycogenolysis , converting glucose-6-phosphate to free glucose. Without it, the liver cannot release glucose into the bloodstream \u2192 severe fasting hypoglycemia , typically noticed shortly after birth.</li><li>\u2022 Caused by a deficiency of glucose-6-phosphatase .</li><li>\u2022 deficiency of glucose-6-phosphatase</li><li>\u2022 This enzyme is crucial for the final step of gluconeogenesis and glycogenolysis , converting glucose-6-phosphate to free glucose.</li><li>\u2022 final step of gluconeogenesis and glycogenolysis</li><li>\u2022 Without it, the liver cannot release glucose into the bloodstream \u2192 severe fasting hypoglycemia , typically noticed shortly after birth.</li><li>\u2022 severe fasting hypoglycemia</li><li>\u2022 Option B: Hereditary Fructose Intolerance (HFI)</li><li>\u2022 Option B: Hereditary Fructose Intolerance (HFI)</li><li>\u2022 Caused by a deficiency of aldolase B . When fructose, sucrose, or sorbitol is introduced (e.g., via formula or weaning), fructose-1-phosphate accumulates , which: Traps phosphate Inhibits glycogenolysis Leads to hypoglycemia and other symptoms like vomiting , hepatomegaly , and failure to thrive .</li><li>\u2022 Caused by a deficiency of aldolase B .</li><li>\u2022 deficiency of aldolase B</li><li>\u2022 When fructose, sucrose, or sorbitol is introduced (e.g., via formula or weaning), fructose-1-phosphate accumulates , which: Traps phosphate Inhibits glycogenolysis</li><li>\u2022 fructose, sucrose, or sorbitol</li><li>\u2022 fructose-1-phosphate accumulates</li><li>\u2022 Traps phosphate Inhibits glycogenolysis</li><li>\u2022 Traps phosphate</li><li>\u2022 Inhibits glycogenolysis</li><li>\u2022 glycogenolysis</li><li>\u2022 Leads to hypoglycemia and other symptoms like vomiting , hepatomegaly , and failure to thrive .</li><li>\u2022 hypoglycemia</li><li>\u2022 vomiting</li><li>\u2022 hepatomegaly</li><li>\u2022 failure to thrive</li><li>\u2022 Note : HFI typically manifests after exposure to fructose-containing foods , so it may not present immediately after birth , but it is a cause of hypoglycemia in infants , especially during weaning.</li><li>\u2022 Note</li><li>\u2022 after exposure to fructose-containing foods</li><li>\u2022 immediately after birth</li><li>\u2022 cause of hypoglycemia in infants</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Be aware of metabolic disorders that can cause hypoglycemia in neonates or infants , particularly:</li><li>\u27a4 metabolic disorders</li><li>\u27a4 hypoglycemia in neonates or infants</li><li>\u27a4 Glycogen Storage Disease Type I (Von Gierke) Hereditary Fructose Intolerance (HFI) Galactosemia Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)</li><li>\u27a4 Glycogen Storage Disease Type I (Von Gierke)</li><li>\u27a4 Glycogen Storage Disease Type I (Von Gierke)</li><li>\u27a4 Hereditary Fructose Intolerance (HFI)</li><li>\u27a4 Hereditary Fructose Intolerance (HFI)</li><li>\u27a4 Galactosemia</li><li>\u27a4 Galactosemia</li><li>\u27a4 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)</li><li>\u27a4 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)</li><li>\u27a4 Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)</li><li>\u27a4 Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)</li><li>\u27a4 Ref : Vasudevan 9/e: 138.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8df42cb7",
      "audio": ""
    },
    {
      "text": "Which of the following laboratory findings are associated with chronic alcoholism?",
      "options": [
        {
          "label": "A",
          "text": "Elevated GGT activity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated ALT activity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased ADH activity",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above.",
          "correct": true
        }
      ],
      "correct_answer": "D. All the above.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)\u00a0 All the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Elevated GGT (Gamma-Glutamyl Transferase) activity: GGT is an enzyme involved in the metabolism of glutathione and is often elevated in alcohol-related liver disease . Its elevation is commonly used as a biomarker for excessive alcohol consumption and liver damage.</li><li>\u2022 Option A. Elevated GGT (Gamma-Glutamyl Transferase) activity:</li><li>\u2022 GGT</li><li>\u2022 metabolism of glutathione</li><li>\u2022 elevated in alcohol-related liver disease</li><li>\u2022 elevation</li><li>\u2022 biomarker for excessive alcohol consumption</li><li>\u2022 liver damage.</li><li>\u2022 Option B. Elevated ALT (Alanine Aminotransferase) activity: ALT is an enzyme found predominantly in the liver . Its elevation in the blood often indicates liver damage , which can occur as a result of chronic alcohol abuse.</li><li>\u2022 Option B. Elevated ALT (Alanine Aminotransferase) activity:</li><li>\u2022 ALT</li><li>\u2022 found</li><li>\u2022 liver</li><li>\u2022 elevation</li><li>\u2022 blood</li><li>\u2022 liver damage</li><li>\u2022 chronic alcohol abuse.</li><li>\u2022 Option C. Decreased ADH (Antidiuretic Hormone) activity: Chronic alcohol consumption can lead to impaired ADH secretion or function , contributing to electrolyte imbalances and an increased risk of dehydration.</li><li>\u2022 Option C. Decreased ADH (Antidiuretic Hormone) activity:</li><li>\u2022 Chronic alcohol consumption</li><li>\u2022 impaired ADH secretion</li><li>\u2022 function</li><li>\u2022 electrolyte imbalances</li><li>\u2022 increased risk of dehydration.</li><li>\u2022 Considering these points, option D) All the above is correct, as each listed factor can be associated with chronic alcoholism and its impact on the body.</li><li>\u2022 option D) All the above is correct,</li><li>\u2022 chronic alcoholism</li><li>\u2022 impact on the body.</li><li>\u2022 Options A, B, and C are individually correct but D encompasses all the possible findings, making it the most comprehensive choice.</li><li>\u2022 Options A, B, and C are</li><li>\u2022 correct</li><li>\u2022 D</li><li>\u2022 all the possible findings,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Increase in serum levels of gamma-glutamyl transferase (GGT) and alanine transaminase (ALT) Decrease in aldehyde dehydrogenase activity (in liver cells and RBCs ) - best marker for alcohol abuse. Disialotransferrin ( sialic acid groups are removed from transferrin ) level in blood- highly sensitive marker for chronic alcohol abuse.</li><li>\u27a4 Increase in serum levels of gamma-glutamyl transferase (GGT) and alanine transaminase (ALT)</li><li>\u27a4 Increase</li><li>\u27a4 gamma-glutamyl transferase (GGT) and alanine transaminase (ALT)</li><li>\u27a4 Decrease in aldehyde dehydrogenase activity (in liver cells and RBCs ) - best marker for alcohol abuse.</li><li>\u27a4 Decrease</li><li>\u27a4 aldehyde dehydrogenase</li><li>\u27a4 liver cells and RBCs</li><li>\u27a4 best</li><li>\u27a4 alcohol abuse.</li><li>\u27a4 Disialotransferrin ( sialic acid groups are removed from transferrin ) level in blood- highly sensitive marker for chronic alcohol abuse.</li><li>\u27a4 Disialotransferrin</li><li>\u27a4 sialic acid</li><li>\u27a4 transferrin</li><li>\u27a4 highly sensitive marker</li><li>\u27a4 chronic</li><li>\u27a4 alcohol abuse.</li><li>\u27a4 Ref : Vasudevan 9/e: 140-141.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 140-141.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "20022bfb",
      "audio": ""
    },
    {
      "text": "A patient with an established diagnosis of diabetes mellitus reports to the clinic for a follow-up, presenting with symptoms of fatigue, weight loss, polyuria, and a burning sensation in the soles. Despite ongoing treatment, his blood glucose levels are significantly elevated. Among the following options, which is LEAST likely to contribute to the hyperglycemia seen in uncontrolled Type 1 diabetes?",
      "options": [
        {
          "label": "A",
          "text": "Decreased skeletal muscle glucose uptake",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased adipose lipogenesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased adipose lipolysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased skeletal muscle Glycogenolysis",
          "correct": true
        }
      ],
      "correct_answer": "D. Increased skeletal muscle Glycogenolysis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Increased skeletal muscle Glycogenolysis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Decreased skeletal muscle glucose uptake : This is a significant contributor to hyperglycaemia in Type 1 diabetes , as insulin deficiency prevents glucose from entering cells, leading to elevated blood glucose levels.</li><li>\u2022 Option A. Decreased skeletal muscle glucose uptake</li><li>\u2022 hyperglycaemia in Type 1 diabetes</li><li>\u2022 insulin deficiency prevents glucose</li><li>\u2022 entering cells,</li><li>\u2022 elevated blood glucose levels.</li><li>\u2022 Option B. Decreased adipose lipogenesis: While decreased formation of fat from glucose in adipose tissue could be observed in insulin deficiency, it's not a direct contributor to elevated glucose levels. Insulin promotes lipogenesis , so its deficiency would decrease this process, but this decrease does not directly cause hyperglycemia.</li><li>\u2022 Option B. Decreased adipose lipogenesis:</li><li>\u2022 decreased formation of fat</li><li>\u2022 insulin deficiency,</li><li>\u2022 not</li><li>\u2022 elevated glucose levels. Insulin</li><li>\u2022 lipogenesis</li><li>\u2022 its deficiency</li><li>\u2022 decrease</li><li>\u2022 decrease does not</li><li>\u2022 hyperglycemia.</li><li>\u2022 Option C. Increased adipose lipolysis: Increased breakdown of fat in the absence of insulin action elevates free fatty acid levels, which can exacerbate insulin resistance and contribute to higher blood glucose levels.</li><li>\u2022 Option C. Increased adipose lipolysis:</li><li>\u2022 Increased breakdown of fat</li><li>\u2022 absence of insulin</li><li>\u2022 elevates free fatty acid levels,</li><li>\u2022 exacerbate insulin resistance</li><li>\u2022 higher blood glucose levels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Skeletal muscle cannot export glucose into the circulation like liver due to absence of enzyme glucose-6-phosphatase. So, intramyocellular glycogen acts as a fuel source for skeletal muscle and doesn\u2019t contribute to the hyperglycaemia in uncontrolled type I diabetes.</li><li>\u27a4 Skeletal muscle cannot</li><li>\u27a4 glucose</li><li>\u27a4 liver</li><li>\u27a4 absence</li><li>\u27a4 glucose-6-phosphatase.</li><li>\u27a4 intramyocellular glycogen</li><li>\u27a4 fuel source for skeletal muscle</li><li>\u27a4 doesn\u2019t</li><li>\u27a4 hyperglycaemia</li><li>\u27a4 uncontrolled</li><li>\u27a4 type I diabetes.</li><li>\u27a4 Reasons of hyperglycemia associated with uncontrolled type I diabetes:</li><li>\u27a4 hyperglycemia</li><li>\u27a4 uncontrolled type I diabetes:</li><li>\u27a4 There will be decreased insulin mediated glucose utilization by skeletal muscle and adipose tissues \u2192 will contribute to hyperglycaemia. There will also be decreased insulin-mediated suppression of hepatic glucose output. Decreased insulin-mediated suppression of lipolysis \u2192 hyperglycaemia , by activation of gluconeogenesis by fatty acid breakdown product acetyl CoA</li><li>\u27a4 There will be decreased insulin mediated glucose utilization by skeletal muscle and adipose tissues \u2192 will contribute to hyperglycaemia.</li><li>\u27a4 decreased insulin mediated glucose</li><li>\u27a4 skeletal muscle and adipose tissues</li><li>\u27a4 hyperglycaemia.</li><li>\u27a4 There will also be decreased insulin-mediated suppression of hepatic glucose output.</li><li>\u27a4 decreased insulin-mediated suppression</li><li>\u27a4 hepatic glucose output.</li><li>\u27a4 Decreased insulin-mediated suppression of lipolysis \u2192 hyperglycaemia , by activation of gluconeogenesis by fatty acid breakdown product acetyl CoA</li><li>\u27a4 Decreased insulin-mediated suppression of lipolysis</li><li>\u27a4 hyperglycaemia</li><li>\u27a4 activation of gluconeogenesis</li><li>\u27a4 fatty acid breakdown product acetyl CoA</li><li>\u27a4 Ref : Harper 30/e:  p 149, DM Vasudevan, 9/e: p 323-326.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 149, DM Vasudevan, 9/e: p 323-326.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6965fcc9",
      "audio": ""
    },
    {
      "text": "A 6-month-old girl presents with developing cataracts, and an inability to track objects visually. Urine tests are positive for reducing sugars but negative for glucose. Which enzyme deficiency is most likely present in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Aldolase B",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fructokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Galactose 1-phosphate uridylyl transferase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Galactokinase",
          "correct": true
        }
      ],
      "correct_answer": "D. Galactokinase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)\u00a0 Galactokinase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Distinguish between types of galactose metabolism disorders :</li><li>\u27a4 types of galactose metabolism disorders</li><li>\u27a4 Galactokinase deficiency : Early-onset cataracts , galactosuria , mild/no systemic symptoms. Classic galactosemia (GALT deficiency) : Severe symptoms including hepatomegaly , vomiting , jaundice , and cataracts . Both cause reducing substances in urine , but galactokinase deficiency is less severe and lacks liver involvement .</li><li>\u27a4 Galactokinase deficiency : Early-onset cataracts , galactosuria , mild/no systemic symptoms.</li><li>\u27a4 Galactokinase deficiency</li><li>\u27a4 cataracts</li><li>\u27a4 galactosuria</li><li>\u27a4 Classic galactosemia (GALT deficiency) : Severe symptoms including hepatomegaly , vomiting , jaundice , and cataracts .</li><li>\u27a4 Classic galactosemia (GALT deficiency)</li><li>\u27a4 Severe symptoms</li><li>\u27a4 hepatomegaly</li><li>\u27a4 vomiting</li><li>\u27a4 jaundice</li><li>\u27a4 cataracts</li><li>\u27a4 Both cause reducing substances in urine , but galactokinase deficiency is less severe and lacks liver involvement .</li><li>\u27a4 Both cause reducing substances in urine</li><li>\u27a4 less severe and lacks liver involvement</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b320fa1",
      "audio": ""
    },
    {
      "text": "A 4-year-old boy experiences headache, dizziness, weakness, and knee joint tenderness after consuming sugarcane juice. Following a diagnosis of Hereditary Fructose Intolerance (HFI), which of the following statements about HFI is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Deficiency of aldolase B.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Accumulation of fructose 1-phosphate in tissues",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hyperglycaemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Liver and kidneys are involved",
          "correct": false
        }
      ],
      "correct_answer": "C. Hyperglycaemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hyperglycaemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Hereditary Fructose Intolerance (HFI) is caused by a deficiency of aldolase B, the enzyme that cleaves fructose 1-phosphate into dihydroxyacetone phosphate (DHAP) and glyceraldehyde.</li><li>\u2022 Hereditary Fructose Intolerance (HFI)</li><li>\u2022 deficiency of aldolase B,</li><li>\u2022 fructose 1-phosphate into dihydroxyacetone phosphate (DHAP) and glyceraldehyde.</li><li>\u2022 In HFI: Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.</li><li>\u2022 In HFI: Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.</li><li>\u2022 Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.</li><li>\u2022 Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.</li><li>\u2022 Fructose 1-phosphate accumulates</li><li>\u2022 Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.</li><li>\u2022 Inhibition of glycogenolysis</li><li>\u2022 Inhibition of glycogenolysis</li><li>\u2022 Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.</li><li>\u2022 hypoglycemia (low blood sugar),</li><li>\u2022 Clinical findings:</li><li>\u2022 Clinical findings:</li><li>\u2022 Hypoglycemia, vomiting, lethargy, abdominal pain after fructose intake. Long-term exposure can cause hepatomegaly, liver dysfunction, and renal involvement.</li><li>\u2022 Hypoglycemia, vomiting, lethargy, abdominal pain after fructose intake.</li><li>\u2022 Long-term exposure can cause hepatomegaly, liver dysfunction, and renal involvement.</li><li>\u2022 hepatomegaly, liver dysfunction, and renal involvement.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Deficiency of aldolase B: True. This is the fundamental enzymatic defect in HFI. Option B. Accumulation of fructose 1-phosphate in tissues: True. This is the hallmark of the disease and leads to metabolic blockages. Option D. Liver and kidneys are involved: True. These organs are significantly affected due to accumulation of fructose 1-phosphate and its toxic effects.</li><li>\u2022 Option A. Deficiency of aldolase B: True. This is the fundamental enzymatic defect in HFI.</li><li>\u2022 Option A. Deficiency of aldolase B:</li><li>\u2022 True.</li><li>\u2022 Option B. Accumulation of fructose 1-phosphate in tissues: True. This is the hallmark of the disease and leads to metabolic blockages.</li><li>\u2022 Option B. Accumulation of fructose 1-phosphate in tissues:</li><li>\u2022 True.</li><li>\u2022 Option D. Liver and kidneys are involved: True. These organs are significantly affected due to accumulation of fructose 1-phosphate and its toxic effects.</li><li>\u2022 Option D. Liver and kidneys are involved:</li><li>\u2022 True.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Biochemical defect in Hereditary Fructose Intolerance</li><li>\u27a4 Deficiency of Fructose-1,6-Bisphosphate Aldolase (Aldolase B)</li><li>\u27a4 Deficiency of this enzyme \u2192 causes accumulation of fructose-1-phosphate \u2192 severe toxic symptoms when a patient is exposed to fructose.</li><li>\u27a4 Clinical manifestations</li><li>\u27a4 Patients with HFI are asymptomatic until fructose or sucrose is ingested (usually from fruit, fruit juice, or sweetened cereal).</li><li>\u27a4 Symptoms may occur early in life, soon after weaning formulas containing these sugars are introduced into the diet.</li><li>\u27a4 Early clinical manifestations include jaundice, hepatomegaly, vomiting, lethargy, irritability, convulsions and hypoglycaemia.</li><li>\u27a4 Ref : Vasudevan 9/e: p 138.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "39a6bbde",
      "audio": ""
    },
    {
      "text": "Assertion (A): A nursing mother with classic Galactosemia is on a galactose-free diet and she is able to produce lactose in breast milk. Reasoning (R): Galactose can be produced from a glucose metabolite by epimerization:",
      "options": [
        {
          "label": "A",
          "text": "A is right but R is a wrong statement",
          "correct": false
        },
        {
          "label": "B",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": true
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": false
        }
      ],
      "correct_answer": "B. A as well as R are right and R is a correct explanation of A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) A as well as R are right, and R is a correct explanation of A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. A is right but R is a wrong statement: This option is incorrect because both the assertion and the reasoning are correct, and the reasoning provides a valid explanation for the assertion.</li><li>\u2022 Option A. A is right but R is a wrong statement:</li><li>\u2022 incorrect</li><li>\u2022 both</li><li>\u2022 assertion</li><li>\u2022 reasoning are correct,</li><li>\u2022 reasoning</li><li>\u2022 valid explanation for the assertion.</li><li>\u2022 Option C. A is wrong, but R is a right statement: This option is incorrect because the assertion is indeed correct; nursing mothers with classic galactosemia on a galactose-free die t can produce lactose in breast milk due to the body's ability to synthesize galactose from glucose.</li><li>\u2022 Option C. A is wrong, but R is a right statement:</li><li>\u2022 incorrect</li><li>\u2022 assertion is indeed correct;</li><li>\u2022 nursing mothers</li><li>\u2022 classic galactosemia</li><li>\u2022 galactose-free die</li><li>\u2022 lactose in breast milk</li><li>\u2022 body's ability to synthesize galactose</li><li>\u2022 glucose.</li><li>\u2022 Option D. A and R both are wrong: This option is incorrect as both the assertion and the reasoning are correct and logically consistent.</li><li>\u2022 Option D. A and R both are wrong:</li><li>\u2022 incorrect</li><li>\u2022 both the assertion</li><li>\u2022 reasoning are correct</li><li>\u2022 logically</li><li>\u2022 consistent.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Galactose can be produced from a glucose metabolite by epimerization. Uridine diphosphate (UDP) glucose is converted to UDP-galactose by UDP hexose 4- epimerase , thereby providing the appropriate form of galactose for lactose synthesis.</li><li>\u27a4 Galactose can be produced from a glucose metabolite by epimerization.</li><li>\u27a4 Galactose</li><li>\u27a4 glucose metabolite by epimerization.</li><li>\u27a4 Uridine diphosphate (UDP) glucose is converted to UDP-galactose by UDP hexose 4- epimerase , thereby providing the appropriate form of galactose for lactose synthesis.</li><li>\u27a4 Uridine diphosphate (UDP)</li><li>\u27a4 glucose</li><li>\u27a4 UDP-galactose</li><li>\u27a4 UDP hexose 4- epimerase</li><li>\u27a4 galactose for lactose synthesis.</li><li>\u27a4 Ref : Harper 30/e: p 155, 203, 205.</li><li>\u27a4 Ref : Harper 30/e: p 155, 203, 205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "90cbee41",
      "audio": ""
    },
    {
      "text": "A 42-year-old visits a local clinic for a routine check-up. The healthcare provider at the clinic performs an Oral Glucose Tolerance Test (OGTT) to assess his glucose metabolism. The results are plotted on a graph showing plasma glucose levels over time after a glucose load. Based on the graph shown, what is your interpretation of the patient\u2019s OGTT results?",
      "options": [
        {
          "label": "A",
          "text": "Symptoms of Diabetes mellitus with inconclusive blood glucose values",
          "correct": false
        },
        {
          "label": "B",
          "text": "Overt Diabetes mellitus",
          "correct": true
        },
        {
          "label": "C",
          "text": "Diabetic nephropathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Follow-up of a case of Diabetes mellitus",
          "correct": false
        }
      ],
      "correct_answer": "B. Overt Diabetes mellitus",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture2%20(2).jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/120.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/121.png"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Based on the graph provided, which shows plasma glucose levels after a glucose load:</li><li>\u2022 The normal curve rises to about 140 mg/dL and then returns to baseline (~90 mg/dL) within 2 hours. The diabetic curve spikes up to ~300 mg/dL at 1 hour and remains significantly elevated (well above 200 mg/dL) even at 2 hours. the Oral Glucose Tolerance Test (OGTT) is interpreted as follows: Normal: Fasting glucose < 100 mg/dL; 2-hour post-load < 140 mg/dL. Impaired glucose tolerance: fasting glucose 100-126 mg/dl; 2-hour post-load 140\u2013199 mg/dL. Diabetes mellitus: Fasting \u2265 126 mg/dL or 2-hour post-load \u2265 200 mg/dL .</li><li>\u2022 The normal curve rises to about 140 mg/dL and then returns to baseline (~90 mg/dL) within 2 hours.</li><li>\u2022 The diabetic curve spikes up to ~300 mg/dL at 1 hour and remains significantly elevated (well above 200 mg/dL) even at 2 hours.</li><li>\u2022 the Oral Glucose Tolerance Test (OGTT) is interpreted as follows:</li><li>\u2022 Normal: Fasting glucose < 100 mg/dL; 2-hour post-load < 140 mg/dL.</li><li>\u2022 Impaired glucose tolerance: fasting glucose 100-126 mg/dl; 2-hour post-load 140\u2013199 mg/dL.</li><li>\u2022 Diabetes mellitus: Fasting \u2265 126 mg/dL or 2-hour post-load \u2265 200 mg/dL .</li><li>\u2022 Interpretation :</li><li>\u2022 Interpretation</li><li>\u2022 The patient's OGTT pattern on the graph matches the diabetic curve (persistent elevation above 200 mg/dL even after 2 hours), clearly meeting criteria for overt diabetes mellitus.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Symptoms of Diabetes mellitus with inconclusive blood glucose values : This applies when symptoms are present but glucose levels don\u2019t conclusively meet diagnostic thresholds (not the case here, where the glucose is clearly high). Option C. Diabetic nephropathy : This is a complication of diabetes involving kidney damage and is not diagnosed by OGTT . OGTT assesses glucose metabolism, not kidney function. Option D. Follow-up of a case of Diabetes mellitus : OGTT is not recommended for follow-up of known diabetes cases. HbA1c, fasting glucose, and self-monitoring of blood glucose are the preferred methods for monitoring glycemic control in diagnosed patients.</li><li>\u2022 Option A. Symptoms of Diabetes mellitus with inconclusive blood glucose values : This applies when symptoms are present but glucose levels don\u2019t conclusively meet diagnostic thresholds (not the case here, where the glucose is clearly high).</li><li>\u2022 Option A. Symptoms of Diabetes mellitus with inconclusive blood glucose values</li><li>\u2022 Option C. Diabetic nephropathy : This is a complication of diabetes involving kidney damage and is not diagnosed by OGTT . OGTT assesses glucose metabolism, not kidney function.</li><li>\u2022 Option C. Diabetic nephropathy</li><li>\u2022 Option D. Follow-up of a case of Diabetes mellitus : OGTT is not recommended for follow-up of known diabetes cases. HbA1c, fasting glucose, and self-monitoring of blood glucose are the preferred methods for monitoring glycemic control in diagnosed patients.</li><li>\u2022 Option D. Follow-up of a case of Diabetes mellitus</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 Difference between normal, impaired, and diabetic glucose values.</li><li>\u27a4 Ref : Harper 30/e:  p 195-196, 205.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "127286ff",
      "audio": ""
    },
    {
      "text": "A 45-year-old male presents with symptoms of excessive thirst, increased appetite, tiredness, and a thin build. He has been advised to undergo fasting blood sugar (FBS) and postprandial blood sugar (PPBS) tests and is currently 12 hours into his fast. During this period of fasting, which one of the following enzymes is likely to be phosphorylated and active?",
      "options": [
        {
          "label": "A",
          "text": "Arginase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fatty acid synthase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycogen synthase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hormone sensitive lipase",
          "correct": true
        }
      ],
      "correct_answer": "D. Hormone sensitive lipase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Hormone sensitive lipase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Arginase: Arginase is an enzyme involved in the urea cycle , which converts arginine into urea and ornithine . Its activity is not directly influenced by fasting or feeding states .</li><li>\u2022 Option A. Arginase:</li><li>\u2022 Arginase</li><li>\u2022 urea cycle</li><li>\u2022 arginine into urea and ornithine</li><li>\u2022 not</li><li>\u2022 fasting or feeding states</li><li>\u2022 Option B. Fatty acid synthase: Fatty acid synthase is involved in the synthesis of fatty acids , a process that is downregulated during fasting when the body is mobilizing , rather than storing, energy.</li><li>\u2022 Option B. Fatty acid synthase:</li><li>\u2022 Fatty acid synthase</li><li>\u2022 synthesis of fatty acids</li><li>\u2022 downregulated</li><li>\u2022 body is mobilizing</li><li>\u2022 rather than storing, energy.</li><li>\u2022 Option C. Glycogen synthase: Glycogen synthase is responsible for glycogen synthesis in the liver and muscle cells . This enzyme is less active during fasting , as the body is breaking down glycogen stores, not building them.</li><li>\u2022 Option C. Glycogen synthase:</li><li>\u2022 glycogen synthesis in the liver and muscle cells</li><li>\u2022 less active</li><li>\u2022 fasting</li><li>\u2022 breaking down glycogen stores, not</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hormone-sensitive lipase (HSL) is an enzyme in adipose tissue that breaks down stored triglycerides into free fatty acids and glycerol , which can then be used for energy . HSL is activated by phosphorylation in response to low insulin and high glucagon levels , which are typical during fasting . Thus, in a fasting state , HSL would be phosphorylated and active to facilitate the mobilization of fat stores .</li><li>\u27a4 Hormone-sensitive lipase (HSL)</li><li>\u27a4 adipose tissue</li><li>\u27a4 stored triglycerides into free fatty acids</li><li>\u27a4 glycerol</li><li>\u27a4 energy</li><li>\u27a4 activated</li><li>\u27a4 phosphorylation</li><li>\u27a4 low insulin and high glucagon levels</li><li>\u27a4 typical during fasting</li><li>\u27a4 fasting state</li><li>\u27a4 HSL</li><li>\u27a4 phosphorylated and active</li><li>\u27a4 mobilization of fat stores</li><li>\u27a4 Ref : Harper 30/e p 261-263</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p 261-263</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e43a903b",
      "audio": ""
    },
    {
      "text": "An Infant diagnosed with Hereditary Fructose Intolerance (HFI) presents with vomiting, diarrhea, abdominal pain, and hypoglycemia upon attempting weaning. Following a positive IV fructose tolerance test, dietary restriction of fructose is advised. Considering the metabolic pathway affected in HFI, which of the following substances should be restricted in the neonate's diet?",
      "options": [
        {
          "label": "A",
          "text": "Galactose",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucose",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lactose",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sucrose",
          "correct": true
        }
      ],
      "correct_answer": "D. Sucrose",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Sucrose</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In Infants with Hereditary Fructose Intolerance (HFI), dietary restriction of sucrose is crucial due to its breakdown into glucose and fructose, the latter of which cannot be metabolized due to aldolase B deficiency, leading to toxic metabolite buildup and hypoglycemia. Other sugars like galactose, glucose, and lactose, which do not directly contribute to these metabolic issues, do not need to be restricted unless other specific metabolic disorders are present.</li><li>\u27a4 Ref: Harper 30/e:  p 202, 205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94bd42c9",
      "audio": ""
    },
    {
      "text": "A 39-year-old female presents with weight loss, fatigue, nocturia, and excessive thirst. Laboratory findings reveal fasting blood sugar (FBS) >140 mg/dl and postprandial blood sugar (PPBS) >250 mg/dl, leading to a probable diagnosis of Type 1 diabetes mellitus. Considering the pathophysiology of Type 1 diabetes mellitus, which of the following statements is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "Increased lipolysis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Decreased protein catabolism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased hepatic Glucose output",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increase glucose uptake",
          "correct": false
        }
      ],
      "correct_answer": "A. Increased lipolysis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Increased lipolysis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Type 1 diabetes mellitus is characterized by an autoimmune destruction of pancreatic \u03b2-cells , leading to absolute insulin deficiency . Insulin normally inhibits lipolysis , so its deficiency in Type 1 diabetes results in increased lipolysis in adipose tissue . This leads to elevated levels of free fatty acids in the bloodstream, which can contribute to the production of ketone bodies in the liver, a common complication in uncontrolled diabetes.</li><li>\u27a4 Type 1 diabetes mellitus</li><li>\u27a4 autoimmune destruction of pancreatic \u03b2-cells</li><li>\u27a4 absolute insulin deficiency</li><li>\u27a4 Insulin</li><li>\u27a4 inhibits lipolysis</li><li>\u27a4 deficiency in Type 1 diabetes</li><li>\u27a4 increased lipolysis in adipose tissue</li><li>\u27a4 elevated levels</li><li>\u27a4 free fatty acids</li><li>\u27a4 ketone bodies in the liver,</li><li>\u27a4 common complication</li><li>\u27a4 uncontrolled diabetes.</li><li>\u27a4 Ref : Harper 30/e:  p 149</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 149</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bbd46b3b",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with Type 1 diabetes mellitus presents with a blood glucose level greater than 300 mg/dl. In the context of his elevated blood glucose, which of the following metabolic processes continues to occur normally in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Increased protein synthesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glycogenesis in muscle",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased conversion of fatty acid to Acetyl CoA",
          "correct": true
        },
        {
          "label": "D",
          "text": "Decreased triglyceride level",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased conversion of fatty acid to Acetyl CoA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Increased conversion of fatty acid to Acetyl CoA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In Type 1 diabetes mellitus with significantly elevated blood glucose (>300 mg/dl), insulin deficiency leads to dramatic metabolic alterations. Without insulin, glucose uptake by peripheral tissues is impaired, leading to hyperglycemia. Simultaneously, the body shifts to alternative fuel sources:</li><li>\u2022 Increased fatty acid mobilization from adipose tissue occurs in insulin deficiency. These fatty acids undergo \u03b2-oxidation in the liver, resulting in increased conversion to Acetyl CoA.</li><li>\u2022 The excess Acetyl CoA cannot enter the TCA cycle efficiently due to low oxaloacetate availability (diverted to gluconeogenesis), and instead is shunted toward ketogenesis, producing ketone bodies (acetoacetate, \u03b2-hydroxybutyrate, and acetone). This leads to diabetic ketoacidosis in uncontrolled Type 1 diabetes.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Increased protein synthesis : Insulin promotes protein synthesis and inhibits protein breakdown. In Type 1 diabetes with insulin deficiency, protein synthesis decreases while proteolysis increases, providing amino acids for gluconeogenesis. This contributes to the catabolic state and muscle wasting seen in poorly controlled diabetes.</li><li>\u2022 Option A. Increased protein synthesis</li><li>\u2022 Option B. Glycogenesis in muscle : This process requires both insulin and adequate glucose transport into muscle cells via GLUT4 transporters. Insulin deficiency impairs GLUT4 translocation to the cell membrane, reducing glucose uptake and subsequent glycogen synthesis in muscle tissue.</li><li>\u2022 Option B. Glycogenesis in muscle</li><li>\u2022 Option D. Decreased triglyceride level - This is incorrect. In Type 1 diabetes with insulin deficiency, triglyceride levels are not decreased but are typically increased due to impaired clearance of triglyceride-rich lipoproteins due to decreased lipoprotein lipase activity (an insulin-dependent enzyme) This often leads to hypertriglyceridemia, not decreased triglyceride levels.</li><li>\u2022 Option D. Decreased triglyceride level</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In uncontrolled Type 1 diabetes with hyperglycemia, insulin deficiency creates a catabolic state where fat mobilization and fatty acid oxidation are accelerated, leading to increased Acetyl CoA production and ketogenesis. This represents a shift from glucose to fat metabolism. Meanwhile, anabolic processes like protein synthesis and glycogenesis are impaired, highlighting the crucial role of insulin in regulating metabolic pathways.</li><li>\u27a4 Ref : Harper 30/e:  p 149, Lippincott: P 340</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd8c09d4",
      "audio": ""
    },
    {
      "text": "A patient with a known history of diabetes mellitus presents to the outpatient department for a routine follow-up appointment after three months. As part of the management and monitoring plan, the healthcare provider requests an HbA1c test, which is crucial for assessing long-term glycemic control. Considering the various methods available for HbA1c estimation, which of the following is considered the most accurate and reliable method?",
      "options": [
        {
          "label": "A",
          "text": "Affinity chromatography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Electrophoresis",
          "correct": false
        },
        {
          "label": "C",
          "text": "High performance liquid chromatography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Isoelectric Focussing",
          "correct": false
        }
      ],
      "correct_answer": "C. High performance liquid chromatography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) High performance liquid chromatography</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Affinity chromatography: While affinity chromatography can be used for HbA1c measurement, it is not as specific or as widely used as HPLC. It relies on the specific binding of HbA1c to a particular substrate, which can be influenced by the presence of hemoglobin variants.</li><li>\u2022 Option A. Affinity chromatography:</li><li>\u2022 HbA1c measurement,</li><li>\u2022 not as specific</li><li>\u2022 widely</li><li>\u2022 HPLC.</li><li>\u2022 specific binding of HbA1c</li><li>\u2022 presence of</li><li>\u2022 hemoglobin variants.</li><li>\u2022 Option B.  Electrophoresis: Electrophoresis can separate different hemoglobin types based on their electric charge, but it is less precise than HPLC for quantifying HbA1c levels and can be affected by the presence of hemoglobin variants.</li><li>\u2022 Option B.  Electrophoresis:</li><li>\u2022 different hemoglobin types</li><li>\u2022 electric charge,</li><li>\u2022 less</li><li>\u2022 HPLC for quantifying HbA1c levels</li><li>\u2022 affected</li><li>\u2022 presence of hemoglobin variants.</li><li>\u2022 Option D. Isoelectric focusing: This technique separates proteins based on their isoelectric points. While it can differentiate various hemoglobin forms , it is not the preferred method for routine HbA1c estimation due to its complexity and the difficulty in quantification.</li><li>\u2022 Option D. Isoelectric focusing:</li><li>\u2022 proteins based</li><li>\u2022 isoelectric</li><li>\u2022 hemoglobin forms</li><li>\u2022 not</li><li>\u2022 routine HbA1c estimation</li><li>\u2022 its complexity</li><li>\u2022 difficulty</li><li>\u2022 quantification.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 High-performance liquid chromatography (HPLC) is widely recognized as the gold standard for HbA1c estimation due to its accuracy, reliability, and reproducibility . HPLC separates various forms of hemoglobin, including HbA1c, based on their charge and size under high pressure , allowing for precise quantification. This method minimizes interference from hemoglobin variants and provides a clear, specific measurement of HbA1c levels , which reflect the average blood glucose concentration over the previous 2-3 months.</li><li>\u27a4 High-performance liquid chromatography (HPLC)</li><li>\u27a4 widely</li><li>\u27a4 gold standard for HbA1c estimation</li><li>\u27a4 accuracy, reliability, and reproducibility</li><li>\u27a4 HPLC</li><li>\u27a4 hemoglobin, including HbA1c,</li><li>\u27a4 their charge and size</li><li>\u27a4 high pressure</li><li>\u27a4 precise quantification.</li><li>\u27a4 minimizes interference from hemoglobin variants</li><li>\u27a4 clear, specific measurement of HbA1c levels</li><li>\u27a4 average blood glucose concentration</li><li>\u27a4 previous 2-3 months.</li><li>\u27a4 Ref : Tietz fundamentals of Clinical Chemistry, 6th edition, page 396</li><li>\u27a4 Ref</li><li>\u27a4 : Tietz fundamentals of Clinical Chemistry, 6th edition, page 396</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e224724",
      "audio": ""
    },
    {
      "text": "Assertion (A): Glucagon is needed for glycogenesis to occur. Reasoning (R): The enzyme glycogen phosphorylase is the rate limiting enzyme for glycogenesis and it is active in phosphorylated form for which glucagon is needed. Evaluate the accuracy of the assertion and reasoning provided.",
      "options": [
        {
          "label": "A",
          "text": "A is right but R is a wrong statement",
          "correct": false
        },
        {
          "label": "B",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": false
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": true
        }
      ],
      "correct_answer": "D. A and R both are wrong",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) A and R both are wrong</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 For glycogenesis, presence of insulin is must, because Insulin is required for dephosphorylation of glycogen synthase enzyme, which is the rate limiting enzyme for glycogenesis. Glycogen synthase is active in a dephosphorylated state.</li><li>\u2022 For glycogenesis, presence of insulin is must, because Insulin is required for dephosphorylation of glycogen synthase enzyme, which is the rate limiting enzyme for glycogenesis.</li><li>\u2022 For glycogenesis,</li><li>\u2022 insulin</li><li>\u2022 dephosphorylation of glycogen synthase</li><li>\u2022 rate limiting enzyme</li><li>\u2022 glycogenesis.</li><li>\u2022 Glycogen synthase is active in a dephosphorylated state.</li><li>\u2022 Glycogen synthase</li><li>\u2022 active</li><li>\u2022 dephosphorylated state.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glycogen phosphorylase is the key enzyme in glycogenolysis, the breakdown of glycogen into glucose-1-phosphate, not glycogenesis. This enzyme is activated in its phosphorylated form, but this activation is triggered by glucagon and adrenaline during fasting or stress, not for promoting glycogen synthesis but for breaking down glycogen into glucose to raise blood glucose levels. Glycogen synthase is the key rate-limiting enzyme in glycogenesis and is regulated by insulin and glucose levels , not glucagon.</li><li>\u27a4 Glycogen phosphorylase</li><li>\u27a4 glycogenolysis,</li><li>\u27a4 breakdown of glycogen</li><li>\u27a4 glucose-1-phosphate,</li><li>\u27a4 not</li><li>\u27a4 glycogenesis.</li><li>\u27a4 phosphorylated</li><li>\u27a4 activation</li><li>\u27a4 glucagon and adrenaline</li><li>\u27a4 fasting or stress, not</li><li>\u27a4 glycogen synthesis</li><li>\u27a4 breaking down glycogen into glucose</li><li>\u27a4 raise blood glucose levels.</li><li>\u27a4 Glycogen synthase</li><li>\u27a4 rate-limiting enzyme in glycogenesis</li><li>\u27a4 insulin and glucose levels</li><li>\u27a4 not glucagon.</li><li>\u27a4 Ref : Harper 30/e: p 142,178-183.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 142,178-183.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c1ac18b9",
      "audio": ""
    },
    {
      "text": "A 25-year-old male presents with complaints of pain in his calves during and after physical activity. Upon further evaluation, including a detailed examination and muscle biopsy, it was noted that there was an increased glycogen accumulation in the muscle tissues. Based on these findings, which of the following enzymes is most likely deficient in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Muscle phosphorylase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Liver phosphorylase kinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucose 6 phosphatase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Branching enzyme",
          "correct": false
        }
      ],
      "correct_answer": "A. Muscle phosphorylase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture14.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture15.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Muscle phosphorylase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B.  Liver phosphorylase kinase: Is a type VIII disorder with hepatomegaly, accumulation of glycogen in liver and mild hypoglycaemia.</li><li>\u2022 Option B.  Liver phosphorylase kinase:</li><li>\u2022 type VIII</li><li>\u2022 hepatomegaly,</li><li>\u2022 glycogen in liver</li><li>\u2022 hypoglycaemia.</li><li>\u2022 Option C. Glucose 6 phosphatase: Is deficient in Von Gierke disease (Ia), C/F includes glycogen accumulation in liver and renal tubule cells, hypoglycaemia, lactic academia, ketosis and hyperlipemia. (No muscle weakness).</li><li>\u2022 Option C. Glucose 6 phosphatase:</li><li>\u2022 deficient</li><li>\u2022 Von Gierke disease (Ia),</li><li>\u2022 glycogen</li><li>\u2022 liver and renal</li><li>\u2022 tubule cells, hypoglycaemia, lactic academia, ketosis and hyperlipemia.</li><li>\u2022 Option D.  Branching enzyme: Is defective in Andersen disease with Hepatosplenomegaly ; accumulation of polysaccharide with few branch points ; death from heart or liver failure before age 5.</li><li>\u2022 Option D.  Branching enzyme:</li><li>\u2022 Andersen disease</li><li>\u2022 Hepatosplenomegaly</li><li>\u2022 polysaccharide</li><li>\u2022 few</li><li>\u2022 branch points</li><li>\u2022 death</li><li>\u2022 heart or liver failure before age 5.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Harper 30/e: P 179.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: P 179.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "982e7c59",
      "audio": ""
    },
    {
      "text": "A 20-year-old male with a history of short stature presents to the clinic with recurrent episodes of hypoglycemia, hepatomegaly, and bleeding tendencies. On examination, the patient also has notable hepatomegaly and enlarged kidneys. Laboratory findings include elevated levels of lactate, cholesterol, triglycerides, and uric acid. Considering the constellation of symptoms and lab findings, which enzyme deficiency is most likely responsible for this patient's clinical presentation?",
      "options": [
        {
          "label": "A",
          "text": "Branching enzyme",
          "correct": false
        },
        {
          "label": "B",
          "text": "Debranching enzyme",
          "correct": false
        },
        {
          "label": "C",
          "text": "Muscle phosphorylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glucose-6-phosphatase",
          "correct": true
        }
      ],
      "correct_answer": "D. Glucose-6-phosphatase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Glucose-6-phosphatase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Branching enzyme: deficiency results in Anderson disease . C/F: failure to thrive, liver failure, and hypotonia.</li><li>\u2022 Option A.  Branching enzyme:</li><li>\u2022 Anderson disease</li><li>\u2022 failure to thrive, liver failure, and hypotonia.</li><li>\u2022 Option B.  Debranching enzyme: deficiency results in Cori disease . C/F: hypoglycemia, hepatomegaly, short-stature, and myopathy.</li><li>\u2022 Option B.  Debranching enzyme:</li><li>\u2022 Cori disease</li><li>\u2022 hypoglycemia, hepatomegaly, short-stature, and myopathy.</li><li>\u2022 Option C. Muscle phosphorylase: deficiency results in McArdle disease. C/F: pain, cramps and myoglobinuria on strenuous exercise.</li><li>\u2022 Option C. Muscle phosphorylase:</li><li>\u2022 McArdle disease.</li><li>\u2022 pain, cramps and myoglobinuria on strenuous exercise.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Von Gierke's disease (Type I glycogen storage disease) , characterized by a deficiency in glucose-6-phosphatase. This enzyme is crucial for the final steps of gluconeogenesis and glycogenolysis, converting glucose-6-phosphate into free glucose . Its deficiency leads to impaired glucose production , resulting in hypoglycemia, and the accumulation of glycogen and fat in the liver and kidneys, causing hepatomegaly and renal enlargement . The increased levels of lactate, cholesterol, triglycerides, and uric acid are also consistent with the metabolic disturbances seen in von Gierke's disease.</li><li>\u27a4 Von Gierke's disease (Type I glycogen storage disease)</li><li>\u27a4 deficiency in glucose-6-phosphatase.</li><li>\u27a4 final steps of gluconeogenesis and glycogenolysis,</li><li>\u27a4 glucose-6-phosphate</li><li>\u27a4 free glucose</li><li>\u27a4 deficiency</li><li>\u27a4 impaired glucose production</li><li>\u27a4 hypoglycemia,</li><li>\u27a4 glycogen and fat</li><li>\u27a4 liver and kidneys,</li><li>\u27a4 hepatomegaly and renal enlargement</li><li>\u27a4 increased</li><li>\u27a4 lactate, cholesterol, triglycerides,</li><li>\u27a4 uric acid</li><li>\u27a4 metabolic disturbances</li><li>\u27a4 von Gierke's disease.</li><li>\u27a4 Ref : Harper 30/e:  p 179,355</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 179,355</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8bcb1994",
      "audio": ""
    },
    {
      "text": "In a pediatric grand rounds presentation, a challenging case involving a 6-month-old infant with recurrent episodes of early morning hypoglycemia is discussed. The attending physician explains that administering glucagon raised the infant's blood glucose levels when fed but was ineffective during fasting periods. A liver biopsy revealed abnormal glycogen accumulation. The audience, consisting of pediatricians JRs, is then asked to determine the enzyme deficiency responsible for the infant's condition based on the clinical findings?",
      "options": [
        {
          "label": "A",
          "text": "Debranching enzyme",
          "correct": true
        },
        {
          "label": "B",
          "text": "Muscle phosphorylase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucose-6-phosphatase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Branching enzyme",
          "correct": false
        }
      ],
      "correct_answer": "A. Debranching enzyme",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)\u00a0 Debranching enzyme</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Muscle phosphorylase : Type V \u2013 McArdle\u2019s syndrome; Poor exercise tolerance with high muscle glycogen and low blood lactate after exercise.</li><li>\u2022 Option B. Muscle phosphorylase</li><li>\u2022 Type V \u2013 McArdle\u2019s syndrome; Poor exercise tolerance</li><li>\u2022 high muscle glycogen</li><li>\u2022 low blood</li><li>\u2022 lactate</li><li>\u2022 Option C. Glucose-6-phosphatase: Is deficient in Von Gierke disease (Ia) ,C/F includes glycogen accumulation in liver and renal t ubule cells , hypoglycaemia, lactic academia , ketosis and hyperlipidemia.</li><li>\u2022 Option C. Glucose-6-phosphatase:</li><li>\u2022 deficient in Von Gierke disease (Ia)</li><li>\u2022 glycogen accumulation in liver</li><li>\u2022 renal</li><li>\u2022 ubule cells</li><li>\u2022 hypoglycaemia, lactic academia</li><li>\u2022 ketosis and hyperlipidemia.</li><li>\u2022 Option D. Branching enzyme: Is defective in Anderson disease with Hepatosplenomegaly; accumulation of polysaccharide with few branch points; death from heart or liver failure before age 5.</li><li>\u2022 Option D. Branching enzyme:</li><li>\u2022 defective in Anderson disease</li><li>\u2022 Hepatosplenomegaly;</li><li>\u2022 polysaccharide</li><li>\u2022 few</li><li>\u2022 branch</li><li>\u2022 death from heart or liver failure</li><li>\u2022 age 5.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical features of Type III Glycogen Storage Disease (Cori's or Forbes' Disease) caused by a deficiency in the debranching enzyme, leading to impaired glycogenolysis , glycogen accumulation in the liver, and fasting hypoglycemia.</li><li>\u27a4 Type III Glycogen Storage Disease (Cori's or Forbes' Disease)</li><li>\u27a4 deficiency</li><li>\u27a4 debranching</li><li>\u27a4 impaired glycogenolysis</li><li>\u27a4 glycogen accumulation</li><li>\u27a4 liver, and fasting hypoglycemia.</li><li>\u27a4 Ref : Harper 30/e: p 179.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 179.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d9195b1",
      "audio": ""
    },
    {
      "text": "Which of the following statements about mitochondria is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Glycolytic enzymes are in mitochondrial matrix",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inner mitochondrial membrane contains enzymes of electron transport chain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fluid matrix contains enzymes of TCA cycle",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acyl-CoA synthetase in localized in the outer mitochondrial membrane",
          "correct": false
        }
      ],
      "correct_answer": "A. Glycolytic enzymes are in mitochondrial matrix",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture7.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Glycolytic enzymes are in mitochondrial matrix</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: The inner mitochondrial membrane contains enzymes of the electron transport chain: This is true . The inner mitochondrial membrane is the site of the electron transport chain , where ATP is synthesized.</li><li>\u2022 Option B:</li><li>\u2022 The inner mitochondrial membrane contains enzymes of the electron transport chain:</li><li>\u2022 true</li><li>\u2022 inner mitochondrial membrane</li><li>\u2022 electron transport chain</li><li>\u2022 ATP is synthesized.</li><li>\u2022 Option C : The fluid matrix contains enzymes of the TCA cycle: This is also true . The mitochondrial matrix houses enzymes of the TCA cycle, which is involved in energy production.</li><li>\u2022 Option C</li><li>\u2022 : The fluid matrix contains enzymes of the TCA cycle:</li><li>\u2022 true</li><li>\u2022 mitochondrial matrix</li><li>\u2022 TCA cycle,</li><li>\u2022 energy production.</li><li>\u2022 Option D: Acyl-CoA synthetase is localized in the outer mitochondrial membrane: True, acyl-CoA synthetase , involved in fatty acid metabolism, is found on the outer mitochondrial membrane.</li><li>\u2022 Option D:</li><li>\u2022 Acyl-CoA synthetase is localized in the outer mitochondrial membrane:</li><li>\u2022 True, acyl-CoA synthetase</li><li>\u2022 fatty acid</li><li>\u2022 metabolism,</li><li>\u2022 outer mitochondrial membrane.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 LOCATION OF ENZYMES IN MITOCHONDRIA</li><li>\u27a4 LOCATION OF ENZYMES IN MITOCHONDRIA</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 259.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 259.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "140c7786",
      "audio": ""
    },
    {
      "text": "The diagram below represents the various fates of pyruvate. Which letter on the diagram shows the reaction requiring biotin as a cofactor and is activated by acetylcoenzyme A?",
      "options": [
        {
          "label": "A",
          "text": "B",
          "correct": false
        },
        {
          "label": "B",
          "text": "C",
          "correct": true
        },
        {
          "label": "C",
          "text": "D",
          "correct": false
        },
        {
          "label": "D",
          "text": "A",
          "correct": false
        }
      ],
      "correct_answer": "B. C",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture9.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) C</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. B: Denotes PDH present in mitochondria, which oxidatively decarboxylates pyruvate to acetyl CoA.</li><li>\u2022 Option A. B:</li><li>\u2022 PDH present in mitochondria,</li><li>\u2022 oxidatively decarboxylates pyruvate to acetyl CoA.</li><li>\u2022 Option C. D: Denotes ALT. Alanine is formed by transamination of pyruvate by the enzyme alanine aminotransferase (ALT), which requires PLP.</li><li>\u2022 Option C. D:</li><li>\u2022 ALT.</li><li>\u2022 transamination of pyruvate</li><li>\u2022 alanine aminotransferase (ALT),</li><li>\u2022 PLP.</li><li>\u2022 Pyruvate + Glutamate \u2192 Alanine + alpha ketoglutarate</li><li>\u2022 Pyruvate + Glutamate \u2192 Alanine + alpha ketoglutarate</li><li>\u2022 Option D. A: Pyruvate kinase dephosphorylates phosphoenolpyruvate to pyruvate, which is a substrate level key glycolytic enzyme.</li><li>\u2022 Option D. A:</li><li>\u2022 Pyruvate kinase dephosphorylates phosphoenolpyruvate to pyruvate,</li><li>\u2022 substrate</li><li>\u2022 glycolytic enzyme.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The role of biotin is a cofactor in the carboxylation reaction catalyzed by pyruvate carboxylase and how acetyl-CoA serves as an allosteric activator of the enzyme, linking the state of cellular energy to gluconeogenesis.</li><li>\u27a4 biotin is a cofactor</li><li>\u27a4 carboxylation</li><li>\u27a4 pyruvate carboxylase</li><li>\u27a4 acetyl-CoA</li><li>\u27a4 allosteric activator</li><li>\u27a4 state of cellular energy to gluconeogenesis.</li><li>\u27a4 Ref : Harper 30/e: p 165,166.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 165,166.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3cbf6245",
      "audio": ""
    },
    {
      "text": "A medical student is studying the unique metabolic pathways of erythrocytes (red blood cells). Due to the absence of mitochondria, erythrocytes rely on glycolysis for ATP production. Within this context, the student is interested in the yield of ATP from glucose through the Rapoport-Luebering cycle. What is the net gain of ATP by this cycle in red blood cells from one molecule of glucose?",
      "options": [
        {
          "label": "A",
          "text": "1",
          "correct": false
        },
        {
          "label": "B",
          "text": "2",
          "correct": false
        },
        {
          "label": "C",
          "text": "0",
          "correct": true
        },
        {
          "label": "D",
          "text": "4",
          "correct": false
        }
      ],
      "correct_answer": "C. 0",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 Understand RBC Metabolism: Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis. Learn the Rapoport-Luebering Cycle: Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.</li><li>\u27a4 Understand RBC Metabolism: Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.</li><li>\u27a4 Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.</li><li>\u27a4 Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.</li><li>\u27a4 Learn the Rapoport-Luebering Cycle: Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.</li><li>\u27a4 Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.</li><li>\u27a4 Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.</li><li>\u27a4 Ref : Harper 30/e p173, 174</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8c175ba3",
      "audio": ""
    },
    {
      "text": "A 6-year-old boy presents with hemolytic anemia, and further investigation reveals a deficiency in hexokinase, a key enzyme in the glycolytic pathway, leading to the premature destruction of energy-depleted red blood cells (RBCs). Which of the following statements about hexokinase is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "Has higher affinity to glucose compared to glucokinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Has higher Km to glucose compared to glucokinase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Involved in providing glucose to the peripheral tissues",
          "correct": false
        },
        {
          "label": "D",
          "text": "Not involved in glucose storage by the liver",
          "correct": false
        }
      ],
      "correct_answer": "B. Has higher Km to glucose compared to glucokinase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture18_qXRYnGM.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Has higher Km to glucose compared to Glucokinase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Has higher affinity to glucose compared to Glucokinase.</li><li>\u2022 Option A:</li><li>\u2022 higher affinity</li><li>\u2022 glucose</li><li>\u2022 Option C: Involved in providing glucose to the peripheral tissues.</li><li>\u2022 Option C:</li><li>\u2022 glucose to the peripheral tissues.</li><li>\u2022 Option D: Not involved in glucose storage by the liver</li><li>\u2022 Option D:</li><li>\u2022 Not</li><li>\u2022 glucose storage by the liver</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glucose to glucose-6-phosphate is converted by either Glucokinase or hexokinase</li><li>\u27a4 Ref : Harper 30/e: p 191-192.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 191-192.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf69b729",
      "audio": ""
    },
    {
      "text": "A pediatric team is evaluating a 6-month-old full-term baby girl who presents with failure to thrive, hypotonia, decreased muscle mass, head lag, and metabolic acidosis. Her blood work shows elevated levels of lactate, pyruvate, and alanine. These clinical findings suggest a deficiency in a key metabolic enzyme. Which enzyme is most likely to be deficient in this infant, given her clinical and laboratory presentation?",
      "options": [
        {
          "label": "A",
          "text": "Alanine aminotransferase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lactate dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pyruvate carboxylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pyruvate dehydrogenase",
          "correct": true
        }
      ],
      "correct_answer": "D. Pyruvate dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Pyruvate dehydrogenase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alanine aminotransferase: This enzyme is involved in the transamination of alanine to pyruvate . A deficiency would not likely result in elevated levels of pyruvate or lactate.</li><li>\u2022 Option A. Alanine aminotransferase:</li><li>\u2022 transamination of alanine to pyruvate</li><li>\u2022 deficiency</li><li>\u2022 not</li><li>\u2022 elevated levels of pyruvate or lactate.</li><li>\u2022 Option B. Lactate dehydrogenase: A deficiency in this enzyme would typically lead to lower levels of lactate , not higher.</li><li>\u2022 Option B. Lactate dehydrogenase:</li><li>\u2022 deficiency</li><li>\u2022 lower levels of lactate</li><li>\u2022 Option C. Pyruvate carboxylase: While this enzyme is involved in gluconeogenesis , its deficiency usually leads to hypoglycemia and does not typically cause elevated lactate levels.</li><li>\u2022 Option C. Pyruvate carboxylase:</li><li>\u2022 gluconeogenesis</li><li>\u2022 deficiency</li><li>\u2022 hypoglycemia</li><li>\u2022 does not</li><li>\u2022 elevated lactate levels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pyruvate dehydrogenase deficiency is characterized by the accumulation of pyruvate that cannot be effectively converted into acetyl CoA, leading to its reduction to lactate resulting in lactic acidosis and transamination to alanine</li><li>\u27a4 Pyruvate dehydrogenase deficiency</li><li>\u27a4 accumulation of pyruvate</li><li>\u27a4 cannot</li><li>\u27a4 acetyl CoA,</li><li>\u27a4 reduction to lactate</li><li>\u27a4 lactic acidosis</li><li>\u27a4 transamination to alanine</li><li>\u27a4 Ref : Vasudevan 9/e: p115-116,253-254.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: p115-116,253-254.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "82f636dd",
      "audio": ""
    },
    {
      "text": "In a fitness center, a personal trainer discusses with a client the metabolic changes that occur during intense aerobic workouts. The trainer explains how the body metabolizes glucose to meet the increased energy demands of vigorous exercise. The conversation leads to a question about the form in which carbon atoms from glucose enter the tricarboxylic acid (TCA) cycle during such high-energy activities. What is the correct form in which these carbons enter the TCA cycle?",
      "options": [
        {
          "label": "A",
          "text": "Citrate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oxaloacetate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetyl-CoA",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pyruvate",
          "correct": false
        }
      ],
      "correct_answer": "C. Acetyl-CoA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Acetyl-CoA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Citrate: Oxaloacetate condenses with acetyl CoA entering TCA cycle to form citrate (a tricarboxylic molecule ) (inside TCA cycle ) with the help of the enzyme citrate synthase.</li><li>\u2022 Option A. Citrate:</li><li>\u2022 Oxaloacetate</li><li>\u2022 acetyl CoA entering TCA cycle</li><li>\u2022 citrate</li><li>\u2022 tricarboxylic molecule</li><li>\u2022 TCA</li><li>\u2022 cycle</li><li>\u2022 enzyme citrate synthase.</li><li>\u2022 Option B. Oxaloacetate: Pyruvate is carboxylated to oxaloacetate which is then used for gluconeogenesis.</li><li>\u2022 Option B. Oxaloacetate:</li><li>\u2022 Pyruvate</li><li>\u2022 carboxylated</li><li>\u2022 oxaloacetate</li><li>\u2022 used for gluconeogenesis.</li><li>\u2022 Option D. Pyruvate: Glucose is converted to pyruvate which is then converted to acetyl-CoA \u2192 enter TCA cycle and Pyruvate as such cannot enter TCA cycle.</li><li>\u2022 Option D. Pyruvate:</li><li>\u2022 Glucose</li><li>\u2022 converted</li><li>\u2022 pyruvate</li><li>\u2022 converted to acetyl-CoA</li><li>\u2022 enter TCA cycle</li><li>\u2022 Pyruvate</li><li>\u2022 cannot enter TCA cycle.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In aerobic glycolysis , glucose is converted into pyruvate \u2192 then c onverted to Acetyl-CoA , which actually enters the citric acid cycle. Two Acetyl-CoA , each containing two of the glucose\u2019s carbons , are formed from each glucose molecule.</li><li>\u27a4 In aerobic glycolysis , glucose is converted into pyruvate \u2192 then c onverted to Acetyl-CoA , which actually enters the citric acid cycle.</li><li>\u27a4 aerobic glycolysis</li><li>\u27a4 glucose</li><li>\u27a4 pyruvate</li><li>\u27a4 onverted to Acetyl-CoA</li><li>\u27a4 enters the citric</li><li>\u27a4 acid cycle.</li><li>\u27a4 Two Acetyl-CoA , each containing two of the glucose\u2019s carbons , are formed from each glucose molecule.</li><li>\u27a4 Two Acetyl-CoA</li><li>\u27a4 two of the glucose\u2019s carbons</li><li>\u27a4 each</li><li>\u27a4 glucose molecule.</li><li>\u27a4 Ref : Lippincott 7/e: P 96-98.</li><li>\u27a4 Ref</li><li>\u27a4 : Lippincott 7/e: P 96-98.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "add4585f",
      "audio": ""
    },
    {
      "text": "Examines the following diagram, illustrating the PDH complex and its enzymatic components, labelled A, B, and C What is the name of enzyme component 'C' within the PDH complex?",
      "options": [
        {
          "label": "A",
          "text": "Pyruvate dehydrogenase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dihydrolipoyl Transacetylase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lipoamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dihydrolipoyl dehydrogenase",
          "correct": true
        }
      ],
      "correct_answer": "D. Dihydrolipoyl dehydrogenase",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture21_2waVOtU.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Dihydrolipoyl dehydrogenase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pyruvate dehydrogenase: This is the first enzyme in the complex and is responsible for the decarboxylation of pyruvate.</li><li>\u2022 Option A. Pyruvate dehydrogenase:</li><li>\u2022 first enzyme</li><li>\u2022 complex</li><li>\u2022 decarboxylation of pyruvate.</li><li>\u2022 Option B. Dihydrolipoyl transacetylase: The second enzyme in the complex, responsible for transferring the acetyl group to CoA to form acetyl-CoA.</li><li>\u2022 Option B. Dihydrolipoyl transacetylase:</li><li>\u2022 second enzyme</li><li>\u2022 complex,</li><li>\u2022 transferring the acetyl group to CoA</li><li>\u2022 form acetyl-CoA.</li><li>\u2022 Option C. Lipoamide: Not an enzyme but rather a cofactor bound to the enzymes in the PDH complex.</li><li>\u2022 Option C. Lipoamide:</li><li>\u2022 Not</li><li>\u2022 cofactor bound</li><li>\u2022 PDH complex.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The enzyme part of the PDH complex is made up of three component enzymes. PYRUVATE DEHYDROGENASE (ENZYME 1): Catalyses oxidative decarboxylation; Coenzyme: TPP; Enzyme bound hydroxyethyl TPP is formed DIHYDRO LIPOYL TRANSACETYLASE (ENZYME 2): Hydroxyethyl group is oxidized to form acetyl group \u2192 transferred from TPP to lipoamide \u2192 acetyl lipoamide. DIHYDROLIPOYL DEHYDROGENASE (ENZYME 3): Oxidation of lipoamide; cofactors: TPP, lipoamide and FAD are regenerated</li><li>\u27a4 The enzyme part of the PDH complex is made up of three component enzymes.</li><li>\u27a4 PDH complex</li><li>\u27a4 three component enzymes.</li><li>\u27a4 PYRUVATE DEHYDROGENASE (ENZYME 1): Catalyses oxidative decarboxylation; Coenzyme: TPP; Enzyme bound hydroxyethyl TPP is formed</li><li>\u27a4 PYRUVATE DEHYDROGENASE (ENZYME 1):</li><li>\u27a4 DIHYDRO LIPOYL TRANSACETYLASE (ENZYME 2): Hydroxyethyl group is oxidized to form acetyl group \u2192 transferred from TPP to lipoamide \u2192 acetyl lipoamide.</li><li>\u27a4 DIHYDRO LIPOYL TRANSACETYLASE (ENZYME 2):</li><li>\u27a4 DIHYDROLIPOYL DEHYDROGENASE (ENZYME 3): Oxidation of lipoamide; cofactors: TPP, lipoamide and FAD are regenerated</li><li>\u27a4 DIHYDROLIPOYL DEHYDROGENASE (ENZYME 3):</li><li>\u27a4 Ref : Harper 30/e: p 173, Vasudevan 9/ ed: p 115</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 173, Vasudevan 9/ ed: p 115</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "718632f3",
      "audio": ""
    },
    {
      "text": "Which of the following statements about the oxidative decarboxylation of pyruvate to acetyl CoA is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "PDH complex is analogous to \u03b1-ketoglutarate dehydrogenase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fat can be converted to glucose, because PDH cycle is reversible",
          "correct": true
        },
        {
          "label": "C",
          "text": "TPP, lipoic acid, coenzyme A, FAD, NAD are the coenzymes involved",
          "correct": false
        },
        {
          "label": "D",
          "text": "PDH defect leads to lactic acidosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Fat can be converted to glucose, because PDH cycle is reversible",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Fat can be converted to glucose, because PDH cycle is reversible</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A: True , the PDH complex is analogous to the \u03b1-ketoglutarate dehydrogenase complex in terms of function and coenzyme requirements.</li><li>\u2022 Option A:</li><li>\u2022 True</li><li>\u2022 PDH complex</li><li>\u2022 analogous</li><li>\u2022 \u03b1-ketoglutarate dehydrogenase complex</li><li>\u2022 function and coenzyme</li><li>\u2022 Option C: True , these coenzymes are all involved in the function of the PDH complex.</li><li>\u2022 Option C:</li><li>\u2022 True</li><li>\u2022 coenzymes</li><li>\u2022 function</li><li>\u2022 PDH complex.</li><li>\u2022 Option D: True, a defect in the PDH complex can lead to lactic acidosis because pyruvate is then preferentially converted to lactate by lactate dehydrogenase .</li><li>\u2022 Option D:</li><li>\u2022 True,</li><li>\u2022 PDH complex</li><li>\u2022 lactic acidosis</li><li>\u2022 pyruvate</li><li>\u2022 converted to lactate</li><li>\u2022 lactate dehydrogenase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The conversion of pyruvate to acetyl CoA via the PDH complex is an irreversible step in metabolism. This means that fat, which is broken down into acetyl CoA, cannot be converted back to glucose through this pathway. This is a fundamental concept in metabolism, as it explains why fatty acids cannot undergo gluconeogenesis to form glucose.</li><li>\u27a4 conversion of pyruvate to acetyl CoA</li><li>\u27a4 PDH complex</li><li>\u27a4 irreversible</li><li>\u27a4 fat,</li><li>\u27a4 broken down into acetyl CoA,</li><li>\u27a4 cannot</li><li>\u27a4 back</li><li>\u27a4 glucose</li><li>\u27a4 fundamental</li><li>\u27a4 fatty acids cannot</li><li>\u27a4 gluconeogenesis to form glucose.</li><li>\u27a4 Ref : Harper 30/e: p 173, Vasudevan 9/ ed: p 115</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 173, Vasudevan 9/ ed: p 115</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c1ea466",
      "audio": ""
    },
    {
      "text": "A neurology team is managing a 2-month-old boy with neurological symptoms and lactic acidosis. To determine the underlying metabolic issue, they perform an enzyme assay on extracts from the patient's cultured skin fibroblasts, assessing the activity of the pyruvate dehydrogenase (PDH) complex. They find that the complex operates at only 5% of the normal activity with a standard amount of thiamine pyrophosphate (TPP) but achieves 80% of normal activity with a much higher TPP concentration. What is the correct interpretation concerning the patient's condition and potential interventions?",
      "options": [
        {
          "label": "A",
          "text": "Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms.",
          "correct": true
        },
        {
          "label": "B",
          "text": "A high carbohydrate diet would be expected to be beneficial for this patient.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Citrate production from aerobic glycolysis is expected to be increased.",
          "correct": false
        },
        {
          "label": "D",
          "text": "PDH kinase, a regulatory enzyme of the PDH complex, is expected to be active.",
          "correct": false
        }
      ],
      "correct_answer": "A. Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thiamine (Vitamin B1) is the precursor for TPP , a coenzyme for PDH complex, \u03b1-ketoglutarate dehydrogenase, and transketolase . Some PDH deficiencies are thiamine-responsive , especially those with a mutated E1 subunit that has a high Km for TPP . Thiamine therapy can significantly reduce serum lactate and improve neurological symptoms in responsive cases</li><li>\u27a4 Thiamine (Vitamin B1) is the precursor for TPP , a coenzyme for PDH complex, \u03b1-ketoglutarate dehydrogenase, and transketolase .</li><li>\u27a4 Thiamine (Vitamin B1)</li><li>\u27a4 TPP</li><li>\u27a4 PDH complex, \u03b1-ketoglutarate dehydrogenase, and transketolase</li><li>\u27a4 Some PDH deficiencies are thiamine-responsive , especially those with a mutated E1 subunit that has a high Km for TPP .</li><li>\u27a4 PDH deficiencies are thiamine-responsive</li><li>\u27a4 mutated E1 subunit</li><li>\u27a4 high Km for TPP</li><li>\u27a4 Thiamine therapy can significantly reduce serum lactate and improve neurological symptoms in responsive cases</li><li>\u27a4 Thiamine therapy</li><li>\u27a4 serum lactate</li><li>\u27a4 neurological symptoms</li><li>\u27a4 Ref : Harper 30/e: p 165-167, 174.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6b78d16",
      "audio": ""
    },
    {
      "text": "A genetic counselor is discussing the potential impact of enzyme deficiencies on metabolic pathways with a couple awaiting the birth of their child. The counselor explains that certain genetic conditions can disrupt normal metabolic processes. She asks the couple to consider the statement: \"A defect in the pyruvate dehydrogenase (PDH) complex can lead to lactic acidosis.\" Is this statement true or false?",
      "options": [
        {
          "label": "A",
          "text": "True",
          "correct": true
        },
        {
          "label": "B",
          "text": "False",
          "correct": false
        },
        {
          "label": "C",
          "text": "Information Insufficient",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. True",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) True</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 A PDH defect can indeed lead to lactic acidosis. The PDH complex is responsible for converting pyruvate to acetyl CoA, a step that links glycolysis to the citric acid cycle . If PDH is deficient or defective , pyruvate cannot effectively enter the citric acid cycle and is instead converted to lactate by lactate dehydrogenase. This can lead to an accumulation of lactate in the blood, resulting in lactic acidosis.</li><li>\u2022 PDH defect</li><li>\u2022 lactic acidosis.</li><li>\u2022 PDH complex</li><li>\u2022 converting pyruvate to acetyl CoA,</li><li>\u2022 links glycolysis to the citric acid cycle</li><li>\u2022 PDH is deficient or defective</li><li>\u2022 pyruvate cannot</li><li>\u2022 enter</li><li>\u2022 citric acid cycle</li><li>\u2022 converted to lactate by lactate dehydrogenase.</li><li>\u2022 accumulation of lactate</li><li>\u2022 lactic</li><li>\u2022 acidosis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Significance of PDH Complex</li><li>\u27a4 Significance of PDH Complex</li><li>\u27a4 Thiamine deficiency affect PDH and thereby the complete oxidation of Glucose PDH defect can lead to Lactic Acidosis due to excess of pyruvate and conversion to lactate instead of acetyl CoA Fat cannot be converted to glucose because of the irreversible nature of PDH</li><li>\u27a4 Thiamine deficiency affect PDH and thereby the complete oxidation of Glucose</li><li>\u27a4 Thiamine deficiency</li><li>\u27a4 PDH</li><li>\u27a4 complete oxidation of Glucose</li><li>\u27a4 PDH defect can lead to Lactic Acidosis due to excess of pyruvate and conversion to lactate instead of acetyl CoA</li><li>\u27a4 PDH defect</li><li>\u27a4 Lactic Acidosis</li><li>\u27a4 excess of pyruvate</li><li>\u27a4 conversion to lactate</li><li>\u27a4 Fat cannot be converted to glucose because of the irreversible nature of PDH</li><li>\u27a4 Fat</li><li>\u27a4 cannot</li><li>\u27a4 glucose</li><li>\u27a4 irreversible nature of PDH</li><li>\u27a4 Ref : Vasudevan 9/e p:115-117.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e p:115-117.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "739c47d2",
      "audio": ""
    },
    {
      "text": "PG Junior Residents of Biochemistry department are discussing a complex case of metabolic disorder; a debate arises regarding the metabolic flexibility of pyruvate under various physiological conditions. A senior consultant poses a question to the team to clarify the understanding of pyruvate metabolism. Which of the following is a fate of pyruvate in human metabolism?",
      "options": [
        {
          "label": "A",
          "text": "To Glucose",
          "correct": false
        },
        {
          "label": "B",
          "text": "To Lactate",
          "correct": false
        },
        {
          "label": "C",
          "text": "To Oxaloacetate",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All the above",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture23.jpg"
      ],
      "explanation": "<p><strong>Ans. D) All the above</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The major fates of pyruvate in human metabolism include:</li><li>\u27a4 Conversion to glucose through gluconeogenesis (pyruvate carboxylase) Reduction to lactate under anaerobic conditions (lactate dehydrogenase) Carboxylation to oxaloacetate for the TCA cycle or gluconeogenesis (pyruvate carboxylase) Oxidative decarboxylation to acetyl-CoA (pyruvate dehydrogenase complex) Transamination to form alanine (alanine aminotransferase)</li><li>\u27a4 Conversion to glucose through gluconeogenesis (pyruvate carboxylase)</li><li>\u27a4 Reduction to lactate under anaerobic conditions (lactate dehydrogenase)</li><li>\u27a4 Carboxylation to oxaloacetate for the TCA cycle or gluconeogenesis (pyruvate carboxylase)</li><li>\u27a4 Oxidative decarboxylation to acetyl-CoA (pyruvate dehydrogenase complex)</li><li>\u27a4 Transamination to form alanine (alanine aminotransferase)</li><li>\u27a4 Ref : Vasudevan 9/e p:117.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "257e286d",
      "audio": ""
    },
    {
      "text": "A 1-year-old child, while playing, accidentally ingests a small amount of rat poison containing fluoroacetate, found in the cupboard. This substance reacts with oxaloacetate to produce fluorocitrate. Which major metabolic pathway is most likely to be inhibited by this poison?",
      "options": [
        {
          "label": "A",
          "text": "ETC",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glycolysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "HMP shunt",
          "correct": false
        },
        {
          "label": "D",
          "text": "TCA Cycle",
          "correct": true
        }
      ],
      "correct_answer": "D. TCA Cycle",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) TCA Cycle</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fluorocitrate , formed from the reaction of fluoroacetate with oxaloacetate, is a potent inhibitor of the TCA cycle . It specifically inhibits aconitase , an enzyme in the TCA cycle , thereby blocking the conversion of citrate to isocitrate and disrupting cellular energy production.</li><li>\u27a4 Fluorocitrate</li><li>\u27a4 fluoroacetate with oxaloacetate,</li><li>\u27a4 potent inhibitor</li><li>\u27a4 TCA cycle</li><li>\u27a4 inhibits aconitase</li><li>\u27a4 TCA cycle</li><li>\u27a4 blocking</li><li>\u27a4 citrate to isocitrate</li><li>\u27a4 disrupting</li><li>\u27a4 energy production.</li><li>\u27a4 Ref : Harper 30/e: p 161-163.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 161-163.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2f44659f",
      "audio": ""
    },
    {
      "text": "Which enzyme catalyzes the substrate-level phosphorylation step in the TCA cycle?",
      "options": [
        {
          "label": "A",
          "text": "Isocitrate dehydrogenase",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u03b1- ketoglutarate dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Succinyl CoA synthetase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Succinate dehydrogenase",
          "correct": false
        }
      ],
      "correct_answer": "C. Succinyl CoA synthetase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Succinyl CoA synthetase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Succinyl CoA synthetase catalyzes the only substrate-level phosphorylation step within the TCA cycle, where GDP (guanosine diphosphate) is phosphorylated to GTP (guanosine triphosphate), which can then be converted to ATP. This step involves the conversion of succinyl CoA to succinate.</li><li>\u27a4 Succinyl CoA synthetase catalyzes</li><li>\u27a4 substrate-level phosphorylation</li><li>\u27a4 TCA cycle,</li><li>\u27a4 GDP</li><li>\u27a4 phosphorylated to GTP</li><li>\u27a4 converted to ATP.</li><li>\u27a4 conversion</li><li>\u27a4 succinyl CoA to succinate.</li><li>\u27a4 Ref : Vasudevan 9/e: 247-249.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 247-249.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f13e202",
      "audio": ""
    },
    {
      "text": "Which of the following is true about Krebs Cycle?",
      "options": [
        {
          "label": "A",
          "text": "Pyruvate condenses with Oxaloacetate to form Citrate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alpha ketoglutarate is a five Carbon compound",
          "correct": true
        },
        {
          "label": "C",
          "text": "Oxidative Phosphorylation occurs in the cytoplasm only",
          "correct": false
        },
        {
          "label": "D",
          "text": "Krebs cycle can operate in anaerobic condition",
          "correct": false
        }
      ],
      "correct_answer": "B. Alpha ketoglutarate is a five Carbon compound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Alpha ketoglutarate is a five Carbon compound.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 \u03b1-Ketoglutarate Dehydrogenase:</li><li>\u27a4 \u03b1-Ketoglutarate Dehydrogenase:</li><li>\u27a4 \u03b1-ketoglutarate (5C) oxidised and decarboxylated to Succinyl CoA (4C) Second Oxidative Decarboxylation 1 NADH is formed Physiologically Unidirectional step Multienzyme Complex similar to Pyruvate Dehydrogenase</li><li>\u27a4 \u03b1-ketoglutarate (5C) oxidised and decarboxylated to Succinyl CoA (4C)</li><li>\u27a4 \u03b1-ketoglutarate (5C) oxidised</li><li>\u27a4 decarboxylated</li><li>\u27a4 Succinyl CoA</li><li>\u27a4 (4C)</li><li>\u27a4 Second Oxidative Decarboxylation</li><li>\u27a4 Second</li><li>\u27a4 Oxidative Decarboxylation</li><li>\u27a4 1 NADH is formed</li><li>\u27a4 1 NADH</li><li>\u27a4 Physiologically Unidirectional step</li><li>\u27a4 Unidirectional</li><li>\u27a4 Multienzyme Complex similar to Pyruvate Dehydrogenase</li><li>\u27a4 Multienzyme Complex</li><li>\u27a4 Pyruvate Dehydrogenase</li><li>\u27a4 Ref : Harper 30/e p161-167.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p161-167.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e2f70ad7",
      "audio": ""
    },
    {
      "text": "Which of the following substances is known to bind to CoA and condense with oxaloacetate, thereby inhibiting the TCA cycle?",
      "options": [
        {
          "label": "A",
          "text": "Malonate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Arsenite",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fluoroacetate",
          "correct": true
        },
        {
          "label": "D",
          "text": "None",
          "correct": false
        }
      ],
      "correct_answer": "C. Fluoroacetate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Fluoroacetate.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fluorocitrate is a potent inhibitor of aconitase , an enzyme in the TCA cycle, leading to the inhibition of the cycle and disruption of cellular energy metabolism.</li><li>\u27a4 Fluorocitrate</li><li>\u27a4 inhibitor of aconitase</li><li>\u27a4 TCA cycle,</li><li>\u27a4 inhibition of the</li><li>\u27a4 cycle</li><li>\u27a4 disruption</li><li>\u27a4 cellular energy metabolism.</li><li>\u27a4 Ref : Harper 30/e p161-167</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p161-167</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6a2830fd",
      "audio": ""
    },
    {
      "text": "During the Tricarboxylic Acid (TCA) cycle, citrate undergoes a series of transformations to facilitate cellular energy production. One of the initial steps involves the conversion of citrate to cis-aconitate. This reaction is catalyzed by the enzyme aconitase. Understanding the specific changes that occur during this conversion is essential for comprehending the intricate details of the TCA cycle. What is liberated during the conversion of citrate to cis-aconitate?",
      "options": [
        {
          "label": "A",
          "text": "H2O",
          "correct": true
        },
        {
          "label": "B",
          "text": "H2",
          "correct": false
        },
        {
          "label": "C",
          "text": "H2O2",
          "correct": false
        },
        {
          "label": "D",
          "text": "CO2",
          "correct": false
        }
      ],
      "correct_answer": "A. H2O",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) H2O.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Citrate isomerized to Isocitrate by Aconitase which is a reversible reaction. The reaction occurs in two steps : dehydration to cis aconitate and rehydration to isocitrate.</li><li>\u27a4 Citrate isomerized to Isocitrate by Aconitase which is a reversible reaction.</li><li>\u27a4 Citrate isomerized to Isocitrate</li><li>\u27a4 Aconitase</li><li>\u27a4 reversible reaction.</li><li>\u27a4 The reaction occurs in two steps : dehydration to cis aconitate and rehydration to isocitrate.</li><li>\u27a4 reaction</li><li>\u27a4 two steps</li><li>\u27a4 dehydration to cis aconitate</li><li>\u27a4 rehydration to isocitrate.</li><li>\u27a4 Ref : Harper 30/e p163</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p163</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "60e4dda1",
      "audio": ""
    },
    {
      "text": "In evaluating compounds involved in the rapid provision of energy within cells, particularly in muscle tissue during high-demand activities, which of the following is recognized as a high-energy compound capable of instantaneously replenishing ATP?",
      "options": [
        {
          "label": "A",
          "text": "Creatine Phosphate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glucose 1-Phosphate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycerol 3-Phosphate",
          "correct": false
        },
        {
          "label": "D",
          "text": "ADP",
          "correct": false
        }
      ],
      "correct_answer": "A. Creatine Phosphate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture3.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Creatine Phosphate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Examples of High energy Phosphates</li><li>\u27a4 Examples of High energy Phosphates</li><li>\u27a4 Pyrophosphate , e.g. ATP Acyl Phosphate , e.g. 1,3 Bisphosphoglycerate Enol Phosphate , e.g., Phosphoenolpyruvate Thioester, e.g. Acetyl CoA, Succinyl CoA Phosphagen, e.g. Phosphocreatine, Phosphoarginine.</li><li>\u27a4 Pyrophosphate , e.g. ATP</li><li>\u27a4 Pyrophosphate</li><li>\u27a4 Acyl Phosphate , e.g. 1,3 Bisphosphoglycerate</li><li>\u27a4 Acyl Phosphate</li><li>\u27a4 Enol Phosphate , e.g., Phosphoenolpyruvate</li><li>\u27a4 Enol Phosphate</li><li>\u27a4 Thioester, e.g. Acetyl CoA, Succinyl CoA</li><li>\u27a4 Thioester,</li><li>\u27a4 Phosphagen, e.g. Phosphocreatine, Phosphoarginine.</li><li>\u27a4 Phosphagen,</li><li>\u27a4 Ref : Harper 30/e p116.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p116.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9081e75",
      "audio": ""
    },
    {
      "text": "The assertion and reasoning provided require analysis to understand the action of atractyloside and its effects on mitochondrial function. Assertion (A): Atractyloside prevents ATP synthesis in the matrix of mitochondria. Reasoning (R): Atractyloside blocks complex V, the F0 component of inner mitochondrial membrane and stops the inflow of H+ into the matrix.",
      "options": [
        {
          "label": "A",
          "text": "A and R both are right but R is not the correct explanation of A",
          "correct": false
        },
        {
          "label": "B",
          "text": "A is right but R is a wrong statement",
          "correct": true
        },
        {
          "label": "C",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": false
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": false
        }
      ],
      "correct_answer": "B. A is right but R is a wrong statement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) A is right but R is a wrong statement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Atractyloside is known to inhibit ATP synthesis, but not by blocking complex V (ATP synthase) or the F0 component. Instead, atractyloside inhibits the ADP/ATP carrier (also known as the adenine nucleotide translocase ) in the inner mitochondrial membrane , which is responsible for exchanging ADP and ATP between the mitochondrial matrix and the cytosol . This inhibition prevents the export of ATP from the mitochondria to the cytosol and the import of ADP from the cytosol to the matrix, thus inhibiting ATP synthesis indirectly.</li><li>\u2022 Atractyloside</li><li>\u2022 inhibit ATP synthesis,</li><li>\u2022 not</li><li>\u2022 blocking complex V</li><li>\u2022 F0</li><li>\u2022 atractyloside inhibits the ADP/ATP carrier</li><li>\u2022 adenine nucleotide</li><li>\u2022 translocase</li><li>\u2022 inner mitochondrial membrane</li><li>\u2022 exchanging ADP and ATP</li><li>\u2022 mitochondrial matrix and the cytosol</li><li>\u2022 inhibition</li><li>\u2022 export of ATP</li><li>\u2022 mitochondria to the cytosol</li><li>\u2022 ADP from the cytosol to the matrix,</li><li>\u2022 inhibiting ATP</li><li>\u2022 synthesis indirectly.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Atractyloside blocks ATP/ADP transporter and prevents ADP transport into the matrix. In absence of ADP in the matrix, ATP synthesis does not occur. Oligomycin blocks complex V (F0) and prevents transportation of H+ within the matrix.</li><li>\u27a4 Atractyloside blocks ATP/ADP transporter and prevents ADP transport into the matrix.</li><li>\u27a4 Atractyloside blocks ATP/ADP transporter</li><li>\u27a4 ADP transport into the matrix.</li><li>\u27a4 In absence of ADP in the matrix, ATP synthesis does not occur.</li><li>\u27a4 absence of ADP</li><li>\u27a4 ATP</li><li>\u27a4 does not</li><li>\u27a4 Oligomycin blocks complex V (F0) and prevents transportation of H+ within the matrix.</li><li>\u27a4 Oligomycin</li><li>\u27a4 complex V</li><li>\u27a4 transportation of H+</li><li>\u27a4 Ref : Harper 30/e: p 130-133.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 130-133.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b3fd7cc8",
      "audio": ""
    },
    {
      "text": "In the past, the uncoupler 2,4-dinitrophenol was used as a weight- reducing drug until side effects such as fatigue and breathlessness precluded its use. How could the use of this drug result in weight loss?",
      "options": [
        {
          "label": "A",
          "text": "2,4-dinitrophenol is an allosteric activator of ATP synthase and thus increases the rate of H+ translocation and oxidation of fats and other fuels.",
          "correct": false
        },
        {
          "label": "B",
          "text": "2,4-dinitrophenol inhibits transport of pyruvate into the mitochondria. Fats are therefore metabolized to glycerol and subsequently to pyruvate, depleting fat stores.",
          "correct": false
        },
        {
          "label": "C",
          "text": "2,4-dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.",
          "correct": true
        },
        {
          "label": "D",
          "text": "2,4-dinitrophenol causes ATP to be produced at a higher rate than normal, thus causing weight loss.",
          "correct": false
        }
      ],
      "correct_answer": "C. 2,4-dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 2,4 dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Uncouplers such as 2,4-dinitrophenol dissociate oxidation from phosphorylation \u2192 ADP is not phosphorylated to produce ATP and respiration becomes uncontrolled as it tries to replenish ATP supplies \u2192 leads to increased metabolic turnover in the attempt to generate ATP . ( Incorrect option A , B, D ). Less ADP will be converted to ATP \u2192 increased ADP and decreased rates of oxidative phosphorylation. Prolonged energy deficits will lead to fatigue in energy-dependent tissues such as muscle or heart (cardiomyopathy), which is potentially lethal.</li><li>\u27a4 Uncouplers such as 2,4-dinitrophenol dissociate oxidation from phosphorylation \u2192 ADP is not phosphorylated to produce ATP and respiration becomes uncontrolled as it tries to replenish ATP supplies \u2192 leads to increased metabolic turnover in the attempt to generate ATP . ( Incorrect option A , B, D ).</li><li>\u27a4 Uncouplers</li><li>\u27a4 2,4-dinitrophenol</li><li>\u27a4 oxidation from phosphorylation</li><li>\u27a4 ADP</li><li>\u27a4 not</li><li>\u27a4 phosphorylated</li><li>\u27a4 ATP</li><li>\u27a4 respiration</li><li>\u27a4 uncontrolled</li><li>\u27a4 replenish ATP supplies</li><li>\u27a4 increased metabolic</li><li>\u27a4 turnover</li><li>\u27a4 generate ATP</li><li>\u27a4 Incorrect option A , B, D</li><li>\u27a4 Less ADP will be converted to ATP \u2192 increased ADP and decreased rates of oxidative phosphorylation.</li><li>\u27a4 Less ADP</li><li>\u27a4 ATP \u2192 increased ADP</li><li>\u27a4 decreased</li><li>\u27a4 oxidative phosphorylation.</li><li>\u27a4 Prolonged energy deficits will lead to fatigue in energy-dependent tissues such as muscle or heart (cardiomyopathy), which is potentially lethal.</li><li>\u27a4 energy deficits</li><li>\u27a4 fatigue</li><li>\u27a4 energy-dependent tissues</li><li>\u27a4 (cardiomyopathy),</li><li>\u27a4 lethal.</li><li>\u27a4 Ref : Harper Illustrated Biochemistry 31/e p 323-24.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper Illustrated Biochemistry 31/e p 323-24.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1c0d660",
      "audio": ""
    },
    {
      "text": "Which subunit within ATP synthase is directly responsible for ATP formation?",
      "options": [
        {
          "label": "A",
          "text": "Fo Sub complex",
          "correct": false
        },
        {
          "label": "B",
          "text": "subunit of F1",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u03b2 subunit of F1 sub complex",
          "correct": true
        },
        {
          "label": "D",
          "text": "C disc of Fo sub complex",
          "correct": false
        }
      ],
      "correct_answer": "C. \u03b2 subunit of F1 sub complex",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) \u03b2 subunit of F1 sub complex</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ATP SYNTHASE / COMPLEX V OF ELECTRON TRANSPORT CHAIN:</li><li>\u27a4 ATP SYNTHASE / COMPLEX V OF ELECTRON TRANSPORT CHAIN:</li><li>\u27a4 The enzyme complex consists of an F0 sub complex which acts as a disk of \u201cC\u201d protein subunits. A \u03b3 subunit is attached as a \u201cbent axle.\u201d Protons passing through the disk of \u201cC\u201d units cause it and the \u03b3-subunit attached to it to rotate. The \u03b3 subunit fits inside the F1 sub complex , consists of 3 \u03b1 and 3 \u03b2 subunits , which are fixed to the membrane , and they do not rotate. ADP and Pi are taken up by the \u03b2 subunits to form ATP, which is expelled as the rotating \u03b3 subunit pushes each \u03b2 subunit in turn and changes its conformation \u2192 3 ATP molecules are generated per revolution.</li><li>\u27a4 The enzyme complex consists of an F0 sub complex which acts as a disk of \u201cC\u201d protein subunits.</li><li>\u27a4 enzyme complex</li><li>\u27a4 F0 sub complex</li><li>\u27a4 \u201cC\u201d</li><li>\u27a4 A \u03b3 subunit is attached as a \u201cbent axle.\u201d</li><li>\u27a4 \u03b3 subunit</li><li>\u27a4 \u201cbent axle.\u201d</li><li>\u27a4 Protons passing through the disk of \u201cC\u201d units cause it and the \u03b3-subunit attached to it to rotate.</li><li>\u27a4 Protons</li><li>\u27a4 disk of \u201cC\u201d units</li><li>\u27a4 \u03b3-subunit</li><li>\u27a4 The \u03b3 subunit fits inside the F1 sub complex , consists of 3 \u03b1 and 3 \u03b2 subunits , which are fixed to the membrane , and they do not rotate.</li><li>\u27a4 \u03b3 subunit</li><li>\u27a4 F1 sub complex</li><li>\u27a4 3 \u03b1 and 3 \u03b2 subunits</li><li>\u27a4 fixed</li><li>\u27a4 membrane</li><li>\u27a4 do not rotate.</li><li>\u27a4 ADP and Pi are taken up by the \u03b2 subunits to form ATP, which is expelled as the rotating \u03b3 subunit pushes each \u03b2 subunit in turn and changes its conformation \u2192 3 ATP molecules are generated per revolution.</li><li>\u27a4 ADP and Pi</li><li>\u27a4 \u03b2 subunits</li><li>\u27a4 ATP,</li><li>\u27a4 expelled</li><li>\u27a4 \u03b3</li><li>\u27a4 subunit</li><li>\u27a4 \u03b2 subunit</li><li>\u27a4 its conformation</li><li>\u27a4 3 ATP</li><li>\u27a4 generated per revolution.</li><li>\u27a4 Ref : Harper 30/e:  p 131-133.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 131-133.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "242ec161",
      "audio": ""
    },
    {
      "text": "A 4-year-old presents with seizures and lethargy. Diagnosed with a mitochondrial disorder affecting the electron transport chain, you recall the P:O ratios for various oxidations. Which statement about P:O ratios is false?",
      "options": [
        {
          "label": "A",
          "text": "Defined as the ratio of high energy inorganic phosphates incorporated to the atoms of O2 consumed.",
          "correct": false
        },
        {
          "label": "B",
          "text": "P:O for NAD linked oxidation is 2.5",
          "correct": false
        },
        {
          "label": "C",
          "text": "P:O for FMN linked oxidation is 3.5",
          "correct": true
        },
        {
          "label": "D",
          "text": "P:O for FAD linked oxidation is 1.5",
          "correct": false
        }
      ],
      "correct_answer": "C. P:O for FMN linked oxidation is 3.5",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) P:O for FMN linked oxidation is 3.5</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 P: O Ratio is defined as the ratio of high energy inorganic phosphates incorporated to the atoms of O2 consumed. NADH oxidation provides 2.5 ATP & FADH oxidation provides 1.5 ATP per oxygen atom consumption.</li><li>\u27a4 P: O Ratio is defined as the ratio of high energy inorganic phosphates incorporated to the atoms of O2 consumed.</li><li>\u27a4 P: O Ratio</li><li>\u27a4 high energy inorganic phosphates</li><li>\u27a4 atoms of O2 consumed.</li><li>\u27a4 NADH oxidation provides 2.5 ATP & FADH oxidation provides 1.5 ATP per oxygen atom consumption.</li><li>\u27a4 NADH</li><li>\u27a4 oxidation</li><li>\u27a4 2.5 ATP</li><li>\u27a4 FADH oxidation</li><li>\u27a4 1.5 ATP</li><li>\u27a4 oxygen atom consumption.</li><li>\u27a4 Ref : Harper 30/e: p 131.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 131.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "720a8173",
      "audio": ""
    },
    {
      "text": "The chemiosmotic theory about the coupling of electron transport via the respiratory chain to the process of oxidative phosphorylation is proposed by Peter Mitchell. Which of the following statements does NOT accurately represent the chemiosmotic theory as proposed by Peter Mitchell?",
      "options": [
        {
          "label": "A",
          "text": "The electrochemical potential difference across IMM due to the electron transport is positive on the matrix side.",
          "correct": true
        },
        {
          "label": "B",
          "text": "As electrons pass down the respiratory chain, it pumps protons across the IMM",
          "correct": false
        },
        {
          "label": "C",
          "text": "This proton gradient across the IMM generated by electron transport favours ATP synthesis.",
          "correct": false
        },
        {
          "label": "D",
          "text": "ATP synthesis occurs through an ATP synthase enzyme complex",
          "correct": false
        }
      ],
      "correct_answer": "A. The electrochemical potential difference across IMM due to the electron transport is positive on the matrix side.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) The electrochemical potential difference across IMM due to the electron transport is positive on the matrix side.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The electrochemical potential difference across IMM due to the electron transport should be negative on the matrix side, thereby protons are forced to re-enter through the ATP synthase complex to discharge the electrochemical gradient. Complexes I, III, and IV act as proton pumps \u2192 creates a proton gradient across the membrane, which is negative on the matrix side. The proton motive force drives the synthesis of ATP as the protons flow back into the matrix through the ATP synthase enzyme complex.</li><li>\u27a4 The electrochemical potential difference across IMM due to the electron transport should be negative on the matrix side, thereby protons are forced to re-enter through the ATP synthase complex to discharge the electrochemical gradient.</li><li>\u27a4 electrochemical potential difference</li><li>\u27a4 IMM</li><li>\u27a4 electron transport</li><li>\u27a4 negative</li><li>\u27a4 protons are forced</li><li>\u27a4 re-enter</li><li>\u27a4 ATP synthase</li><li>\u27a4 complex</li><li>\u27a4 electrochemical gradient.</li><li>\u27a4 Complexes I, III, and IV act as proton pumps \u2192 creates a proton gradient across the membrane, which is negative on the matrix side.</li><li>\u27a4 Complexes I, III, and IV</li><li>\u27a4 proton pumps</li><li>\u27a4 proton gradient across</li><li>\u27a4 negative</li><li>\u27a4 matrix side.</li><li>\u27a4 The proton motive force drives the synthesis of ATP as the protons flow back into the matrix through the ATP synthase enzyme complex.</li><li>\u27a4 proton motive force</li><li>\u27a4 ATP</li><li>\u27a4 protons flow back</li><li>\u27a4 ATP synthase enzyme complex.</li><li>\u27a4 Ref : Harper 30/e:  p 129-132.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 129-132.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "11f5ee8d",
      "audio": ""
    },
    {
      "text": "What is the net change in the number of protons across the mitochondrial membrane for each set of two electrons transferred through Complexes I, III, and IV, respectively?",
      "options": [
        {
          "label": "A",
          "text": "2; 4; 4",
          "correct": false
        },
        {
          "label": "B",
          "text": "4; 4; 2",
          "correct": true
        },
        {
          "label": "C",
          "text": "3; 3; 4",
          "correct": false
        },
        {
          "label": "D",
          "text": "4; 2; 4",
          "correct": false
        }
      ],
      "correct_answer": "B. 4; 4; 2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 4; 4; 2</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ETC : Complex-I /NADH-CoQ reductase or NADH dehydrogenase complex - It is tightly bound to the inner membrane of mitochondria \u2192 large negative free energy change occurs which is utilized to drive 4 protons out of the mitochondrial matrix into intermembrane space. Complex III or Cytochrome Reductase -the free energy change through this complex due to electron transfer causes 4 protons to be pumped out. Complex IV or Cytochrome Oxidase \u2013 It is tightly bound to the mitochondrial membrane, and pumps out 2 protons to the intermembrane space.</li><li>\u27a4 ETC : Complex-I /NADH-CoQ reductase or NADH dehydrogenase complex - It is tightly bound to the inner membrane of mitochondria \u2192 large negative free energy change occurs which is utilized to drive 4 protons out of the mitochondrial matrix into intermembrane space.</li><li>\u27a4 ETC</li><li>\u27a4 Complex-I /NADH-CoQ reductase or NADH dehydrogenase complex</li><li>\u27a4 tightly</li><li>\u27a4 inner membrane</li><li>\u27a4 mitochondria</li><li>\u27a4 large negative</li><li>\u27a4 drive 4 protons out of the mitochondrial</li><li>\u27a4 matrix</li><li>\u27a4 intermembrane space.</li><li>\u27a4 Complex III or Cytochrome Reductase -the free energy change through this complex due to electron transfer causes 4 protons to be pumped out.</li><li>\u27a4 Complex III or Cytochrome Reductase</li><li>\u27a4 free energy</li><li>\u27a4 complex</li><li>\u27a4 electron transfer</li><li>\u27a4 4</li><li>\u27a4 protons</li><li>\u27a4 Complex IV or Cytochrome Oxidase \u2013 It is tightly bound to the mitochondrial membrane, and pumps out 2 protons to the intermembrane space.</li><li>\u27a4 Complex IV or Cytochrome Oxidase</li><li>\u27a4 tightly</li><li>\u27a4 mitochondrial membrane,</li><li>\u27a4 pumps out 2 protons</li><li>\u27a4 intermembrane space.</li><li>\u27a4 Ref : Harper 30/e: p 131.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 131.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "13665b74",
      "audio": ""
    },
    {
      "text": "Dehydrogenases such as glucose-6-phosphate dehydrogenase serve to transfer Hydride (H-) ions or H atom from one substrate to another in coupled oxidation-reduction reactions, ultimately (in the respiratory chain) generating energy by oxygen/water reduction. Dehydrogenases can use which of the following compounds as an electron acceptor?",
      "options": [
        {
          "label": "A",
          "text": "H2O",
          "correct": false
        },
        {
          "label": "B",
          "text": "NAD+",
          "correct": true
        },
        {
          "label": "C",
          "text": "O2",
          "correct": false
        },
        {
          "label": "D",
          "text": "Peroxide",
          "correct": false
        }
      ],
      "correct_answer": "B. NAD+",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) NAD+</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dehydrogenases are specifi c for their substrates , but most use either NAD+ or NADP+ as the coenzyme. Some dehydrogenases use Flavin coenzymes similar to FMN and FAD used by the oxidases. The final steps in the conversion of oxygen to water in the respiratory chain are carried out by cytochrome oxidase (cytochrome a3) as part of complex IV. This final enzyme is an oxidase , defined by its use of oxygen to oxidize metabolites and form water or hydrogen peroxide. The prior cytochromes of the respiratory chain (b, cl, c, a) can be described as dehydrogenases, transferring electrons (or Protons in reverse ) by oscillation between ferric (Fe+++) and ferrous (Fe++) ions.</li><li>\u27a4 Dehydrogenases are specifi c for their substrates , but most use either NAD+ or NADP+ as the coenzyme.</li><li>\u27a4 Dehydrogenases</li><li>\u27a4 specifi</li><li>\u27a4 substrates</li><li>\u27a4 either NAD+ or NADP+</li><li>\u27a4 coenzyme.</li><li>\u27a4 Some dehydrogenases use Flavin coenzymes similar to FMN and FAD used by the oxidases.</li><li>\u27a4 Flavin coenzymes</li><li>\u27a4 FMN and FAD</li><li>\u27a4 oxidases.</li><li>\u27a4 The final steps in the conversion of oxygen to water in the respiratory chain are carried out by cytochrome oxidase (cytochrome a3) as part of complex IV.</li><li>\u27a4 oxygen to water</li><li>\u27a4 respiratory chain</li><li>\u27a4 cytochrome oxidase</li><li>\u27a4 complex IV.</li><li>\u27a4 This final enzyme is an oxidase , defined by its use of oxygen to oxidize metabolites and form water or hydrogen peroxide.</li><li>\u27a4 final</li><li>\u27a4 oxidase</li><li>\u27a4 use of oxygen</li><li>\u27a4 oxidize metabolites</li><li>\u27a4 form water</li><li>\u27a4 hydrogen</li><li>\u27a4 peroxide.</li><li>\u27a4 The prior cytochromes of the respiratory chain (b, cl, c, a) can be described as dehydrogenases, transferring electrons (or Protons in reverse ) by oscillation between ferric (Fe+++) and ferrous (Fe++) ions.</li><li>\u27a4 prior cytochromes of the respiratory chain</li><li>\u27a4 dehydrogenases,</li><li>\u27a4 transferring electrons</li><li>\u27a4 Protons in reverse</li><li>\u27a4 oscillation between ferric</li><li>\u27a4 ferrous</li><li>\u27a4 Ref : Harper 30/e: p 122.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 122.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9badbbc",
      "audio": ""
    },
    {
      "text": "A 27-year-old male is involved in a research study examining mitochondrial function. He is in excellent health and reports no significant medical history. As part of the study, he undergoes various tests to assess his cellular metabolism. One particular focus of the study is the efficiency and regulation of oxidative phosphorylation within the electron transport chain (ETC) in his mitochondria. Given this context, which of the following enzymes or complexes is LEAST likely to play a regulatory role in oxidative phosphorylation?",
      "options": [
        {
          "label": "A",
          "text": "NADH CoQ reductase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cytochrome C oxidase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Isocitrate dehydrogenase",
          "correct": true
        },
        {
          "label": "D",
          "text": "CoQ Cytochrome C reductase",
          "correct": false
        }
      ],
      "correct_answer": "C. Isocitrate dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Isocitrate dehydrogenase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Components of the Electron Transport Chain are contained in four large protein complexes:</li><li>\u27a4 Components of the Electron Transport Chain are contained in four large protein complexes:</li><li>\u27a4 Complex I NADH CoQ Oxidoreductase Complex II CoQ Succinate Reductase. Complex III CoQ Cytochrome C Oxidoreductase Complex IV Cytochrome C Oxidase</li><li>\u27a4 Complex I NADH CoQ Oxidoreductase</li><li>\u27a4 Complex II CoQ Succinate Reductase.</li><li>\u27a4 Complex III CoQ Cytochrome C Oxidoreductase</li><li>\u27a4 Complex IV Cytochrome C Oxidase</li><li>\u27a4 Ref : Harper 30/e p130, 133.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p130, 133.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1f0407ee",
      "audio": ""
    },
    {
      "text": "Oligomycin is a macrolide antibiotic derived from Streptomyces, a genus of soil bacteria that has contributed over two-thirds of naturally derived antibiotics, that inhibits ATP synthase required for oxidative phosphorylation. Which of the following options best explains the consequence of this inhibition?",
      "options": [
        {
          "label": "A",
          "text": "Selective disruption of complex II function",
          "correct": false
        },
        {
          "label": "B",
          "text": "Disruption of ubiquinone phosphorylation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Disruption of NADH entry into the respiratory chain",
          "correct": false
        },
        {
          "label": "D",
          "text": "Disruption of proton flow across the inner mitochondrial membrane",
          "correct": true
        }
      ],
      "correct_answer": "D. Disruption of proton flow across the inner mitochondrial membrane",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Disruption of proton flow across the inner mitochondrial membrane</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Selective complex inhibitors such as carboxin for complex II or barbiturates for complex I where NADH enters the chain would cause partial disruption of electron transfer.</li><li>\u2022 Option A:</li><li>\u2022 Selective complex inhibitors</li><li>\u2022 carboxin</li><li>\u2022 complex II</li><li>\u2022 barbiturates for complex I</li><li>\u2022 NADH</li><li>\u2022 partial disruption of electron transfer.</li><li>\u2022 Option B: Ubiquinone is one of three oxidation states of coenzyme Q ( quinol to quinone to semiquinone ) that cycle with forms of cytochrome c at the level of complex III; no coenzyme Q intermediates are phosphorylated.</li><li>\u2022 Option B:</li><li>\u2022 Ubiquinone</li><li>\u2022 three oxidation states of coenzyme Q</li><li>\u2022 quinol to quinone to semiquinone</li><li>\u2022 cytochrome c</li><li>\u2022 complex III;</li><li>\u2022 no coenzyme Q</li><li>\u2022 phosphorylated.</li><li>\u2022 Option C: Oligomycin does not interfere with NADH.</li><li>\u2022 Option C:</li><li>\u2022 Oligomycin does not</li><li>\u2022 NADH.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Oligomycin blocks ATP synthase , the enzyme responsible for synthesizing ATP from ADP and inorganic phosphate. This blockade prevents protons from flowing back into the mitochondrial matrix through ATP synthase, effectively stopping the utilization of the proton gradient generated by the electron transport chain. The gradient builds up, halting further proton pumping by the complexes of the electron transport chain, thus indirectly affecting ATP production.</li><li>\u27a4 Oligomycin</li><li>\u27a4 blocks ATP synthase</li><li>\u27a4 synthesizing ATP from ADP</li><li>\u27a4 inorganic phosphate.</li><li>\u27a4 blockade</li><li>\u27a4 prevents protons</li><li>\u27a4 flowing back</li><li>\u27a4 mitochondrial matrix</li><li>\u27a4 ATP synthase,</li><li>\u27a4 stopping</li><li>\u27a4 proton gradient</li><li>\u27a4 electron transport chain.</li><li>\u27a4 gradient builds</li><li>\u27a4 proton pumping</li><li>\u27a4 complexes</li><li>\u27a4 electron transport chain,</li><li>\u27a4 indirectly</li><li>\u27a4 ATP production.</li><li>\u27a4 Ref : Harper Illustrated Biochemistry 31/e p 123.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper Illustrated Biochemistry 31/e p 123.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e990d19",
      "audio": ""
    },
    {
      "text": "In the resting state, what is the primary condition that limits the rate of respiration?",
      "options": [
        {
          "label": "A",
          "text": "Availability of ADP",
          "correct": true
        },
        {
          "label": "B",
          "text": "Availability of oxygen",
          "correct": false
        },
        {
          "label": "C",
          "text": "Availability of substrate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Availability of both ADP and substrate",
          "correct": false
        }
      ],
      "correct_answer": "A. Availability of ADP",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Availability of ADP</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Availability of oxygen is generally not the limiting facto r in the resting state , as oxygen is typically abundant in well-perfused tissues under normal physiological conditions.</li><li>\u2022 Option B:</li><li>\u2022 oxygen</li><li>\u2022 not</li><li>\u2022 limiting facto</li><li>\u2022 resting state</li><li>\u2022 abundant in well-perfused tissues</li><li>\u2022 Option C: The availability of substrate (such as glucose or fatty acids ) is usually not a limiting factor in the resting state, as cells have mechanisms to store or obtain these substrates.</li><li>\u2022 Option C:</li><li>\u2022 substrate</li><li>\u2022 glucose or fatty acids</li><li>\u2022 not a limiting factor</li><li>\u2022 resting state,</li><li>\u2022 cells</li><li>\u2022 store or obtain</li><li>\u2022 substrates.</li><li>\u2022 Option D: While both ADP and substrates are required for respiration, ADP is the primary limiting factor in the resting state due to its role in signaling the cell's energy needs.</li><li>\u2022 Option D:</li><li>\u2022 both ADP and substrates</li><li>\u2022 respiration,</li><li>\u2022 ADP</li><li>\u2022 primary limiting factor</li><li>\u2022 resting state</li><li>\u2022 signaling the cell's energy needs.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the resting state, the level of ADP should be low and thus respiration will be slow ( incorrect answers B-D) . An increase in ADP indicates that the cell is in the working state and respiration will increase. During heavy workloads, such as during exercise, respiration may be regulated by the availability of oxygen or the limit of the capacity of the respiratory chain itself.</li><li>\u27a4 In the resting state, the level of ADP should be low and thus respiration will be slow ( incorrect answers B-D) .</li><li>\u27a4 resting state,</li><li>\u27a4 level of ADP</li><li>\u27a4 low</li><li>\u27a4 respiration</li><li>\u27a4 slow</li><li>\u27a4 incorrect answers B-D)</li><li>\u27a4 An increase in ADP indicates that the cell is in the working state and respiration will increase.</li><li>\u27a4 increase in ADP</li><li>\u27a4 cell is in the working state</li><li>\u27a4 respiration will increase.</li><li>\u27a4 During heavy workloads, such as during exercise, respiration may be regulated by the availability of oxygen or the limit of the capacity of the respiratory chain itself.</li><li>\u27a4 heavy workloads,</li><li>\u27a4 during exercise, respiration</li><li>\u27a4 availability of oxygen</li><li>\u27a4 limit</li><li>\u27a4 capacity of the respiratory chain</li><li>\u27a4 Ref : Harper Illustrated Biochemistry 31/e p320.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper Illustrated Biochemistry 31/e p320.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5fcb8e6a",
      "audio": ""
    },
    {
      "text": "Which of the following options correctly identifies this final electron acceptor?",
      "options": [
        {
          "label": "A",
          "text": "Cyt C",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oxygen",
          "correct": true
        },
        {
          "label": "C",
          "text": "FAD",
          "correct": false
        },
        {
          "label": "D",
          "text": "CoQ",
          "correct": false
        }
      ],
      "correct_answer": "B. Oxygen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Oxygen.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Electrons are transferred in the ascending order of redox potential, the final oxygen electron acceptor is oxygen.</li><li>\u27a4 Electrons</li><li>\u27a4 ascending order of redox potential,</li><li>\u27a4 final oxygen</li><li>\u27a4 electron acceptor</li><li>\u27a4 oxygen.</li><li>\u27a4 Ref : Harper 30/e p133.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p133.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "57f4a75a",
      "audio": ""
    },
    {
      "text": "Cytochrome c, typically associated with the electron transport chain, also plays a role in mediating apoptosis. Is this statement true or false?.",
      "options": [
        {
          "label": "A",
          "text": "True",
          "correct": true
        },
        {
          "label": "B",
          "text": "False",
          "correct": false
        },
        {
          "label": "C",
          "text": "None of the above",
          "correct": false
        },
        {
          "label": "D",
          "text": "Not sure",
          "correct": false
        }
      ],
      "correct_answer": "A. True",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) True</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Cytochrome c indeed mediates apoptosis. Upon release from the mitochondria into the cytosol in response to apoptotic stimuli, cytochrome c interacts with Apaf-1 (apoptotic protease activating factor-1) and procaspase-9 to form the apoptosome . This complex initiates the caspase cascade, leading to the execution phase of apoptosis, characterized by cell shrinkage, chromatin condensation, and DNA fragmentation.</li><li>\u2022 Cytochrome c</li><li>\u2022 apoptosis.</li><li>\u2022 mitochondria into the cytosol</li><li>\u2022 apoptotic stimuli,</li><li>\u2022 cytochrome c</li><li>\u2022 Apaf-1 (apoptotic protease activating factor-1) and procaspase-9</li><li>\u2022 apoptosome</li><li>\u2022 complex</li><li>\u2022 caspase cascade,</li><li>\u2022 execution phase of apoptosis,</li><li>\u2022 cell shrinkage, chromatin</li><li>\u2022 condensation, and DNA fragmentation.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Cytochrome C is a mobile electron carrier between Complex III and Complex IV. It plays an important role in programmed cell death.</li><li>\u27a4 Cytochrome C is a mobile electron carrier between Complex III and Complex IV.</li><li>\u27a4 Cytochrome C</li><li>\u27a4 mobile electron carrier</li><li>\u27a4 Complex III and Complex IV.</li><li>\u27a4 It plays an important role in programmed cell death.</li><li>\u27a4 programmed cell death.</li><li>\u27a4 Ref: Harper 30/e p127-130.</li><li>\u27a4 Ref: Harper 30/e p127-130.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1591cfe4",
      "audio": ""
    },
    {
      "text": "How should the following inhibitors be matched with their corresponding complexes or sites?",
      "options": [
        {
          "label": "A",
          "text": "1-d, 2-c, 3-b, 4-a",
          "correct": true
        },
        {
          "label": "B",
          "text": "1-d, 2-b, 3-c, 4-a",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-a, 2-b, 3-c, 4-d",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-a, 2-d, 3-b, 4-c",
          "correct": false
        }
      ],
      "correct_answer": "A. 1-d, 2-c, 3-b, 4-a",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture4_784r4vb.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture5.jpg"
      ],
      "explanation": "<p><strong>Ans. A) 1-d, 2-c, 3-b, 4-a</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Cyanide is known to inhibit Complex IV of the electron transport chain by binding to the cytochrome c oxidase , preventing the transfer of electrons to oxygen and thereby halting ATP synthesis. Malonate is a competitive inhibitor of succinate dehydrogenase (Complex II), specifically inhibiting the site between succinate dehydrogenase and Co-Q (coenzyme Q). BAL (British Anti-Lewisite) does not directly inhibit any specific complex within the electron transport chain; thus, its inclusion might be misleading . However, in the context of this question and the available options, it is matched with b, but this is not reflective of its actual function. Chlorpromazine is not a classical inhibitor of the electron transport chain , and its inclusion in this list might not be accurate for educational purposes . However, based on the available options, it is matched with a, Complex I to Co-Q.</li><li>\u2022 Cyanide is known to inhibit Complex IV of the electron transport chain by binding to the cytochrome c oxidase , preventing the transfer of electrons to oxygen and thereby halting ATP synthesis.</li><li>\u2022 Cyanide</li><li>\u2022 inhibit Complex IV</li><li>\u2022 cytochrome c oxidase</li><li>\u2022 preventing</li><li>\u2022 electrons to oxygen</li><li>\u2022 halting ATP synthesis.</li><li>\u2022 Malonate is a competitive inhibitor of succinate dehydrogenase (Complex II), specifically inhibiting the site between succinate dehydrogenase and Co-Q (coenzyme Q).</li><li>\u2022 Malonate</li><li>\u2022 competitive</li><li>\u2022 succinate dehydrogenase (Complex II),</li><li>\u2022 inhibiting</li><li>\u2022 succinate dehydrogenase and Co-Q (coenzyme Q).</li><li>\u2022 BAL (British Anti-Lewisite) does not directly inhibit any specific complex within the electron transport chain; thus, its inclusion might be misleading . However, in the context of this question and the available options, it is matched with b, but this is not reflective of its actual function.</li><li>\u2022 BAL (British Anti-Lewisite) does not</li><li>\u2022 inhibit</li><li>\u2022 complex</li><li>\u2022 electron transport chain;</li><li>\u2022 inclusion</li><li>\u2022 misleading</li><li>\u2022 it is matched with b,</li><li>\u2022 not reflective</li><li>\u2022 actual function.</li><li>\u2022 Chlorpromazine is not a classical inhibitor of the electron transport chain , and its inclusion in this list might not be accurate for educational purposes . However, based on the available options, it is matched with a, Complex I to Co-Q.</li><li>\u2022 Chlorpromazine</li><li>\u2022 not</li><li>\u2022 classical inhibitor</li><li>\u2022 electron transport chain</li><li>\u2022 might not</li><li>\u2022 educational purposes</li><li>\u2022 matched with a, Complex I to Co-Q.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 266.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 266.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6b11997",
      "audio": ""
    },
    {
      "text": "In examining the electron transport chain (ETC) for ATP production, which component is responsible for transferring four protons across the mitochondrial membrane?",
      "options": [
        {
          "label": "A",
          "text": "NADH-Q Oxidoreductase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cytochrome-C Oxidase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Isocitrate Dehydrogenase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Succinate Q Reductase",
          "correct": false
        }
      ],
      "correct_answer": "A. NADH-Q Oxidoreductase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) NADH-Q Oxidoreductase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Cytochrome C Oxidase (Complex IV): While crucial in the electron transport chain for transferring electrons to oxygen, the number of protons it translocates does not precisely match four per cycle.</li><li>\u2022 Option B. Cytochrome C Oxidase (Complex IV):</li><li>\u2022 electron transport chain</li><li>\u2022 electrons to oxygen,</li><li>\u2022 number of protons</li><li>\u2022 does not</li><li>\u2022 four per cycle.</li><li>\u2022 Option C. Isocitrate Dehydrogenase: Not involved in the electron transport chain; it functions in the citric acid cycle.</li><li>\u2022 Option C. Isocitrate Dehydrogenase:</li><li>\u2022 Not</li><li>\u2022 electron transport chain;</li><li>\u2022 citric acid cycle.</li><li>\u2022 Option D. Succinate: Ubiquinone Oxidoreductase (Complex II): Transfers electrons without pumping protons across the membrane .</li><li>\u2022 Option D. Succinate:</li><li>\u2022 Ubiquinone Oxidoreductase (Complex II):</li><li>\u2022 Transfers</li><li>\u2022 electrons</li><li>\u2022 without</li><li>\u2022 across the membrane</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Complex I : NADH Coenzyme Q Oxidoreductase: 4 H+ Complex II pumps : Succinate Q Reductase: no protons Complex III pumps: Cytochrome CoQ oxidoreductase: 4 H+ Complex IV pumps : Cytochrome C Oxidase: 2 H+.</li><li>\u27a4 Complex I : NADH Coenzyme Q Oxidoreductase: 4 H+</li><li>\u27a4 Complex I</li><li>\u27a4 Complex II pumps : Succinate Q Reductase: no protons</li><li>\u27a4 Complex II pumps</li><li>\u27a4 Complex III pumps: Cytochrome CoQ oxidoreductase: 4 H+</li><li>\u27a4 Complex III pumps:</li><li>\u27a4 Complex IV pumps : Cytochrome C Oxidase: 2 H+.</li><li>\u27a4 Complex IV pumps</li><li>\u27a4 Ref : Harper 30/e, p 130.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e, p 130.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0650ea7",
      "audio": ""
    },
    {
      "text": "During a clinical review session, a medical instructor is discussing the various substrates that contribute to the production of glucose through gluconeogenesis. One of the students asks which substrates can be used by the liver to synthesize glucose. The instructor provides a list but includes one substrate that does not contribute to the net synthesis of glucose in gluconeogenesis. Which of the following does not serve as a substrate for net glucose production in gluconeogenesis?",
      "options": [
        {
          "label": "A",
          "text": "Lactate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acetyl CoA",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pyruvate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alanine",
          "correct": false
        }
      ],
      "correct_answer": "B. Acetyl CoA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Acetyl CoA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Lactate: Lactate can be converted to pyruvate by lactate dehydrogenase and then to glucose via gluconeogenesis.</li><li>\u2022 Option A. Lactate:</li><li>\u2022 converted to pyruvate</li><li>\u2022 lactate dehydrogenase</li><li>\u2022 glucose via gluconeogenesis.</li><li>\u2022 Option C. Pyruvate: Pyruvate is a key gluconeogenic substrate that can be carboxylated to oxaloacetate and eventually converted to glucose.</li><li>\u2022 Option C. Pyruvate:</li><li>\u2022 key gluconeogenic substrate</li><li>\u2022 carboxylated to oxaloacetate</li><li>\u2022 converted to glucose.</li><li>\u2022 Option D. Alanine: Alanine can undergo transamination to form pyruvate, which can then enter the gluconeogenesis pathway to synthesize glucose.</li><li>\u2022 Option D. Alanine:</li><li>\u2022 Alanine</li><li>\u2022 undergo transamination</li><li>\u2022 pyruvate,</li><li>\u2022 enter the gluconeogenesis</li><li>\u2022 synthesize glucose.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Substrates for Gluconeogenesis:</li><li>\u27a4 Substrates for Gluconeogenesis:</li><li>\u27a4 Glucogenic Amino Acid [Alanine is the major contributor] Lactate Glycerol Propionyl CoA.</li><li>\u27a4 Glucogenic Amino Acid [Alanine is the major contributor]</li><li>\u27a4 Glucogenic Amino Acid</li><li>\u27a4 Lactate</li><li>\u27a4 Lactate</li><li>\u27a4 Glycerol</li><li>\u27a4 Glycerol</li><li>\u27a4 Propionyl CoA.</li><li>\u27a4 Propionyl CoA.</li><li>\u27a4 Ref : Harper 30/e p185, 186.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p185, 186.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "737085b7",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history of chronic obstructive pulmonary disease presents to the emergency department with symptoms of acute poisoning. Laboratory investigations are initiated to determine the cause. The medical team suspects exposure to a substance that specifically inhibits Complex IV of the electron transport chain (ETC) in the mitochondria. Which of the following substances is most likely responsible for the inhibition of Complex IV in this patient's mitochondria?",
      "options": [
        {
          "label": "A",
          "text": "Cyanide",
          "correct": true
        },
        {
          "label": "B",
          "text": "Alkylguanides",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oligomycin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxygen",
          "correct": false
        }
      ],
      "correct_answer": "A. Cyanide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Cyanide</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cytochrome Oxidase [Complex IV] is inhibited by CO, HCN, H2S and Na Azide.</li><li>\u27a4 Cytochrome Oxidase [Complex IV]</li><li>\u27a4 inhibited</li><li>\u27a4 CO, HCN, H2S and Na Azide.</li><li>\u27a4 Ref: Harper 30/e p132, 133.</li><li>\u27a4 Ref: Harper 30/e p132, 133.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f9b4428",
      "audio": ""
    },
    {
      "text": "A 30-year-old researcher is conducting an experiment to measure ATP production through oxidative phosphorylation in isolated mitochondria. During the experiment, they specifically focus on the contribution of FADH to the electron transport chain. Considering the efficiency of ATP generation via the oxidation of FADH, how many ATP molecules are typically produced from the oxidation of one molecule of FADH?",
      "options": [
        {
          "label": "A",
          "text": "3 ATP molecules",
          "correct": false
        },
        {
          "label": "B",
          "text": "1.5 ATP molecules",
          "correct": true
        },
        {
          "label": "C",
          "text": "1 ATP molecule",
          "correct": false
        },
        {
          "label": "D",
          "text": "No ATP at all",
          "correct": false
        }
      ],
      "correct_answer": "B. 1.5 ATP molecules",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)\u00a0 1.5 ATP molecules</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understand the bioenergetic yield of different electron donors in the ETC:</li><li>\u27a4 bioenergetic yield</li><li>\u27a4 NADH \u2192 ~2.5 ATP FADH \u2192 ~1.5 ATP</li><li>\u27a4 NADH \u2192 ~2.5 ATP</li><li>\u27a4 NADH</li><li>\u27a4 FADH \u2192 ~1.5 ATP</li><li>\u27a4 FADH</li><li>\u27a4 This knowledge is critical for calculating total ATP yield from glucose , fatty acid oxidation , or in experimental mitochondrial assays .</li><li>\u27a4 ATP yield from glucose</li><li>\u27a4 fatty acid oxidation</li><li>\u27a4 experimental mitochondrial assays</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 263.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96effea5",
      "audio": ""
    },
    {
      "text": "A 25-year-old man presents to the neurology clinic with a history of progressive vision loss and a family history of similar symptoms. Genetic testing reveals a mutation affecting the electron transport chain, specifically in the NADH-Q reductase (Complex I). Which of the following conditions is most likely associated with this mutation?",
      "options": [
        {
          "label": "A",
          "text": "Amyotrophic lateral sclerosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leber\u2019s optic myopathy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ragged red fibre disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Duchenne muscular dystrophy",
          "correct": false
        }
      ],
      "correct_answer": "B. Leber\u2019s optic myopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Leber\u2019s optic myopathy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Amyotrophic lateral sclerosis: This is a progressive neurodegenerative disorder affecting motor neurons but is not typically associated with mutations in NADH-Q reductase.</li><li>\u2022 Option A. Amyotrophic lateral sclerosis:</li><li>\u2022 progressive neurodegenerative disorder</li><li>\u2022 motor neurons</li><li>\u2022 not</li><li>\u2022 mutations in NADH-Q reductase.</li><li>\u2022 Option C. Ragged red fibre disease: Also known as mitochondrial myopathy , this condition is characterized by muscle weakness and the p resence of ragged red fibers in muscle biopsies . It can be associated with various mitochondrial defects but is not specifically linked to mutations in NADH-Q reductase.</li><li>\u2022 Option C. Ragged red fibre disease:</li><li>\u2022 mitochondrial myopathy</li><li>\u2022 muscle weakness</li><li>\u2022 resence of ragged red fibers</li><li>\u2022 muscle biopsies</li><li>\u2022 various mitochondrial defects</li><li>\u2022 not</li><li>\u2022 linked</li><li>\u2022 mutations in NADH-Q reductase.</li><li>\u2022 Option D. Duchenne muscular dystrophy: This is a genetic disorder characterized by progressive muscle degeneration and weakness due to mutations in the dystrophin gene, not directly related to mitochondrial function or NADH-Q reductase mutations.</li><li>\u2022 Option D. Duchenne muscular dystrophy:</li><li>\u2022 genetic disorder</li><li>\u2022 progressive muscle degeneration and weakness</li><li>\u2022 mutations in the dystrophin gene, not</li><li>\u2022 mitochondrial function or NADH-Q reductase mutations.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mutations in mitochondrial DNA causes:</li><li>\u27a4 Mutations in mitochondrial DNA causes:</li><li>\u27a4 Lethal infantile mitochondrial ophthalmoplegia Leber\u2019s hereditary optic neuropathy (LHON) Myoclonic epilepsy Mitochondrial encephalomyopathy lactic acidosis stroke like episodes (MELAS) MERRF Kearns-Sayre syndrome Pearson syndrome Leigh syndrome NARP</li><li>\u27a4 Lethal infantile mitochondrial ophthalmoplegia</li><li>\u27a4 Leber\u2019s hereditary optic neuropathy (LHON)</li><li>\u27a4 Myoclonic epilepsy</li><li>\u27a4 Mitochondrial encephalomyopathy lactic acidosis stroke like episodes (MELAS)</li><li>\u27a4 MERRF</li><li>\u27a4 Kearns-Sayre syndrome</li><li>\u27a4 Pearson syndrome</li><li>\u27a4 Leigh syndrome</li><li>\u27a4 NARP</li><li>\u27a4 Mitochondrial DNA Mutations are inherited maternally ( mother to all children ) Leber\u2019s hereditary optic myopathy is characterized by blindness in young males and caused by a single base mutation in NADH Coenzyme Q reductase.</li><li>\u27a4 Mitochondrial DNA Mutations</li><li>\u27a4 inherited maternally</li><li>\u27a4 mother to all children</li><li>\u27a4 Leber\u2019s hereditary optic myopathy</li><li>\u27a4 blindness in young males</li><li>\u27a4 single base mutation</li><li>\u27a4 NADH</li><li>\u27a4 Coenzyme Q reductase.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 358</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 358</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f71e6b0c",
      "audio": ""
    },
    {
      "text": "Which of the following statements about the electron transport chain is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Located in inner mitochondrial membrane",
          "correct": false
        },
        {
          "label": "B",
          "text": "Components are organized in decreasing order of redox potential",
          "correct": true
        },
        {
          "label": "C",
          "text": "Involved with ATP synthesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cyanide inhibits electron flow",
          "correct": false
        }
      ],
      "correct_answer": "B. Components are organized in decreasing order of redox potential",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Components are organized in decreasing order of redox potential</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ETC</li><li>\u27a4 ETC</li><li>\u27a4 Site: In the Inner Mitochondrial Membrane Components of the Electron Transport Chain are contained in four large protein complexes Electrons are transferred in the ascending or increasing order of redox potential . NADH has lowest and Oxygen has highest redox potential. The flow of electrons through the respiratory chain generates ATP by the process of oxidative phosphorylation. Inhibitors are mentioned in the image.</li><li>\u27a4 Site: In the Inner Mitochondrial Membrane</li><li>\u27a4 Site:</li><li>\u27a4 Inner Mitochondrial Membrane</li><li>\u27a4 Components of the Electron Transport Chain are contained in four large protein complexes</li><li>\u27a4 Components</li><li>\u27a4 four large protein complexes</li><li>\u27a4 Electrons are transferred in the ascending or increasing order of redox potential . NADH has lowest and Oxygen has highest redox potential.</li><li>\u27a4 Electrons</li><li>\u27a4 ascending or increasing order</li><li>\u27a4 redox potential</li><li>\u27a4 NADH</li><li>\u27a4 lowest and Oxygen</li><li>\u27a4 highest redox potential.</li><li>\u27a4 The flow of electrons through the respiratory chain generates ATP by the process of oxidative phosphorylation.</li><li>\u27a4 flow of electrons</li><li>\u27a4 respiratory chain generates ATP</li><li>\u27a4 oxidative phosphorylation.</li><li>\u27a4 Inhibitors are mentioned in the image.</li><li>\u27a4 Inhibitors</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 260.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 260.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d534c2d5",
      "audio": ""
    },
    {
      "text": "Which one of the following components of the respiratory chain directly reacts with molecular oxygen to facilitate this reduction?",
      "options": [
        {
          "label": "A",
          "text": "Coenzyme Q",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cytochrome b",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cytochrome aa3",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cytochrome c",
          "correct": false
        }
      ],
      "correct_answer": "C. Cytochrome aa3",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Cytochrome aa3</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Complex IV contains different proteins such as cytochrome a and cytochrome a3. Four electrons are accepted from cytochrome c and passed on to molecular oxygen 4 H+ + O2 + 4 Cyt c-Fe++ \u2192 2 H2O + 4 Cyt c+++ 2 protons are pumped out to the intermembrane space . Cytochrome oxidase has 4 redox centres a, a3, CuA and CuB and the electron transfer in this complex is as shown</li><li>\u27a4 Complex IV contains different proteins such as cytochrome a and cytochrome a3.</li><li>\u27a4 Complex IV</li><li>\u27a4 proteins</li><li>\u27a4 cytochrome a and cytochrome a3.</li><li>\u27a4 Four electrons are accepted from cytochrome c and passed on to molecular oxygen 4 H+ + O2 + 4 Cyt c-Fe++ \u2192 2 H2O + 4 Cyt c+++</li><li>\u27a4 Four electrons</li><li>\u27a4 cytochrome c</li><li>\u27a4 molecular oxygen</li><li>\u27a4 4 H+ + O2 + 4 Cyt c-Fe++ \u2192 2 H2O + 4 Cyt c+++</li><li>\u27a4 2 protons are pumped out to the intermembrane space .</li><li>\u27a4 2 protons</li><li>\u27a4 out</li><li>\u27a4 intermembrane space</li><li>\u27a4 Cytochrome oxidase has 4 redox centres a, a3, CuA and CuB and the electron transfer in this complex is as shown</li><li>\u27a4 Cytochrome oxidase</li><li>\u27a4 4 redox centres a, a3, CuA and CuB</li><li>\u27a4 electron transfer</li><li>\u27a4 Cyt c \u2192CuA \u2192Cyt a \u2192Cyt a3 \u2192CuB</li><li>\u27a4 Cyt c \u2192CuA \u2192Cyt a \u2192Cyt a3 \u2192CuB</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 262.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 262.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2ecea4cf",
      "audio": ""
    },
    {
      "text": "Which of the following statements correctly describes the ATP Synthase complex?",
      "options": [
        {
          "label": "A",
          "text": "It is the fourth complex of ETC",
          "correct": false
        },
        {
          "label": "B",
          "text": "F0 spans inner mitochondrial membrane & F1 projects into matrix",
          "correct": true
        },
        {
          "label": "C",
          "text": "F1 spans inner mitochondrial membrane & F0 projects into matrix",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amobarbital is an inhibitor of this complex",
          "correct": false
        }
      ],
      "correct_answer": "B. F0 spans inner mitochondrial membrane & F1 projects into matrix",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) F0 spans inner mitochondrial membrane & F1 projects into matrix</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 It is the Fifth Complex of Electron transport Chain (option a) Location - Embedded in the inner mitochondrial membrane. Divided into two Subcomplexes: F0 Subcomplex and F1 Subcomplex. F0 Subcomplex: Hydrophobic in nature , F0 spans the inner mitochondrial membrane and forms a proton channel. F1 Subcomplex : Hydrophilic in nature, Projects into the mitochondrial matrix and is attached to F0 Subcomplex. Inhibitors of oxidative phosphorylation: Atractyloside , inhibits translocase Oligomycin , inhibits flow of protons through Fo Ionophores , e.g. Valinomycin</li><li>\u27a4 It is the Fifth Complex of Electron transport Chain (option a)</li><li>\u27a4 Fifth Complex of Electron transport Chain</li><li>\u27a4 Location - Embedded in the inner mitochondrial membrane.</li><li>\u27a4 Location</li><li>\u27a4 inner mitochondrial membrane.</li><li>\u27a4 Divided into two Subcomplexes: F0 Subcomplex and F1 Subcomplex.</li><li>\u27a4 two Subcomplexes: F0 Subcomplex and F1 Subcomplex.</li><li>\u27a4 F0 Subcomplex: Hydrophobic in nature , F0 spans the inner mitochondrial membrane and forms a proton channel.</li><li>\u27a4 F0 Subcomplex: Hydrophobic in nature</li><li>\u27a4 F0</li><li>\u27a4 inner mitochondrial membrane</li><li>\u27a4 proton channel.</li><li>\u27a4 F1 Subcomplex : Hydrophilic in nature, Projects into the mitochondrial matrix and is attached to F0 Subcomplex.</li><li>\u27a4 F1 Subcomplex</li><li>\u27a4 Hydrophilic in nature, Projects</li><li>\u27a4 mitochondrial matrix</li><li>\u27a4 attached to F0 Subcomplex.</li><li>\u27a4 Inhibitors of oxidative phosphorylation: Atractyloside , inhibits translocase Oligomycin , inhibits flow of protons through Fo Ionophores , e.g. Valinomycin</li><li>\u27a4 Inhibitors</li><li>\u27a4 oxidative phosphorylation:</li><li>\u27a4 Atractyloside , inhibits translocase Oligomycin , inhibits flow of protons through Fo Ionophores , e.g. Valinomycin</li><li>\u27a4 Atractyloside , inhibits translocase</li><li>\u27a4 Atractyloside</li><li>\u27a4 translocase</li><li>\u27a4 Oligomycin , inhibits flow of protons through Fo</li><li>\u27a4 Oligomycin</li><li>\u27a4 flow of protons through Fo</li><li>\u27a4 Ionophores , e.g. Valinomycin</li><li>\u27a4 Ionophores</li><li>\u27a4 Valinomycin</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 264.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 264.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72725e5a",
      "audio": ""
    },
    {
      "text": "A researcher is investigating the effects of various biochemical substances on mitochondrial oxidative phosphorylation in a laboratory setting. They are particularly interested in substances that can disrupt the proton gradient across the mitochondrial membrane, thereby acting as uncouplers. Which of the following substances is capable of acting as an uncoupler in oxidative phosphorylation?",
      "options": [
        {
          "label": "A",
          "text": "Bilirubin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Free fatty acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thyroxine",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All of the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bilirubin: While not its primary role or effect, bilirubin can act as an uncoupler under certain conditions, particularly at high concentrations.</li><li>\u2022 Option A. Bilirubin:</li><li>\u2022 not</li><li>\u2022 act as</li><li>\u2022 uncoupler</li><li>\u2022 high concentrations.</li><li>\u2022 Option B. Free fatty acid: Free fatty acids are more commonly recognized as uncouplers , disrupting the proton gradient across the mitochondrial membrane.</li><li>\u2022 Option B. Free fatty acid:</li><li>\u2022 more</li><li>\u2022 uncouplers</li><li>\u2022 disrupting the proton gradient</li><li>\u2022 mitochondrial membrane.</li><li>\u2022 Option C. Thyroxine: Thyroxine is known to increase the metabolic rate by uncoupling oxidative phosphorylation, leading to increased heat production.</li><li>\u2022 Option C. Thyroxine:</li><li>\u2022 increase the metabolic rate</li><li>\u2022 uncoupling oxidative phosphorylation,</li><li>\u2022 increased heat production.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Physiological Uncoupler</li><li>\u27a4 Physiological Uncoupler</li><li>\u27a4 Thermogenin [Uncoupling Protein 1] in Brown Adipose Tissue (naturally occurring uncoupler) Thyroxine Long Chain Free Fatty Acid Unconjugated Bilirubin .</li><li>\u27a4 Thermogenin [Uncoupling Protein 1] in Brown Adipose Tissue (naturally occurring uncoupler)</li><li>\u27a4 Thermogenin</li><li>\u27a4 Thyroxine</li><li>\u27a4 Thyroxine</li><li>\u27a4 Long Chain Free Fatty Acid</li><li>\u27a4 Long Chain Free Fatty Acid</li><li>\u27a4 Unconjugated Bilirubin .</li><li>\u27a4 Unconjugated Bilirubin</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 266.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 266.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c673a67",
      "audio": ""
    },
    {
      "text": "A professor is discussing mitochondrial disorders with her students, focusing on diseases associated with defects in oxidative phosphorylation (OXPHOS). She highlights several conditions that result from mutations affecting mitochondrial DNA and impairing the electron transport chain and ATP synthesis. Which of the following conditions are considered OXPHOS diseases?",
      "options": [
        {
          "label": "A",
          "text": "LHON",
          "correct": false
        },
        {
          "label": "B",
          "text": "MERRF",
          "correct": false
        },
        {
          "label": "C",
          "text": "Only A",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both A and B",
          "correct": true
        }
      ],
      "correct_answer": "D. Both A and B",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture6.jpg"
      ],
      "explanation": "<p><strong>Ans. D)\u00a0 Both A and B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. LHON: This is an OXPHOS disease affecting the optic nerves , but it is not the only one.</li><li>\u2022 Option A. LHON:</li><li>\u2022 OXPHOS disease</li><li>\u2022 optic nerves</li><li>\u2022 not</li><li>\u2022 Option B. MERRF: This condition, characterized by myoclonic seizures and muscle pathology , is also an OXPHOS disease.</li><li>\u2022 Option B. MERRF:</li><li>\u2022 myoclonic seizures and muscle pathology</li><li>\u2022 OXPHOS disease.</li><li>\u2022 They usually manifestations in nervous system (seizures, deafness, dementia), eyes ( retinitis pigmentosa, optic atrophy, blindness, ptosis ), heart ( cardiomyopathy ), kidneys ( Fanconi\u2019s syndrome , with loss of metabolites in urine) and skeletal muscles ( myoglobinuria ).</li><li>\u2022 manifestations in nervous system</li><li>\u2022 eyes</li><li>\u2022 retinitis pigmentosa, optic atrophy, blindness,</li><li>\u2022 ptosis</li><li>\u2022 heart</li><li>\u2022 cardiomyopathy</li><li>\u2022 kidneys</li><li>\u2022 Fanconi\u2019s syndrome</li><li>\u2022 skeletal muscles</li><li>\u2022 myoglobinuria</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 606.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 606.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c2bc7386",
      "audio": ""
    },
    {
      "text": "Among the following options, which one does NOT act as an uncoupler of oxidative phosphorylation?",
      "options": [
        {
          "label": "A",
          "text": "2,4-dinitrophenol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Valinomycin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thermogenin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oligomycin",
          "correct": true
        }
      ],
      "correct_answer": "D. Oligomycin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Oligomycin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Oligomycin is an antibiotic which inhibits flow of protons through Fo by binding complex V. It is not an uncoupler. Ionophores are lipid-soluble compounds which increases the permeability of lipid bilayers to certain ions. There are two types of ionophores : mobile ion carries (e.g. valinomycin ) and channel formers (e.g. gramicidin). Valinomycin allows potassium to permeate mitochondria and dissipate the proton gradient. 2,4-dinitrophenol is a protonophore and acts as a synthetic uncoupler. Thermogenin is a mitochondrial membrane protein naturally present in brown adipose tissues and acts as an uncoupler. All of these inhibit oxidative phosphorylation by dissipating proton gradient.</li><li>\u27a4 Oligomycin is an antibiotic which inhibits flow of protons through Fo by binding complex V. It is not an uncoupler.</li><li>\u27a4 Oligomycin</li><li>\u27a4 antibiotic</li><li>\u27a4 inhibits flow of protons</li><li>\u27a4 Fo</li><li>\u27a4 complex V.</li><li>\u27a4 not</li><li>\u27a4 uncoupler.</li><li>\u27a4 Ionophores are lipid-soluble compounds which increases the permeability of lipid bilayers to certain ions. There are two types of ionophores : mobile ion carries (e.g. valinomycin ) and channel formers (e.g. gramicidin). Valinomycin allows potassium to permeate mitochondria and dissipate the proton gradient. 2,4-dinitrophenol is a protonophore and acts as a synthetic uncoupler. Thermogenin is a mitochondrial membrane protein naturally present in brown adipose tissues and acts as an uncoupler. All of these inhibit oxidative phosphorylation by dissipating proton gradient.</li><li>\u27a4 Ionophores</li><li>\u27a4 lipid-soluble compounds</li><li>\u27a4 increases</li><li>\u27a4 lipid bilayers to certain ions.</li><li>\u27a4 two types of ionophores</li><li>\u27a4 mobile ion carries</li><li>\u27a4 valinomycin</li><li>\u27a4 channel formers</li><li>\u27a4 Valinomycin</li><li>\u27a4 potassium to permeate mitochondria</li><li>\u27a4 dissipate the proton gradient. 2,4-dinitrophenol</li><li>\u27a4 protonophore</li><li>\u27a4 synthetic uncoupler.</li><li>\u27a4 Thermogenin</li><li>\u27a4 protein</li><li>\u27a4 brown</li><li>\u27a4 adipose tissues</li><li>\u27a4 uncoupler.</li><li>\u27a4 inhibit oxidative phosphorylation</li><li>\u27a4 dissipating proton gradient.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 266.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 266.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24960d7c",
      "audio": ""
    },
    {
      "text": "Which of the following statements about ATP synthesis is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Protein assembly is seen in the inner mitochondrial membrane",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atractyloside inhibits the process",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oxidation is coupled to phosphorylation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Availability of ATP regulates the process",
          "correct": true
        }
      ],
      "correct_answer": "D. Availability of ATP regulates the process",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Availability of ATP regulates the process</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 It is a protein assembly in the inner mitochondrial membrane. Also known as 5th Complex The availability of ADP regulates the process of ATP synthesis . When ATP level is low and ADP level is high, oxidative phosphorylation happens at a rapid rate. This is known as respiratory control or acceptor control. Inhibitors of oxidative phosphorylation Atractyloside , inhibits translocase Oligomycin, inhibits flow of protons through Fo Ionophores , e.g. Valinomycin</li><li>\u27a4 It is a protein assembly in the inner mitochondrial membrane.</li><li>\u27a4 protein</li><li>\u27a4 inner mitochondrial membrane.</li><li>\u27a4 Also known as 5th Complex</li><li>\u27a4 5th Complex</li><li>\u27a4 The availability of ADP regulates the process of ATP synthesis . When ATP level is low and ADP level is high, oxidative phosphorylation happens at a rapid rate.</li><li>\u27a4 ADP regulates</li><li>\u27a4 ATP synthesis</li><li>\u27a4 ATP level is low</li><li>\u27a4 ADP level is high,</li><li>\u27a4 oxidative</li><li>\u27a4 phosphorylation</li><li>\u27a4 a rapid rate.</li><li>\u27a4 This is known as respiratory control or acceptor control.</li><li>\u27a4 respiratory control or acceptor control.</li><li>\u27a4 Inhibitors of oxidative phosphorylation</li><li>\u27a4 Inhibitors of oxidative phosphorylation</li><li>\u27a4 Atractyloside , inhibits translocase</li><li>\u27a4 Atractyloside</li><li>\u27a4 translocase</li><li>\u27a4 Oligomycin, inhibits flow of protons through Fo</li><li>\u27a4 Oligomycin,</li><li>\u27a4 protons through Fo</li><li>\u27a4 Ionophores , e.g. Valinomycin</li><li>\u27a4 Ionophores</li><li>\u27a4 Valinomycin</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 265.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 265.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "31aea6a2",
      "audio": ""
    },
    {
      "text": "A 3-year-old child presents with hypoglycaemia and metabolic acidosis. Laboratory investigations reveal a genetic disorder that causes the liver enzyme fructose 1,6-bisphosphatase to be more sensitive to inhibition by fructose 2,6-bisphosphate. This enzyme is a crucial regulatory point in gluconeogenesis. Based on this enzymatic defect, which of the following metabolic changes would be expected in this child?",
      "options": [
        {
          "label": "A",
          "text": "Level of fructose 1,6-biphosphate is lower than normal",
          "correct": false
        },
        {
          "label": "B",
          "text": "Level of fructose 1,6-biphosphate is higher than normal",
          "correct": true
        },
        {
          "label": "C",
          "text": "Increased Glucose production",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased gluconeogenesis",
          "correct": false
        }
      ],
      "correct_answer": "B. Level of fructose 1,6-biphosphate is higher than normal",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Level of fructose 1,6-biphosphate is higher than normal</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 Fructose 1,6-bisphosphatase is a key regulatory enzyme in gluconeogenesis , inhibited by fructose 2,6-bisphosphate . Its inhibition results in accumulation of fructose 1,6-bisphosphate and impaired glucose production. This can cause fasting hypoglycemia , lactic acidosis , and failure to thrive , especially in early childhood.</li><li>\u27a4 Fructose 1,6-bisphosphatase is a key regulatory enzyme in gluconeogenesis , inhibited by fructose 2,6-bisphosphate .</li><li>\u27a4 Fructose 1,6-bisphosphatase</li><li>\u27a4 key regulatory enzyme in gluconeogenesis</li><li>\u27a4 fructose 2,6-bisphosphate</li><li>\u27a4 Its inhibition results in accumulation of fructose 1,6-bisphosphate and impaired glucose production.</li><li>\u27a4 accumulation of fructose 1,6-bisphosphate</li><li>\u27a4 This can cause fasting hypoglycemia , lactic acidosis , and failure to thrive , especially in early childhood.</li><li>\u27a4 fasting hypoglycemia</li><li>\u27a4 lactic acidosis</li><li>\u27a4 failure to thrive</li><li>\u27a4 Ref : Harper 30/e p169-170.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1817035c",
      "audio": ""
    },
    {
      "text": "A child was recently diagnosed with G6PD deficiency. Glucose 6-phosphate dehydrogenase (G6PD) catalyzes the regulatory step in the HMP shunt. Which is the correct statement about G6PD and HMP shunt?",
      "options": [
        {
          "label": "A",
          "text": "Deficiency of G6PD occurs only in red blood cells.",
          "correct": false
        },
        {
          "label": "B",
          "text": "The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Deficiency of G6PD \u2192 inability to keep glutathione in reduced functional form.",
          "correct": true
        },
        {
          "label": "D",
          "text": "The reduced NADPH formed during the shunt is utilized in fatty acid oxidation.",
          "correct": false
        }
      ],
      "correct_answer": "C. Deficiency of G6PD \u2192 inability to keep glutathione in reduced functional form.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture8.jpg"
      ],
      "explanation": "<p><strong>Ans. C)\u00a0 Deficiency of G6PD \u2192 inability to keep glutathione in reduced functional form.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Deficiency of G6PD occurs only in red blood cells: The oxidative phase of the pathway is seen in Liver, Adipose tissue, Adrenal cortex, Testes and ovaries, RBCs and Lens of eye. The non-oxidative phase is present in all tissues .</li><li>\u2022 Option A. Deficiency of G6PD occurs only in red blood cells:</li><li>\u2022 oxidative phase</li><li>\u2022 Liver, Adipose tissue,</li><li>\u2022 Adrenal cortex, Testes and ovaries, RBCs and Lens of eye.</li><li>\u2022 non-oxidative phase</li><li>\u2022 all tissues</li><li>\u2022 Option B. The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions: involves two irreversible oxidative reactions</li><li>\u2022 Option B. The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions:</li><li>\u2022 two irreversible oxidative reactions</li><li>\u2022 Option D.  The reduced NADPH formed during the shunt is utilized in fatty acid oxidation: used in fatty acid synthesis, steroid hormone, and cholesterol synthesis.</li><li>\u2022 Option D.  The reduced NADPH formed during the shunt is utilized in fatty acid oxidation:</li><li>\u2022 fatty acid synthesis, steroid hormone, and cholesterol synthesis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 G6PD is an enzyme in the hexose monophosphate shunt that is responsible for the production of NADPH. NADPH is crucial for maintaining the reduced form of glutathione , a critical antioxidant in cells. In G6PD deficiency, the reduced production of NADPH leads to a reduced ability to maintain glutathione in its reduced form , making red blood cells more susceptible to oxidative damage .</li><li>\u27a4 G6PD</li><li>\u27a4 hexose monophosphate shunt</li><li>\u27a4 NADPH.</li><li>\u27a4 NADPH</li><li>\u27a4 reduced form of glutathione</li><li>\u27a4 antioxidant in cells.</li><li>\u27a4 G6PD deficiency,</li><li>\u27a4 NADPH</li><li>\u27a4 reduced ability to maintain glutathione</li><li>\u27a4 reduced form</li><li>\u27a4 red blood cells</li><li>\u27a4 oxidative damage</li><li>\u27a4 Ref : Harper 30/e: p 196-200.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 196-200.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "50476c39",
      "audio": ""
    },
    {
      "text": "A middle-aged woman visited a region with known chloroquine-resistant malaria. As a prophylactic measure, she was administered primaquine. Shortly after starting the medication, she exhibited signs of hemolytic anemia and was later diagnosed with a deficiency in glucose 6-phosphate dehydrogenase (G6PD). Given the role of G6PD in cellular metabolism, what is the underlying cause of her hemolytic symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Oxidized form of nicotinamide adenine dinucleotide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucose 6-phosphate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ribose 5-phosphate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decrease Level of Reduced Glutathione",
          "correct": true
        }
      ],
      "correct_answer": "D. Decrease Level of Reduced Glutathione",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Decrease Level of Reduced Glutathione</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 In G6PD deficiency , red blood cells have:</li><li>\u27a4 G6PD deficiency</li><li>\u27a4 Impaired ability to handle oxidative stress Low NADPH levels Decreased reduced glutathione (GSH)</li><li>\u27a4 Impaired ability to handle oxidative stress</li><li>\u27a4 Impaired ability to handle oxidative stress</li><li>\u27a4 Low NADPH levels</li><li>\u27a4 Low NADPH levels</li><li>\u27a4 Decreased reduced glutathione (GSH)</li><li>\u27a4 Decreased reduced glutathione (GSH)</li><li>\u27a4 This makes them susceptible to hemolysis , especially after exposure to oxidant drugs like primaquine .</li><li>\u27a4 hemolysis</li><li>\u27a4 oxidant drugs like primaquine</li><li>\u27a4 Ref: Harper 30/e: p 586, 693-694.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2f84d9a1",
      "audio": ""
    },
    {
      "text": "A 1-year-old child with a diagnosed inborn error of the pentose phosphate pathway is brought to the clinic for a follow-up. The child has a history of hemolytic anemia and developmental delays. The pentose phosphate pathway is crucial for producing NADPH, which is essential for maintaining the reducing environment in cells. Given the importance of this pathway, which of the following organs is least likely to contain enzymes for an active pentose phosphate pathway?",
      "options": [
        {
          "label": "A",
          "text": "Adrenal Gland",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liver",
          "correct": false
        },
        {
          "label": "C",
          "text": "Red Blood Cells",
          "correct": false
        },
        {
          "label": "D",
          "text": "Skeletal Muscle",
          "correct": true
        }
      ],
      "correct_answer": "D. Skeletal Muscle",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Skeletal muscle</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HMP shunt: Involved in synthesis of NADPH and Pentoses.</li><li>\u27a4 HMP shunt:</li><li>\u27a4 synthesis of NADPH and Pentoses.</li><li>\u27a4 Uses of NADPH</li><li>\u27a4 Uses of NADPH</li><li>\u27a4 Reductive biosynthesis of fatty acids, cholesterol, steroid hormones & bile acids. Cofactor for glutathione reductase and MetHb reductase So HMP shunt is active in: Adipose tissue, liver, RBC, ovary, testes, adrenal gland and lactating mammary gland.</li><li>\u27a4 Reductive biosynthesis of fatty acids, cholesterol, steroid hormones & bile acids.</li><li>\u27a4 Reductive</li><li>\u27a4 fatty acids, cholesterol, steroid hormones & bile acids.</li><li>\u27a4 Cofactor for glutathione reductase and MetHb reductase</li><li>\u27a4 Cofactor</li><li>\u27a4 glutathione reductase</li><li>\u27a4 MetHb reductase</li><li>\u27a4 So HMP shunt is active in: Adipose tissue, liver, RBC, ovary, testes, adrenal gland and lactating mammary gland.</li><li>\u27a4 HMP shunt is active</li><li>\u27a4 Adipose tissue, liver, RBC, ovary, testes, adrenal gland and</li><li>\u27a4 lactating mammary gland.</li><li>\u27a4 Sources of NADPH:</li><li>\u27a4 Sources of NADPH:</li><li>\u27a4 HMP (G6PD and 6 phosphogluconate dehydrogenase) Malic enzyme Isocitrate dehydrogenase (Cytosolic)</li><li>\u27a4 HMP (G6PD and 6 phosphogluconate dehydrogenase)</li><li>\u27a4 HMP</li><li>\u27a4 Malic enzyme</li><li>\u27a4 Malic enzyme</li><li>\u27a4 Isocitrate dehydrogenase (Cytosolic)</li><li>\u27a4 Isocitrate dehydrogenase</li><li>\u27a4 Ref : Harper 30/e: p 196-200.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 196-200.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56df10b3",
      "audio": ""
    },
    {
      "text": "In the context of cellular metabolism and redox balance, which pathway is primarily responsible for the generation of NADPH, a key factor in protecting cells from oxidative stress?",
      "options": [
        {
          "label": "A",
          "text": "Glycolysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Citric acid cycle",
          "correct": false
        },
        {
          "label": "C",
          "text": "HMP shunt",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fatty acid oxidation",
          "correct": false
        }
      ],
      "correct_answer": "C. HMP shunt",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) HMP shunt</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 NADPH is used for reductive biosynthetic pathways such as fatty acid synthesis, steroid and cholesterol synthesis and Amino acids by Glutamate dehydrogenase. NADPH is required for regeneration of reduced Glutathione which clears free radicals from erythrocytes and lens.</li><li>\u27a4 NADPH is used for reductive biosynthetic pathways such as fatty acid synthesis, steroid and cholesterol synthesis and Amino acids by Glutamate dehydrogenase.</li><li>\u27a4 NADPH</li><li>\u27a4 reductive biosynthetic pathways</li><li>\u27a4 fatty acid synthesis, steroid and cholesterol synthesis</li><li>\u27a4 Amino acids</li><li>\u27a4 Glutamate dehydrogenase.</li><li>\u27a4 NADPH is required for regeneration of reduced Glutathione which clears free radicals from erythrocytes and lens.</li><li>\u27a4 NADPH</li><li>\u27a4 regeneration of reduced Glutathione</li><li>\u27a4 free radicals</li><li>\u27a4 erythrocytes and lens.</li><li>\u27a4 Ref : Harper 30/e p197.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p197.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "803da7b2",
      "audio": ""
    },
    {
      "text": "In a competitive quiz on cellular metabolism among medical students, a challenging question is posed regarding the regulation of Phosphofructokinase-1 (PFK-1), a key enzyme in the glycolytic pathway. The quizmaster asks which of the following molecules does not serve as an activator for PFK-1, contrary to the common regulatory mechanisms of this crucial enzyme. The options given are:",
      "options": [
        {
          "label": "A",
          "text": "5\u2019AMP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fructose 2, 6 Bisphosphate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fructose 6 Phosphate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Citrate",
          "correct": true
        }
      ],
      "correct_answer": "D. Citrate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture10.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Citrate.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Citrate is an Inhibitor of Phosphofructokinase-I.</li><li>\u27a4 Citrate is an Inhibitor of Phosphofructokinase-I.</li><li>\u27a4 Ref: Harper 30/e p188.</li><li>\u27a4 Ref: Harper 30/e p188.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6ccb5700",
      "audio": ""
    },
    {
      "text": "Identifying the enzymes crucial for gluconeogenesis is essential for understanding metabolic pathways that contribute to glucose homeostasis. Which of the following options lists the key enzymes responsible for this process?",
      "options": [
        {
          "label": "A",
          "text": "Pyruvate carboxylase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phosphoenol pyruvate carboxykinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fructose-1-6-bisphosphatase",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All the above.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pyruvate carboxylase: Initiates gluconeogenesis by converting pyruvate to oxaloacetate.</li><li>\u2022 Option A. Pyruvate carboxylase:</li><li>\u2022 gluconeogenesis</li><li>\u2022 pyruvate to oxaloacetate.</li><li>\u2022 Option B. Phosphoenolpyruvate carboxykinase: Continues the pathway by converting oxaloacetate to phosphoenolpyruvate .</li><li>\u2022 Option B. Phosphoenolpyruvate carboxykinase:</li><li>\u2022 converting oxaloacetate to phosphoenolpyruvate</li><li>\u2022 Option C. Fructose-1,6-bisphosphatase: Crucial for bypassing a key glycolytic step in the reverse direction , converting fructose-1,6-bisphosphate to fructose-6-phosphate.</li><li>\u2022 Option C. Fructose-1,6-bisphosphatase:</li><li>\u2022 glycolytic step</li><li>\u2022 reverse direction</li><li>\u2022 fructose-1,6-bisphosphate to fructose-6-phosphate.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Key Gluconeogenic Enzymes</li><li>\u27a4 Key Gluconeogenic Enzymes</li><li>\u27a4 Pyruvate carboxylase Phosphoenol pyruvate carboxykinase Fructose-1-6-bisphosphatase Glucose-6-phosphatase</li><li>\u27a4 Pyruvate carboxylase</li><li>\u27a4 Phosphoenol pyruvate carboxykinase</li><li>\u27a4 Fructose-1-6-bisphosphatase</li><li>\u27a4 Glucose-6-phosphatase</li><li>\u27a4 Ref : Harper 30/e p187.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p187.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f3f6761",
      "audio": ""
    },
    {
      "text": "In a clinical case discussion, a medical student presents a patient with a genetic defect impacting a key metabolic pathway, leading to abnormal red blood cell function. The discussion focuses on the role of various metabolic pathways in cellular health. The student is asked to identify which of the following statements about the hexose monophosphate (HMP) shunt does not align with its known functions.",
      "options": [
        {
          "label": "A",
          "text": "Serves as a source of NADPH, essential for reductive biosynthesis and detoxification.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Provides Ribose 5-phosphate for nucleotide synthesis.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Plays a role in preventing the formation of methemoglobin by maintaining reduced glutathione.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Is directly implicated in causing free radical injury due to its metabolic processes.",
          "correct": true
        }
      ],
      "correct_answer": "D. Is directly implicated in causing free radical injury due to its metabolic processes.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Is directly implicated in causing free radical injury due to its metabolic processes.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Biochemical Significances of HMP Pathway</li><li>\u27a4 Biochemical Significances of HMP Pathway</li><li>\u27a4 Alternative route for metabolism of Glucose and causes complete oxidation of Glucose Major function is to generate NADPH and Riboses No ATP is generated by this pathway Free radical scavenging Maintain RBC membrane integrity by keeping GSH in reduced state Prevention of met-haemoglobin formation Detoxification by hydroxylation Maintain the transparency of lens Bactericidal activity of macrophages</li><li>\u27a4 Alternative route for metabolism of Glucose and causes complete oxidation of Glucose</li><li>\u27a4 Alternative</li><li>\u27a4 metabolism of Glucose</li><li>\u27a4 complete oxidation of Glucose</li><li>\u27a4 Major function is to generate NADPH and Riboses</li><li>\u27a4 NADPH and Riboses</li><li>\u27a4 No ATP is generated by this pathway</li><li>\u27a4 No ATP</li><li>\u27a4 Free radical scavenging</li><li>\u27a4 Free radical scavenging</li><li>\u27a4 Maintain RBC membrane integrity by keeping GSH in reduced state</li><li>\u27a4 RBC membrane integrity</li><li>\u27a4 GSH in reduced state</li><li>\u27a4 Prevention of met-haemoglobin formation</li><li>\u27a4 met-haemoglobin</li><li>\u27a4 Detoxification by hydroxylation</li><li>\u27a4 Detoxification</li><li>\u27a4 Maintain the transparency of lens</li><li>\u27a4 transparency of lens</li><li>\u27a4 Bactericidal activity of macrophages</li><li>\u27a4 Bactericidal</li><li>\u27a4 macrophages</li><li>\u27a4 Ref : Harper 30/e p197.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p197.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "38a6fe57",
      "audio": ""
    },
    {
      "text": "A 25-year-old male visits his primary care physician complaining of recurrent episodes of pain in his calves triggered by physical activity. He reports no other symptoms or significant medical history. Given the concern for a metabolic muscle disorder, a muscle biopsy is performed, revealing an accumulation of glycogen within the muscle cells. Based on the patient's symptoms and biopsy findings, which enzyme deficiency is most likely responsible for his condition?",
      "options": [
        {
          "label": "A",
          "text": "Muscle debranching enzyme",
          "correct": false
        },
        {
          "label": "B",
          "text": "Muscle phosphorylase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Glucose 6 phosphatase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Branching enzyme",
          "correct": false
        }
      ],
      "correct_answer": "B. Muscle phosphorylase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture12.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Muscle Phosphorylase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Harper 30/e: p 179.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 179.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "099a5ad6",
      "audio": ""
    },
    {
      "text": "Which of the following tissues is INCAPABLE of contributing directly to blood glucose levels through glycogen breakdown?",
      "options": [
        {
          "label": "A",
          "text": "Liver",
          "correct": false
        },
        {
          "label": "B",
          "text": "Muscle",
          "correct": true
        },
        {
          "label": "C",
          "text": "Both",
          "correct": false
        },
        {
          "label": "D",
          "text": "None",
          "correct": false
        }
      ],
      "correct_answer": "B. Muscle",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture13.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Muscle</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Liver: The liver is capable of contributing directly to blood glucose levels through glycogen breakdown. It contains the enzyme glucose-6-phosphatase, which allows for the conversion of glucose-6-phosphate into free glucose that can be released into the bloodstream, thereby maintaining blood glucose levels , especially during fasting .</li><li>\u2022 Option A. Liver:</li><li>\u2022 directly to blood glucose levels</li><li>\u2022 glycogen breakdown.</li><li>\u2022 glucose-6-phosphatase,</li><li>\u2022 glucose-6-phosphate into free glucose</li><li>\u2022 bloodstream,</li><li>\u2022 blood glucose levels</li><li>\u2022 fasting</li><li>\u2022 Option C. Both: This option is incorrect because the liver can directly contribute to blood glucose levels through glycogen breakdown , while muscle cannot.</li><li>\u2022 Option C. Both:</li><li>\u2022 incorrect</li><li>\u2022 liver</li><li>\u2022 blood glucose levels</li><li>\u2022 glycogen</li><li>\u2022 breakdown</li><li>\u2022 muscle cannot.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Differences between Liver Glycogen and Muscle Glycogen.</li><li>\u27a4 Differences between Liver Glycogen and Muscle Glycogen.</li><li>\u27a4 Muscle glycogen is not directly available as a source of blood glucose because muscle lacks glucose-6-phosphatase which releases free glucose from glucose 6-P.</li><li>\u27a4 Muscle glycogen</li><li>\u27a4 not</li><li>\u27a4 source of blood glucose</li><li>\u27a4 lacks glucose-6-phosphatase</li><li>\u27a4 free glucose from glucose 6-P.</li><li>\u27a4 Ref : Harper 30/e p177, 178.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p177, 178.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7ec2d20",
      "audio": ""
    },
    {
      "text": "A 7-year-old child with frequent hypoglycemic episodes during fasting is being evaluated. Laboratory findings indicate normal glycogen structure but impaired glycogenolysis. Given the critical role of Glucose-6-Phosphatase in this process, why isn't Glucose-6-Phosphate immediately converted to glucose in hepatocytes?",
      "options": [
        {
          "label": "A",
          "text": "Only active during gluconeogenesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Requires Protein Kinase activation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enzyme located in the endoplasmic reticulum",
          "correct": true
        },
        {
          "label": "D",
          "text": "Inhibited by albumin in the cytoplasm",
          "correct": false
        }
      ],
      "correct_answer": "C. Enzyme located in the endoplasmic reticulum",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Enzyme located in the endoplasmic reticulum</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Only active during gluconeogenesis: This is incorrect because Glucose-6-Phosphatase is active during both gluconeogenesis and glycogenolysis , not exclusively during gluconeogenesis . Its activity is crucial for maintaining blood glucose levels , especially during fasting.</li><li>\u2022 Option A. Only active during gluconeogenesis:</li><li>\u2022 incorrect</li><li>\u2022 Glucose-6-Phosphatase</li><li>\u2022 active</li><li>\u2022 both</li><li>\u2022 gluconeogenesis and glycogenolysis</li><li>\u2022 not</li><li>\u2022 gluconeogenesis</li><li>\u2022 maintaining blood glucose</li><li>\u2022 levels</li><li>\u2022 fasting.</li><li>\u2022 Option B. Requires Protein Kinase activation: Glucose-6-Phosphatase activity is not directly regulated by protein kinases . The regulation of this enzyme is primarily through substrate availability and its subcellular localization, rather than through activation by phosphorylation .</li><li>\u2022 Option B. Requires Protein Kinase activation:</li><li>\u2022 Glucose-6-Phosphatase</li><li>\u2022 not</li><li>\u2022 protein kinases</li><li>\u2022 substrate availability</li><li>\u2022 subcellular localization,</li><li>\u2022 activation by</li><li>\u2022 phosphorylation</li><li>\u2022 Option D. Inhibited by albumin in the cytoplasm: There is no direct interaction between albumin and Glucose-6-Phosphatase that would inhibit its activity. Albumin, a serum protein produced by the liver, primarily functions in maintaining oncotic pressure and transporting substances ; it does not play a regulatory role in glycogenolysis.</li><li>\u2022 Option D. Inhibited by albumin in the cytoplasm:</li><li>\u2022 no</li><li>\u2022 albumin and Glucose-6-Phosphatase</li><li>\u2022 inhibit</li><li>\u2022 activity.</li><li>\u2022 Albumin,</li><li>\u2022 serum protein</li><li>\u2022 liver,</li><li>\u2022 oncotic pressure</li><li>\u2022 transporting substances</li><li>\u2022 does not</li><li>\u2022 glycogenolysis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glucose-6-phosphatase is in the lumen of the smooth endoplasmic reticulum Glucose-6-phosphate is transported to SER by a transporter known as translocase to be acted by Glucose- 6-phosphatase. Genetic defects of the Glucose-6-phosphate transporter can result in a variant of type I glycogen storage disease.</li><li>\u27a4 Glucose-6-phosphatase is in the lumen of the smooth endoplasmic reticulum</li><li>\u27a4 Glucose-6-phosphatase</li><li>\u27a4 smooth endoplasmic reticulum</li><li>\u27a4 Glucose-6-phosphate is transported to SER by a transporter known as translocase to be acted by Glucose- 6-phosphatase.</li><li>\u27a4 Glucose-6-phosphate</li><li>\u27a4 SER</li><li>\u27a4 translocase</li><li>\u27a4 Glucose- 6-phosphatase.</li><li>\u27a4 Genetic defects of the Glucose-6-phosphate transporter can result in a variant of type I glycogen storage disease.</li><li>\u27a4 Genetic defects</li><li>\u27a4 Glucose-6-phosphate transporter</li><li>\u27a4 type I glycogen storage disease.</li><li>\u27a4 Ref : Harper 30/e p178.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p178.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1cf22834",
      "audio": ""
    },
    {
      "text": "A 3-year-old child presents to the pediatric clinic with recurrent episodes of hypoglycemia, especially noted during fasting periods. The child's growth parameters are below the normal percentile for age. Laboratory investigations reveal lactic acidosis and hyperuricemia. After further evaluation, the child is diagnosed with Glucose-6-phosphatase deficiency. The attending physician explains to the parents the association between the child's condition and the development of hyperuricemia and gout. Which of the following is the most likely cause of hyperuricemia and gout in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Decreased availability of glucose to tissues",
          "correct": false
        },
        {
          "label": "B",
          "text": "More formation of pentoses",
          "correct": true
        },
        {
          "label": "C",
          "text": "Increased accumulation of sorbitol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Impaired degradation of free radicals",
          "correct": false
        }
      ],
      "correct_answer": "B. More formation of pentoses",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) More formation of pentoses</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Decreased availability of glucose to tissues: This is a direct consequence of Glucose-6-phosphatase deficiency leading to hypoglycemia but does not directly cause hyperuricemia and gout . The lack of glucose exacerbates the metabolic imbalance but isn't the primary cause of increased uric acid levels.</li><li>\u2022 Option A. Decreased availability of glucose to tissues: This</li><li>\u2022 Glucose-6-phosphatase deficiency</li><li>\u2022 hypoglycemia</li><li>\u2022 does not</li><li>\u2022 hyperuricemia and gout</li><li>\u2022 lack of glucose</li><li>\u2022 metabolic imbalance</li><li>\u2022 isn't</li><li>\u2022 increased uric acid levels.</li><li>\u2022 Option C. Increased accumulation of sorbitol: Sorbitol accumulation is associated with conditions like diabetes mellitus due to increased activity of the polyol pathway when glucose levels are high. It is not directly related to Glucose-6-phosphatase deficiency or hyperuricemia and gout in this context.</li><li>\u2022 Option C. Increased accumulation of sorbitol:</li><li>\u2022 diabetes mellitus</li><li>\u2022 increased</li><li>\u2022 polyol pathway</li><li>\u2022 glucose levels are high.</li><li>\u2022 not</li><li>\u2022 Glucose-6-phosphatase deficiency</li><li>\u2022 hyperuricemia and gout</li><li>\u2022 Option D. Impaired degradation of free radicals: While oxidative stress and impaired degradation of free radicals can contribute to cellular damage and various metabolic disturbances , they are not directly involved in the mechanism leading to hyperuricemia and gout in patients with Glucose-6-phosphatase deficiency.</li><li>\u2022 Option D. Impaired degradation of free radicals:</li><li>\u2022 oxidative stress</li><li>\u2022 impaired degradation of free radicals</li><li>\u2022 cellular damage</li><li>\u2022 metabolic disturbances</li><li>\u2022 not directly</li><li>\u2022 hyperuricemia</li><li>\u2022 gout</li><li>\u2022 Glucose-6-phosphatase deficiency.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Biochemical defect in von Gierke\u2019s disease:</li><li>\u27a4 Biochemical defect in von Gierke\u2019s disease:</li><li>\u27a4 Deficiency of Glucose 6 Phosphatase \u2192 accumulation of Glucose 6 Phosphate \u2192 it is  channelled to Pentose Phosphate pathway \u2192 more Pentoses are formed \u2192 enters Purine Synthesis \u2192 Uric acid accumulates ( degradation product of Purine )</li><li>\u27a4 Deficiency of Glucose 6 Phosphatase</li><li>\u27a4 Glucose 6 Phosphate</li><li>\u27a4 Pentose Phosphate pathway</li><li>\u27a4 more Pentoses</li><li>\u27a4 Purine Synthesis</li><li>\u27a4 Uric acid</li><li>\u27a4 degradation product of Purine</li><li>\u27a4 Ref : Nelson 20/e: Defects in the metabolism of Carbohydrates</li><li>\u27a4 Ref</li><li>\u27a4 : Nelson 20/e: Defects in the metabolism of Carbohydrates</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0324328d",
      "audio": ""
    },
    {
      "text": "Approximately how many hours does it take for liver glycogen stores to become significantly depleted in an average adult under normal physiological conditions?",
      "options": [
        {
          "label": "A",
          "text": "9",
          "correct": false
        },
        {
          "label": "B",
          "text": "18",
          "correct": true
        },
        {
          "label": "C",
          "text": "24",
          "correct": false
        },
        {
          "label": "D",
          "text": "48",
          "correct": false
        }
      ],
      "correct_answer": "B. 18",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 18 hours</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Under normal physiological conditions , liver glycogen stores can sustain blood glucose levels for about 18 hours of fasting. After this period, the body increasingly relies on gluconeogenesis and the breakdown of fats for energy , marking a transition in the body's primary energy sources to maintain metabolic functions during prolonged fasting.</li><li>\u2022 normal physiological conditions</li><li>\u2022 liver glycogen stores</li><li>\u2022 blood glucose levels</li><li>\u2022 18 hours of fasting.</li><li>\u2022 body increasingly</li><li>\u2022 gluconeogenesis</li><li>\u2022 breakdown of fats for energy</li><li>\u2022 transition in the body's</li><li>\u2022 energy</li><li>\u2022 metabolic functions</li><li>\u2022 prolonged fasting.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Liver and Muscle Glycogen are generally exhausted by 18 hours of fasting.</li><li>\u27a4 Liver and Muscle Glycogen</li><li>\u27a4 exhausted</li><li>\u27a4 18 hours of fasting.</li><li>\u27a4 Ref : Harper 30/e p149.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p149.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "acf76c76",
      "audio": ""
    },
    {
      "text": "A 3-month-old infant is presented to the pediatric outpatient department by the mother, reporting symptoms of rapid heart rate, restlessness, muscle hypotonia, and abdominal distention. The infant has been diagnosed with cardiac failure and is currently being treated with diuretics and an ACE inhibitor. Radiographic evidence indicates left ventricular hypertrophy, and physical examination reveals hepatosplenomegaly. An assay performed on a dried blood spot indicates reduced activity of a specific enzyme, leading to a diagnosis of Pompe disease. Which enzyme deficiency is associated with Pompe disease?",
      "options": [
        {
          "label": "A",
          "text": "Branching enzyme",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acid maltase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Muscle phosphorylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glucose-6-phosphatase",
          "correct": false
        }
      ],
      "correct_answer": "B. Acid maltase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture6.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture7.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Acid maltase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Harper 30/e: p 179.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 179.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "772e2df3",
      "audio": ""
    },
    {
      "text": "A 3-year-old girl child is admitted with progressive abdominal distension for the past 6 months. Mother reported that the baby has difficulty in walking, gets easily tired while playing and restless and sweat in early morning hours. After giving juice or milk, she feels comfortable. On examination, child was found to have motor retardation and was small for age. Liver was found to be enlarged with firm consistency. Laboratory investigations: FBS: 60 mg/dl (normal = 80-110 mg/dl) AST: 355 IU/L (normal = 15-45 IU/L) ALT: 244 IU/L (normal = 15-45 IU/L) ALP: 231 IU/L (normal =98-279 IU/L) Total bilirubin: 2.0 mg/dl (normal = 0-1.0 mg/dl) Liver histology: Glycogen laden vacuoles with no fibrosis or inflammatory cell infiltration. Baby was diagnosed with GSD type III based on the results. What is the causative enzyme deficiency in this disease?",
      "options": [
        {
          "label": "A",
          "text": "Branching enzyme",
          "correct": false
        },
        {
          "label": "B",
          "text": "Debranching enzyme",
          "correct": true
        },
        {
          "label": "C",
          "text": "Muscle phosphorylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glucose-6-phosphatase",
          "correct": false
        }
      ],
      "correct_answer": "B. Debranching enzyme",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture4.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture10.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture11_PgLn01X.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Debranching enzyme</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Branching enzyme: deficiency results in Anderson disease . C/F: failure to thrive, liver failure, and hypotonia.</li><li>\u2022 Option A. Branching enzyme:</li><li>\u2022 deficiency</li><li>\u2022 Anderson disease</li><li>\u2022 failure to thrive, liver failure, and hypotonia.</li><li>\u2022 Option C.  Muscle phosphorylase: deficiency results in McArdle disease. C/F: pain, cramps and myoglobinuria on strenuous exercise.</li><li>\u2022 Option C.  Muscle phosphorylase:</li><li>\u2022 deficiency</li><li>\u2022 McArdle disease.</li><li>\u2022 pain, cramps and myoglobinuria</li><li>\u2022 Option D. Glucose-6-phosphatase: Deficiency results in Von Gierke disease. C/F: Hypoglycemia; hyperketonaemia.</li><li>\u2022 Option D. Glucose-6-phosphatase:</li><li>\u2022 Deficiency</li><li>\u2022 Von Gierke disease.</li><li>\u2022 Hypoglycemia; hyperketonaemia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ref : Harper 30/e: p 179.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 179.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b31c4913",
      "audio": ""
    },
    {
      "text": "An 18-year-old medical student, immersed in the demanding schedule of clinical rotations, often finds himself skipping lunch and dinner. To sustain his energy levels and cognitive function during these prolonged periods without food, his body must mobilize glucose from liver stores. Which enzyme plays a pivotal role in this process by facilitating the release of glucose from glycogen stored in the liver?",
      "options": [
        {
          "label": "A",
          "text": "Acetyl-CoA carboxylase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucose-6-phosphate dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycogen phosphorylase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Glycogen synthase",
          "correct": false
        }
      ],
      "correct_answer": "C. Glycogen phosphorylase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Glycogen phosphorylase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Acetyl-CoA carboxylase: This enzyme is involved in fatty acid synthesis , not in the mobilization or release of glucose from glycogen stores.</li><li>\u2022 Option A.  Acetyl-CoA carboxylase:</li><li>\u2022 fatty acid synthesis</li><li>\u2022 not</li><li>\u2022 release</li><li>\u2022 glucose from</li><li>\u2022 glycogen stores.</li><li>\u2022 Option B. Glucose-6-phosphate dehydrogenase: This enzyme is part of the pentose phosphate pathway and is involved in producing NADPH and ribose-5-phosphate , rather than in the direct mobilization of glucose from stored glycogen.</li><li>\u2022 Option B. Glucose-6-phosphate dehydrogenase:</li><li>\u2022 pentose phosphate pathway</li><li>\u2022 NADPH</li><li>\u2022 ribose-5-phosphate</li><li>\u2022 rather than</li><li>\u2022 glucose from stored glycogen.</li><li>\u2022 Option D. Glycogen synthase: This enzyme is responsible for the synthesis of glycogen from glucose , the opposite process to what is needed in this scenario, where the goal is to mobilize glucose from glycogen stores.</li><li>\u2022 Option D. Glycogen synthase:</li><li>\u2022 synthesis of glycogen from glucose</li><li>\u2022 opposite</li><li>\u2022 mobilize glucose from glycogen stores.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glycogen is the storage form of glucose , which is an easily mobilizable fuel store . When individuals are deprived of or reduced intake of carbohydrate s, the body responds by breaking down glycogen stores in the liver in order to maintain normal blood glucose levels . The two main enzymes involved in the degradation and synthesis of glycogen are glycogen phosphorylase (option c) and glycogen synthase (option d), respectively.</li><li>\u27a4 Glycogen</li><li>\u27a4 storage form</li><li>\u27a4 glucose</li><li>\u27a4 fuel store</li><li>\u27a4 deprived of or reduced</li><li>\u27a4 carbohydrate</li><li>\u27a4 breaking down glycogen stores</li><li>\u27a4 liver</li><li>\u27a4 normal blood glucose levels</li><li>\u27a4 two main enzymes</li><li>\u27a4 degradation and synthesis</li><li>\u27a4 glycogen are glycogen phosphorylase (option c) and glycogen synthase (option d),</li><li>\u27a4 The processes of glycogen synthesis and degradation are coordinated by a hormone-triggered cascade that ensures that when one enzyme is active, the other enzyme is inactive.</li><li>\u27a4 glycogen synthesis and degradation</li><li>\u27a4 hormone-triggered cascade</li><li>\u27a4 enzyme is active,</li><li>\u27a4 other enzyme is inactive.</li><li>\u27a4 Ref : Harper 30/e: p 177-180.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 177-180.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "28a3b88b",
      "audio": ""
    },
    {
      "text": "During a marathon, a runner heavily relies on stored energy sources and oxygen. Considering the metabolic changes that occur over the course of a marathon, which option best describes the changes in glycogen and fatty acid utilization, as well as oxygen consumption, comparing the first mile to the 26th mile?",
      "options": [
        {
          "label": "A",
          "text": "Glycogen used \u2191 Fatty acid used \u2191 Oxygen consumed \u2191",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glycogen used \u2191 Fatty acid used \u2193 Oxygen consumed \u2193",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycogen used \u2191 Fatty acid used \u2193 Oxygen consumed \u2191",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glycogen used \u2193 Fatty acid used \u2191 Oxygen consumed \u2191",
          "correct": true
        }
      ],
      "correct_answer": "D. Glycogen used \u2193 Fatty acid used \u2191 Oxygen consumed \u2191",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Decreased glycogen used, increased fatty acids and oxygen consumed</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 At the beginning of the race, a runner consumes energy at a ratio of 75 percent carbohydrate : 25 percent fatty acids approximately. By the end of the race , glycogen stores are mostly depleted and the generation of ATPs from Beta-oxidation of fatty acids occurs \u2192 produces reducing equivalents for oxidative phosphorylation. This requires an increase in the amount of oxygen consumed.</li><li>\u27a4 At the beginning of the race, a runner consumes energy at a ratio of 75 percent carbohydrate : 25 percent fatty acids approximately.</li><li>\u27a4 beginning</li><li>\u27a4 race,</li><li>\u27a4 runner</li><li>\u27a4 energy</li><li>\u27a4 75 percent carbohydrate</li><li>\u27a4 25 percent fatty acids</li><li>\u27a4 By the end of the race , glycogen stores are mostly depleted and the generation of ATPs from Beta-oxidation of fatty acids occurs \u2192 produces reducing equivalents for oxidative phosphorylation.</li><li>\u27a4 end of the race</li><li>\u27a4 depleted</li><li>\u27a4 ATPs from Beta-oxidation of fatty acids</li><li>\u27a4 reducing equivalents</li><li>\u27a4 oxidative phosphorylation.</li><li>\u27a4 This requires an increase in the amount of oxygen consumed.</li><li>\u27a4 increase</li><li>\u27a4 oxygen consumed.</li><li>\u27a4 Ref : Harper 30/e: p 663.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 663.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3aebae17",
      "audio": ""
    },
    {
      "text": "A 1-year-old child is brought to the outpatient department by their parents due to concerns of muscle hypotonia, failure to thrive, and an enlarged abdomen. Laboratory tests reveal hypoglycemia and ultrasonography shows hepatomegaly. Following a comprehensive evaluation, the child is diagnosed with a type of glycogen storage disease (GSD). In the context of GSD, the glycogen content in the liver is not influenced by which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Serum glucose levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insulin levels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucagon Level",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dietary Riboflavin levels",
          "correct": true
        }
      ],
      "correct_answer": "D. Dietary Riboflavin levels",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture12.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Dietary riboflavin (vitamin B2) levels do not directly influence glycogen content in the liver in the context of glycogen storage diseases (GSDs).</li><li>\u2022 Riboflavin serves as a precursor for flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which function as cofactors for various oxidation-reduction enzymes. While riboflavin is essential for many metabolic processes, it does not play a direct regulatory role in glycogen synthesis or breakdown in the liver.</li><li>\u2022 Glycogen storage diseases are inherited metabolic disorders caused by enzyme deficiencies in glycogen synthesis, breakdown, or regulation pathways. The clinical presentation described in the question (muscle hypotonia, failure to thrive, enlarged abdomen, hypoglycemia, and hepatomegaly) is consistent with several types of GSD.</li><li>\u2022 The regulation of hepatic glycogen content primarily depends on hormonal and metabolic factors that directly control glycogen synthesis (glycogenesis) and breakdown (glycogenolysis).</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Serum glucose levels - This is incorrect as a choice for factors that do NOT influence glycogen content.</li><li>\u2022 Option A. Serum glucose levels</li><li>\u2022 Serum glucose levels directly affect hepatic glycogen metabolism. High blood glucose promotes glycogen synthesis through activation of glycogen synthase, while low blood glucose levels trigger glycogen breakdown to maintain normoglycemia.</li><li>\u2022 Option B. Insulin levels - This is incorrect as a choice for factors that do NOT influence glycogen content. Insulin is a key hormone that promotes glycogen synthesis in the liver by:</li><li>\u2022 Option B. Insulin levels</li><li>\u2022 Activating glycogen synthase (via dephosphorylation) Inhibiting glycogen phosphorylase Increasing glucose uptake and its phosphorylation to glucose-6-phosphate</li><li>\u2022 Activating glycogen synthase (via dephosphorylation)</li><li>\u2022 Inhibiting glycogen phosphorylase</li><li>\u2022 Increasing glucose uptake and its phosphorylation to glucose-6-phosphate</li><li>\u2022 Option C. Glucagon Level - This is incorrect as a choice for factors that do NOT influence glycogen content. Glucagon has effects opposite to insulin on hepatic glycogen. It promotes glycogenolysis (glycogen breakdown) by:</li><li>\u2022 Option C. Glucagon Level</li><li>\u2022 Activating glycogen phosphorylase via a cAMP-dependent protein kinase cascade Inhibiting glycogen synthase</li><li>\u2022 Activating glycogen phosphorylase via a cAMP-dependent protein kinase cascade</li><li>\u2022 Inhibiting glycogen synthase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 In glycogen storage diseases, liver glycogen content is regulated primarily by glucose levels, insulin, Glucagon and factors affecting these parameters (like dietary amino acids).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "69556bc6",
      "audio": ""
    },
    {
      "text": "A patient with a history of diabetes mellitus, previously uncontrolled on oral hypoglycaemic agents, has been on insulin therapy for the past year. In the context of insulin's molecular structure and its therapeutic modifications, which of the following alterations will lead to Various short and long-acting analogs of the hormone ?",
      "options": [
        {
          "label": "A",
          "text": "Change in 29-30 in B chain",
          "correct": true
        },
        {
          "label": "B",
          "text": "Change in 5-6 in A chain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hydrolysis of disulfide bonds",
          "correct": false
        },
        {
          "label": "D",
          "text": "Change in 14-16 in A chain",
          "correct": false
        }
      ],
      "correct_answer": "A. Change in 29-30 in B chain",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1oUJJbM.jpeg"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Other Options Explanation:</li><li>\u2022 Option B. Change at positions 5-6 in the A chain: This region is crucial for maintaining the hormone's structural integrity, and alterations could disrupt its conformation and receptor binding.</li><li>\u2022 Option B. Change at positions 5-6 in the A chain:</li><li>\u2022 hormone's structural integrity,</li><li>\u2022 could disrupt its conformation</li><li>\u2022 receptor binding.</li><li>\u2022 Option C. Hydrolysis of disulfide bonds: The disulfide bonds are essential for maintaining insulin's tertiary structure. Their hydrolysis would lead to a loss of structural integrity, significantly impacting biological activity.</li><li>\u2022 Option C. Hydrolysis of disulfide bonds:</li><li>\u2022 disulfide bonds</li><li>\u2022 insulin's tertiary structure.</li><li>\u2022 hydrolysis</li><li>\u2022 loss of structural integrity,</li><li>\u2022 impacting biological activity.</li><li>\u2022 Option D. change in 14-16 in A chain: Changing the sequence in the A chain can disrupt the structure and function of insulin.</li><li>\u2022 Option D. change in 14-16 in A chain:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Harper 30/e:  p 512; Lippincott 7/e : P 308</li><li>\u27a4 Ref: Harper 30/e:  p 512; Lippincott 7/e : P 308</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f301ec98",
      "audio": ""
    },
    {
      "text": "A 9-month-old male infant is brought to the outpatient department presenting with mental retardation, delayed developmental milestones, and jaundice. Laboratory investigations reveal elevated unconjugated bilirubin and hypoglycemia (RBS \u2013 40 mg/dl). Additionally, the urine analysis indicates aminoaciduria. The infant has been exclusively breastfed and has experienced recurrent vomiting and diarrhea since birth. Based on these findings, what is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Galactosemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hereditary Fructose Intolerance",
          "correct": false
        },
        {
          "label": "C",
          "text": "Latent diabetes mellitus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Crigler-Najjar Syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Galactosemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Galactosemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Hereditary Fructose Intolerance: Fructosemia - due to defect in Aldolase-B \u2192 fructose-1-phosphate in the diet of infants cannot be metabolized \u2192 its accumulation and inhibition of glycogen phosphorylase \u2192 accumulation of glycogen in liver and hypoglycaemia. History of aversion to sweets and history of vomiting after drinking fruit juices . C/F- Vomiting, loss of appetite, hepatomegaly and jaundice . Fructose excreted in urine gives a positive Benedict\u2019s test.</li><li>\u2022 Option B. Hereditary Fructose Intolerance:</li><li>\u2022 Fructosemia</li><li>\u2022 defect</li><li>\u2022 Aldolase-B</li><li>\u2022 fructose-1-phosphate</li><li>\u2022 cannot</li><li>\u2022 accumulation</li><li>\u2022 inhibition of glycogen phosphorylase</li><li>\u2022 glycogen in liver</li><li>\u2022 hypoglycaemia.</li><li>\u2022 aversion to sweets</li><li>\u2022 history of vomiting</li><li>\u2022 drinking fruit juices</li><li>\u2022 Vomiting, loss of appetite,</li><li>\u2022 hepatomegaly and jaundice</li><li>\u2022 Fructose</li><li>\u2022 urine</li><li>\u2022 positive Benedict\u2019s test.</li><li>\u2022 Option C. Latent diabetes mellitus: They have a slow progression of autoimmune beta cell failure with C/F similar to DM.</li><li>\u2022 Option C. Latent diabetes mellitus:</li><li>\u2022 slow</li><li>\u2022 autoimmune beta cell failure</li><li>\u2022 C/F</li><li>\u2022 DM.</li><li>\u2022 Option D.  Crigler-Najjar Syndrome: defective conjugation due to deficiency of UDP glucuronyl transferase \u2192 Unconjugated bilirubin >>20 mg/dl \u2192 kernicterus. History of persistent jaundice since birth .</li><li>\u2022 Option D.  Crigler-Najjar Syndrome:</li><li>\u2022 defective conjugation</li><li>\u2022 deficiency of UDP glucuronyl transferase</li><li>\u2022 Unconjugated</li><li>\u2022 bilirubin >>20 mg/dl</li><li>\u2022 kernicterus.</li><li>\u2022 persistent jaundice since birth</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Galactosemia is a genetic disorder characterized by the inability to metabolize galactose properly due to a deficiency in one of the enzymes involved in its metabolic pathway, most commonly galactose-1-phosphate uridyltransferase.</li><li>\u27a4 Galactosemia</li><li>\u27a4 genetic disorder</li><li>\u27a4 inability to metabolize galactose</li><li>\u27a4 due to a deficiency</li><li>\u27a4 enzymes</li><li>\u27a4 its metabolic pathway,</li><li>\u27a4 galactose-1-phosphate uridyltransferase.</li><li>\u27a4 Ref : Harper 30/e:  p 155, 204</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 155, 204</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cffd80e9",
      "audio": ""
    },
    {
      "text": "A woman presents to the emergency room reporting episodes of diarrhea triggered by the consumption of dairy products. This symptom is suggestive of lactose intolerance, a condition where the body lacks sufficient lactase enzyme to digest lactose, the primary sugar in milk and dairy products. Based on this information, which of the following dairy products might she be able to tolerate better compared to the others?",
      "options": [
        {
          "label": "A",
          "text": "Yogurt",
          "correct": true
        },
        {
          "label": "B",
          "text": "Skimmed milk",
          "correct": false
        },
        {
          "label": "C",
          "text": "Condensed milk",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ice cream",
          "correct": false
        }
      ],
      "correct_answer": "A. Yogurt",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Yogurt</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Yogurt is often better tolerated by those with lactose intolerance due to probiotics aiding lactose digestion, whereas skimmed milk, condensed milk, and ice cream , with their higher lactose content , are more likely to cause intolerance symptoms.</li><li>\u27a4 Yogurt</li><li>\u27a4 better tolerated</li><li>\u27a4 lactose intolerance</li><li>\u27a4 probiotics aiding lactose digestion,</li><li>\u27a4 skimmed milk,</li><li>\u27a4 condensed milk, and ice cream</li><li>\u27a4 higher lactose content</li><li>\u27a4 more</li><li>\u27a4 intolerance symptoms.</li><li>\u27a4 Ref : Maurice Shils, Modern Nutrition in Health and Disease, 10th edition, page 1523</li><li>\u27a4 Ref</li><li>\u27a4 : Maurice Shils, Modern Nutrition in Health and Disease, 10th edition, page 1523</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b02409e5",
      "audio": ""
    },
    {
      "text": "A 55-year-old patient presents with symptoms suggestive of an endocrine disorder and, after a series of diagnostic evaluations, is diagnosed with insulinoma, a rare neuroendocrine tumor primarily affecting the pancreas. Considering the pathophysiology of insulinoma, which of the following is a characteristic feature of this condition?",
      "options": [
        {
          "label": "A",
          "text": "Decreased body weight",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased glucose in the blood",
          "correct": true
        },
        {
          "label": "C",
          "text": "Decreased connecting peptide in the blood",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased insulin in the blood",
          "correct": false
        }
      ],
      "correct_answer": "B. Decreased glucose in the blood",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Decreased glucose in the blood</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Decreased body weight: Insulin, an anabolic hormone causes gain in body weight.</li><li>\u2022 Option A.  Decreased body weight:</li><li>\u2022 Insulin,</li><li>\u2022 anabolic hormone</li><li>\u2022 gain</li><li>\u2022 Option C. Decreased connecting peptide in the blood: Insulinomas results in increased production of insulin (C-peptide) .</li><li>\u2022 Option C. Decreased connecting peptide in the blood:</li><li>\u2022 increased production of insulin (C-peptide)</li><li>\u2022 Option D.  Decreased insulin in the blood: Increase in insulin levels due to constant production by the tumour cells.</li><li>\u2022 Option D.  Decreased insulin in the blood:</li><li>\u2022 Increase in insulin levels</li><li>\u2022 constant production</li><li>\u2022 tumour cells.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Insulinomas are pancreatic neuroendocrine tumors that autonomously secrete insulin , leading to inappropriate insulin levels irrespective of blood glucose concentrations. This excessive insulin secretion results in recurrent episodes of hypoglycemia, which is a hallmark feature of insulinoma. Hypoglycemia can manifest as neuroglycopenic symptoms ( confusion, blurred vision, fainting ) and adrenergic symptoms (sweating, palpitations, hunger) .</li><li>\u27a4 Insulinomas</li><li>\u27a4 pancreatic neuroendocrine tumors</li><li>\u27a4 autonomously</li><li>\u27a4 insulin</li><li>\u27a4 inappropriate insulin levels</li><li>\u27a4 blood glucose concentrations.</li><li>\u27a4 excessive insulin secretion</li><li>\u27a4 recurrent episodes of hypoglycemia,</li><li>\u27a4 hallmark feature</li><li>\u27a4 Hypoglycemia</li><li>\u27a4 neuroglycopenic symptoms</li><li>\u27a4 confusion, blurred vision, fainting</li><li>\u27a4 adrenergic symptoms (sweating, palpitations, hunger)</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 331, Lippincott 6/ed: p 319-320</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 331, Lippincott 6/ed: p 319-320</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "31955cde",
      "audio": ""
    },
    {
      "text": "Which of the following statements about glucagon is INCORRECT?",
      "options": [
        {
          "label": "A",
          "text": "Proglucagon is synthesized in \u03b1 cells of islets of Langerhans",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is a straight polypeptide chain with 29 amino acids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stimulates glycogen synthesis.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It activates the enzyme glycogen phosphorylase",
          "correct": false
        }
      ],
      "correct_answer": "C. Stimulates glycogen synthesis.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Stimulates glycogen synthesis.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glucagon , a hormone produced by the \u03b1 cells of the islets of Langerhans in the pancreas, plays a crucial role in glucose metabolism. Its primary function is to raise blood glucose levels by promoting glycogenolysis (the breakdown of glycogen to glucose) and gluconeogenesis (the synthesis of glucose from non-carbohydrate sources). Therefore, the statement that glucagon stimulates glycogen synthesis is incorrect , as it actually promotes glycogen breakdown.</li><li>\u27a4 Glucagon</li><li>\u27a4 \u03b1 cells</li><li>\u27a4 islets of Langerhans</li><li>\u27a4 pancreas,</li><li>\u27a4 glucose metabolism.</li><li>\u27a4 raise blood glucose levels</li><li>\u27a4 promoting glycogenolysis</li><li>\u27a4 gluconeogenesis</li><li>\u27a4 glucagon stimulates glycogen synthesis</li><li>\u27a4 incorrect</li><li>\u27a4 promotes glycogen breakdown.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 322</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 322</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4cf46a10",
      "audio": ""
    },
    {
      "text": "A 10-year-old girl presents to the emergency department with severe polyuria and polydipsia. Laboratory tests reveal the presence of ketones in her urine. Considering the metabolic conditions, which is the most likely source of these ketones?",
      "options": [
        {
          "label": "A",
          "text": "Gluconeogenesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Free fatty acid breakdown",
          "correct": true
        },
        {
          "label": "C",
          "text": "Glycogenolysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Triglyceride breakdown",
          "correct": false
        }
      ],
      "correct_answer": "B. Free fatty acid breakdown",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Free fatty acid breakdown</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ketone bodies are produced primarily in the live r through the process of ketogenesis, which occurs when there is an increased breakdown of free fatty acids . This situation typically arises in states of decreased carbohydrate availability or impaired glucose utilization, leading the body to switch to fat as an alternative energy source . In this patient's case, the presence of ketones in the urine suggests that her body is utilizing fatty acids for energy, which results in the production of ketones as a byproduct of fatty acid metabolism in the liver.</li><li>\u27a4 Ketone bodies</li><li>\u27a4 live</li><li>\u27a4 ketogenesis,</li><li>\u27a4 increased breakdown of free fatty acids</li><li>\u27a4 decreased carbohydrate</li><li>\u27a4 impaired glucose utilization,</li><li>\u27a4 body to switch to fat</li><li>\u27a4 alternative energy source</li><li>\u27a4 presence</li><li>\u27a4 ketones in the urine</li><li>\u27a4 body is utilizing fatty acids for energy,</li><li>\u27a4 ketones</li><li>\u27a4 byproduct of fatty acid metabolism in the liver.</li><li>\u27a4 Ref : Harper 30/e: p 231-233</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 231-233</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "87c86bf3",
      "audio": ""
    },
    {
      "text": "Identify the incorrect statement regarding the involvement of the Uronic acid pathway.",
      "options": [
        {
          "label": "A",
          "text": "Conjugation of bilirubin",
          "correct": false
        },
        {
          "label": "B",
          "text": "GAG Synthesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vitamin C Synthesis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Biotransformation",
          "correct": false
        }
      ],
      "correct_answer": "C. Vitamin C Synthesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Vitamin C Synthesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Conjugation of bilirubin: Glucuronic acid , derived from the Uronic acid pathway , is crucial for the conjugation of bilirubin in the liver, making it water-soluble for excretion in bile.</li><li>\u2022 Option A.  Conjugation of bilirubin:</li><li>\u2022 Glucuronic acid</li><li>\u2022 Uronic acid pathway</li><li>\u2022 conjugation of bilirubin</li><li>\u2022 water-soluble for excretion</li><li>\u2022 Option B. GAG (Glycosaminoglycan) Synthesis: The Uronic acid pathway provides essential components for the synthesis of glycosaminoglycans , which are important constituents of connective tissues and extracellular matrices .</li><li>\u2022 Option B. GAG (Glycosaminoglycan) Synthesis:</li><li>\u2022 Uronic acid pathway</li><li>\u2022 essential components</li><li>\u2022 synthesis of glycosaminoglycans</li><li>\u2022 connective tissues and extracellular matrices</li><li>\u2022 Option D. Biotransformation: Glucuronic acid plays a significant role in the biotransformation of various substances by facilitating their excretion , enhancing the solubility of drugs, hormones, and toxins.</li><li>\u2022 Option D. Biotransformation:</li><li>\u2022 Glucuronic acid</li><li>\u2022 biotransformation</li><li>\u2022 facilitating their excretion</li><li>\u2022 enhancing</li><li>\u2022 solubility of drugs, hormones, and toxins.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Uronic acid pathway is involved in the conversion of glucose to glucuronic acid, which is a critical component in the conjugation of bilirubin , the synthesis of glycosaminoglycans (GAGs), and various biotransformation processes. However, it is not directly involved in the synthesis of Vitamin C (ascorbic acid). In humans, the synthesis of Vitamin C is not possible due to the lack of the enzyme L-gulonolactone oxidase , required for the last step of Vitamin C biosynthesis.</li><li>\u27a4 Uronic acid pathway</li><li>\u27a4 conversion of glucose to glucuronic acid,</li><li>\u27a4 component</li><li>\u27a4 conjugation</li><li>\u27a4 bilirubin</li><li>\u27a4 synthesis of glycosaminoglycans (GAGs),</li><li>\u27a4 biotransformation</li><li>\u27a4 not</li><li>\u27a4 synthesis of Vitamin C (ascorbic acid).</li><li>\u27a4 synthesis of Vitamin C</li><li>\u27a4 not</li><li>\u27a4 lack of the enzyme L-gulonolactone oxidase</li><li>\u27a4 required</li><li>\u27a4 Vitamin C biosynthesis.</li><li>\u27a4 Ref : Harper 30/e p202, 203</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p202, 203</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1b9bacc9",
      "audio": ""
    },
    {
      "text": "A 45-year-old obese male presents with fatigue, increased appetite, thirst, and polyuria, with a negative Rothera's test. He is diagnosed with type 2 diabetes. Regarding the characteristics of type 2 diabetes, which of the following statements is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "Has sudden onset of symptoms which is relieved after taking insulin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Plasma glucagon level is lower than normal individuals during early disease process",
          "correct": false
        },
        {
          "label": "C",
          "text": "Plasma insulin level is lower than normal individuals during the early disease process",
          "correct": false
        },
        {
          "label": "D",
          "text": "If body weight is reduced, then improvement in glucose tolerance is observed.",
          "correct": true
        }
      ],
      "correct_answer": "D. If body weight is reduced, then improvement in glucose tolerance is observed.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) If body weight is reduced, then improvement in glucose tolerance is observed.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Has sudden onset of symptoms which is relieved after taking insulin: Gradual onset of Symptoms.</li><li>\u2022 Option A. Has sudden onset of symptoms which is relieved after taking insulin:</li><li>\u2022 Option B.  Plasma glucagon level is lower than normal individuals during early disease process: Glucagon levels are normal.</li><li>\u2022 Option B.  Plasma glucagon level is lower than normal individuals during early disease process:</li><li>\u2022 Option C. Plasma insulin level is lower than normal individuals during the early disease process: elevated insulin levels are observed in patients and requires insulin late in the disease.</li><li>\u2022 Option C. Plasma insulin level is lower than normal individuals during the early disease process:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Weight reduction through lifestyle changes can significantly improve metabolic control in individuals with type 2 diabetes by enhancing insulin sensitivity and reducing insulin resistance, underscoring the importance of non-pharmacological interventions in the management of the disease.</li><li>\u27a4 Weight reduction</li><li>\u27a4 lifestyle changes</li><li>\u27a4 improve metabolic</li><li>\u27a4 type 2 diabetes</li><li>\u27a4 enhancing insulin sensitivity</li><li>\u27a4 reducing insulin resistance,</li><li>\u27a4 non-pharmacological interventions</li><li>\u27a4 Ref : Harper 30/e:  p 185, 192-194.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 185, 192-194.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a427738c",
      "audio": ""
    },
    {
      "text": "In a fasting state, which substrate is primarily used by Red Blood Cells (RBCs) for energy?",
      "options": [
        {
          "label": "A",
          "text": "Glucose",
          "correct": true
        },
        {
          "label": "B",
          "text": "Amino Acids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ketone body",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fatty acid",
          "correct": false
        }
      ],
      "correct_answer": "A. Glucose",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1_BuSFrTM.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Glucose</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Amino Acids: RBCs do not utilize amino acids for energy production. Amino acids are primarily used by muscles and other tissues for protein synthesis or as an energy source through gluconeogenesis in the liver.</li><li>\u2022 Option B. Amino Acids:</li><li>\u2022 RBCs do not</li><li>\u2022 amino acids</li><li>\u2022 energy production. Amino acids</li><li>\u2022 used by muscles</li><li>\u2022 tissues for protein synthesis</li><li>\u2022 energy source</li><li>\u2022 gluconeogenesis in the liver.</li><li>\u2022 Option C. Ketone Body: Ketone bodies are used as an alternative energy source by many tissues, including the brain, during prolonged fasting or starvation . However, RBCs do not use ketone bodies for energy due to their lack of mitochondria.</li><li>\u2022 Option C. Ketone Body:</li><li>\u2022 used as</li><li>\u2022 alternative energy source</li><li>\u2022 brain,</li><li>\u2022 prolonged fasting or starvation</li><li>\u2022 RBCs do not</li><li>\u2022 ketone bodies</li><li>\u2022 lack of mitochondria.</li><li>\u2022 Option D. Fatty Acid: RBCs are also unable to oxidize fatty acids for energy. Fatty acid oxidation occurs in the mitochondria, which RBCs lack.</li><li>\u2022 Option D. Fatty Acid:</li><li>\u2022 RBCs</li><li>\u2022 unable to oxidize fatty acids</li><li>\u2022 Fatty acid oxidation</li><li>\u2022 mitochondria,</li><li>\u2022 RBCs lack.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Harper 30/e p150.</li><li>\u27a4 Ref:</li><li>\u27a4 Harper 30/e p150.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93e19105",
      "audio": ""
    },
    {
      "text": "A 60-year-old man with a long history of diabetes presents with visual disturbances, including difficulty seeing and floaters. Given his elevated blood glucose levels, which enzyme is most likely responsible for his eye manifestations?",
      "options": [
        {
          "label": "A",
          "text": "Hexokinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sorbitol dehydrogenase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aldose reductase",
          "correct": true
        }
      ],
      "correct_answer": "D. Aldose reductase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Aldose reductase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hexokinase: Hexokinase catalyzes the phosphorylation of glucose to glucose-6-phosphate in most tissues and is not directly associated with the specific complications seen in the eyes due to diabetes.</li><li>\u2022 Option A. Hexokinase:</li><li>\u2022 phosphorylation of glucose to glucose-6-phosphate</li><li>\u2022 not</li><li>\u2022 specific complications</li><li>\u2022 eyes due to diabetes.</li><li>\u2022 Option B. Glucokinase: Glucokinase acts as a glucose sensor in the pancreas and liver , catalyzing the phosphorylation of glucose to glucose-6-phosphate . It is not directly linked to the pathogenesis of diabetic eye complications.</li><li>\u2022 Option B. Glucokinase:</li><li>\u2022 Glucokinase</li><li>\u2022 glucose sensor</li><li>\u2022 pancreas and liver</li><li>\u2022 phosphorylation of glucose</li><li>\u2022 glucose-6-phosphate</li><li>\u2022 not</li><li>\u2022 diabetic eye complications.</li><li>\u2022 Option C. Sorbitol dehydrogenase: While sorbitol dehydrogenase is involved in the conversion of sorbitol to fructose in the polyol pathway, it is the accumulation of sorbitol due to the action of aldose reductase that is primarily responsible for the osmotic damage seen in diabetic complications of the eye.</li><li>\u2022 Option C. Sorbitol dehydrogenase:</li><li>\u2022 sorbitol dehydrogenase</li><li>\u2022 conversion of sorbitol to fructose</li><li>\u2022 polyol</li><li>\u2022 sorbitol</li><li>\u2022 aldose reductase</li><li>\u2022 osmotic damage</li><li>\u2022 diabetic complications of the eye.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glucose can enter the lens of the eye and get converted to Sorbitol with the help of aldose reductase. This enzyme is a major contributor to diabetic complication due to accumulation of sorbitol which is hygroscopic sugar and causes swelling of the eye in untreated diabetic patients</li><li>\u27a4 Glucose</li><li>\u27a4 lens of the eye</li><li>\u27a4 converted to Sorbitol</li><li>\u27a4 aldose reductase.</li><li>\u27a4 diabetic complication</li><li>\u27a4 accumulation of sorbitol</li><li>\u27a4 hygroscopic sugar</li><li>\u27a4 swelling of the eye</li><li>\u27a4 untreated diabetic patients</li><li>\u27a4 Ref : Harper 30/e:  p 205; Vasudevan 9/e: 135.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 205; Vasudevan 9/e: 135.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7b57ce0",
      "audio": ""
    },
    {
      "text": "Which of the following statements is true regarding the specialized mammalian tissue/organ where fuel oxidation is primarily used to generate heat rather than produce ATP?",
      "options": [
        {
          "label": "A",
          "text": "It is concerned with energy storage",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-shivering thermogenesis is a hormonal stimulus",
          "correct": true
        },
        {
          "label": "C",
          "text": "It is primarily important in adults",
          "correct": false
        },
        {
          "label": "D",
          "text": "It liberates heat by coupling oxidation from phosphorylation",
          "correct": false
        }
      ],
      "correct_answer": "B. Non-shivering thermogenesis is a hormonal stimulus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Non-shivering thermogenesis is a hormonal stimulus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. It is concerned with energy storage: This statement is more applicable to white adipose tissue , which is the body's main form of energy storage. Brown adipose tissue , on the other hand, is specialized for energy expenditure in the form of heat .</li><li>\u2022 Option A. It is concerned with energy storage:</li><li>\u2022 more applicable</li><li>\u2022 white adipose tissue</li><li>\u2022 body's main form of energy storage. Brown adipose tissue</li><li>\u2022 energy expenditure</li><li>\u2022 heat</li><li>\u2022 Option C. It is primarily important in adults: Brown adipose tissue is most prominent and active in infants , where it plays a critical role in thermogenesis to maintain body temperature . Its prevalence and activity typically decrease with age .</li><li>\u2022 Option C. It is primarily important in adults:</li><li>\u2022 Brown adipose tissue</li><li>\u2022 prominent and active in infants</li><li>\u2022 thermogenesis</li><li>\u2022 body temperature</li><li>\u2022 prevalence and activity</li><li>\u2022 decrease with age</li><li>\u2022 Option D. It liberates heat by coupling oxidation from phosphorylation: The correct mechanism in brown adipose tissue involves the uncoupling of oxidation from phosphorylation , not coupling , which allows the energy from fuel oxidation to be released as heat instead of being used to produce ATP.</li><li>\u2022 Option D. It liberates heat by coupling oxidation from phosphorylation:</li><li>\u2022 correct</li><li>\u2022 brown adipose tissue</li><li>\u2022 uncoupling of oxidation</li><li>\u2022 phosphorylation</li><li>\u2022 not coupling</li><li>\u2022 energy from fuel oxidation</li><li>\u2022 released as heat</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Brown adipose tissue (BAT) is primarily involved in non-shivering thermogenesis, a process of heat production in mammals . This process is stimulated hormonally, particularly by norepinephrine , which is released in response to cold exposure. BAT contains a high number of mitochondria with uncoupling protein 1 (UCP1), which allows the uncoupling of oxidative phosphorylation; instead of producing ATP , the energy is released as heat .</li><li>\u27a4 Brown adipose tissue (BAT)</li><li>\u27a4 non-shivering thermogenesis,</li><li>\u27a4 heat production in mammals</li><li>\u27a4 stimulated hormonally,</li><li>\u27a4 norepinephrine</li><li>\u27a4 cold exposure. BAT</li><li>\u27a4 high number of mitochondria</li><li>\u27a4 uncoupling protein 1</li><li>\u27a4 uncoupling of oxidative phosphorylation; instead</li><li>\u27a4 producing ATP</li><li>\u27a4 energy</li><li>\u27a4 heat</li><li>\u27a4 Ref : Harper 30/e: p 132,264, Vasudevan 9/e: p 162,266.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 132,264, Vasudevan 9/e: p 162,266.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ad4f47f",
      "audio": ""
    },
    {
      "text": "Which of the following transamination reactions yields an intermediate that directly supports both oxidative phosphorylation and gluconeogenesis?",
      "options": [
        {
          "label": "A",
          "text": "Asparagine to aspartate to oxaloacetate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cystine to cysteine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lysine to glutaryl-CoA",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serine to glycine",
          "correct": false
        }
      ],
      "correct_answer": "A. Asparagine to aspartate to oxaloacetate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Asparagine to aspartate to oxaloacetate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Cystine to cysteine: The conversion of cystine to cysteine does not produce an intermediate that is directly involved in both oxidative phosphorylation and gluconeogenesis.</li><li>\u2022 Option B. Cystine to cysteine:</li><li>\u2022 does not</li><li>\u2022 directly</li><li>\u2022 oxidative phosphorylation and gluconeogenesis.</li><li>\u2022 Option C. Lysine to glutaryl-CoA: The metabolism of lysine through its conversion to glutaryl-CoA leads to acetoacetate and acetyl-CoA, which are more involved in ketogenesis and energy production in specific tissues , not directly in gluconeogenesis and oxidative phosphorylation in the context described.</li><li>\u2022 Option C. Lysine to glutaryl-CoA:</li><li>\u2022 lysine</li><li>\u2022 conversion to glutaryl-CoA</li><li>\u2022 acetoacetate</li><li>\u2022 acetyl-CoA,</li><li>\u2022 more</li><li>\u2022 ketogenesis and energy production</li><li>\u2022 specific tissues</li><li>\u2022 not</li><li>\u2022 gluconeogenesis and oxidative</li><li>\u2022 phosphorylation</li><li>\u2022 Option D. Serine to glycine: While the conversion of serine to glycine is part of amino acid metabolism and can feed into various pathways, it does not directly yield an intermediate that is as pivotal for both oxidative phosphorylation and gluconeogenesis as oxaloacetate.</li><li>\u2022 Option D. Serine to glycine:</li><li>\u2022 conversion of serine to glycine</li><li>\u2022 amino acid metabolism</li><li>\u2022 feed</li><li>\u2022 does not</li><li>\u2022 intermediate</li><li>\u2022 pivotal</li><li>\u2022 both oxidative phosphorylation and gluconeogenesis</li><li>\u2022 oxaloacetate.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Oxaloacetate is a critical intermediate in both gluconeogenesis, where it serves as a starting point for the synthesis of glucose , and in the citric acid cycle (TCA cycle) for oxidative phosphorylation . The presence of oxaloacetate in the mitochondria is essential for the TCA cycle to proceed, as it combines with acetyl-CoA to form citrate , thus facilitating ATP production through oxidative phosphorylation .</li><li>\u27a4 Oxaloacetate</li><li>\u27a4 both gluconeogenesis,</li><li>\u27a4 synthesis of glucose</li><li>\u27a4 citric acid cycle (TCA cycle)</li><li>\u27a4 oxidative phosphorylation</li><li>\u27a4 oxaloacetate in the mitochondria</li><li>\u27a4 TCA cycle</li><li>\u27a4 acetyl-CoA to form citrate</li><li>\u27a4 ATP production</li><li>\u27a4 oxidative phosphorylation</li><li>\u27a4 Ref: Vasudevan 9/e: 226.</li><li>\u27a4 Ref:</li><li>\u27a4 Vasudevan 9/e: 226.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "48a9bac4",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman was brought to the hospital in a disoriented, confused state by her husband. She is a known case of type 1 diabetes for the last 25 years. O/E \u2013she had signs of dehydration, Low BP and acidosis with faintly fruity odour. The diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "Diabetic ketoacidosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Uncontrolled diabetes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lactic acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Diabetes insipidus",
          "correct": false
        }
      ],
      "correct_answer": "A. Diabetic ketoacidosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture3_QNkydRl.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Diabetic ketoacidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Uncontrolled diabetes : While the patient does have diabetes, the specific presentation with acidosis, ketonemia, and the clinical context suggest DKA rather than just uncontrolled diabetes.</li><li>\u2022 Option B. Uncontrolled diabetes</li><li>\u2022 Option C. Lactic acidosis : Lactic acidosis presents with acidosis but is typically associated with severe hypoperfusion or hypoxia, and the ketone levels would not be elevated as they are in this case.</li><li>\u2022 Option C. Lactic acidosis</li><li>\u2022 Option D. Diabetes insipidus : Diabetes insipidus is characterized by polyuria and polydipsia due to a deficiency of antidiuretic hormone (ADH) or kidney's response to ADH, but it does not cause hyperglycemia, acidosis, or ketonemia.</li><li>\u2022 Option D. Diabetes insipidus</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Diabetic ketoacidosis is an acute, potentially life-threatening complication of diabetes characterized by hyperglycemia, ketosis, and metabolic acidosis. Clinical presentation typically includes dehydration, Kussmaul breathing, fruity breath odor (acetone), altered mental status, and hypotension.</li><li>\u27a4 Ref : Harper 30/e: p 231.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a486acd1",
      "audio": ""
    },
    {
      "text": "A 6-year-old obese girl presents with dehydration after 3 days of vomiting and diarrhoea. Her parents gave history that a sibling was diagnosed with a type of diabetes that spilled sugar into the urine but did not need treatment. This condition is most likely due to accumulation of which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Galactose",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucose",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lactose",
          "correct": false
        },
        {
          "label": "D",
          "text": "Xylulose",
          "correct": true
        }
      ],
      "correct_answer": "D. Xylulose",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture4_v6N5rNm.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Xylulose</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Galactose: Accumulation of galactose in the urine is usually associated with galactosemia, a serious condition that typically presents in infancy with symptoms like jaundice, vomiting, and hepatomegaly shortly after the introduction of lactose into the diet.</li><li>\u2022 Option A.  Galactose:</li><li>\u2022 galactose in the urine</li><li>\u2022 galactosemia,</li><li>\u2022 infancy</li><li>\u2022 jaundice, vomiting, and hepatomegaly</li><li>\u2022 lactose</li><li>\u2022 diet.</li><li>\u2022 Option B. Glucose: A negative urine glucose oxidase test rules out glucose as the accumulated substance. Conditions causing glucose accumulation, like diabetes mellitus, would also present with elevated blood glucose levels , which is not the case here.</li><li>\u2022 Option B. Glucose:</li><li>\u2022 negative urine glucose oxidase test</li><li>\u2022 glucose</li><li>\u2022 glucose accumulation,</li><li>\u2022 diabetes mellitus,</li><li>\u2022 elevated blood glucose levels</li><li>\u2022 not</li><li>\u2022 Option C. Lactose: Lactose in the urine is uncommon and would indicate a more severe disorder of galactose metabolism than essential pentosuria . It would also likely present with more severe systemic symptoms.</li><li>\u2022 Option C. Lactose:</li><li>\u2022 Lactose</li><li>\u2022 urine</li><li>\u2022 uncommon</li><li>\u2022 more severe disorder of galactose metabolism</li><li>\u2022 pentosuria</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Essential Pentosuria is a benign condition characterized by the excretion of the pentose sugar xylulose in the urine . This diagnosis is supported by the presence of reducing sugars in the urine with normal blood glucose levels and negative glucose-specific urine tests.</li><li>\u27a4 Pentosuria is a benign</li><li>\u27a4 excretion of the pentose sugar xylulose</li><li>\u27a4 urine</li><li>\u27a4 presence of reducing sugars in the urine</li><li>\u27a4 normal blood glucose levels</li><li>\u27a4 negative glucose-specific urine</li><li>\u27a4 tests.</li><li>\u27a4 Ref : Harper 30/e: p 200-201</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 200-201</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c9d5aeb4",
      "audio": ""
    },
    {
      "text": "A patient with Hereditary Fructose Intolerance (HFI) presents with symptoms indicative of the condition. Consider the following statements: Assertion (A): Hereditary fructose intolerance (HFI) results in accumulation of fructose-6-phosphate, which is the reason behind organomegaly seen in this condition. Reasoning (R): Above condition is due to aldolase B deficiency. Choose the correct option regarding the assertion and reasoning.",
      "options": [
        {
          "label": "A",
          "text": "A is right but R is a wrong statement",
          "correct": false
        },
        {
          "label": "B",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": false
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": true
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": false
        }
      ],
      "correct_answer": "C. A is wrong but R is a right statement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) A is wrong, but R is a right statement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  A is right but R is a wrong statement: This option is incorrect because the assertion incorrectly identifies the metabolite that accumulates in HFI.</li><li>\u2022 Option A.  A is right but R is a wrong statement:</li><li>\u2022 incorrect</li><li>\u2022 assertion incorrectly identifies</li><li>\u2022 Option B. A as well as R are right and R is a correct explanation of A: This option is incorrect because the assertion incorrectly states the metabolite involved in HFI.</li><li>\u2022 Option B. A as well as R are right and R is a correct explanation of A:</li><li>\u2022 incorrect</li><li>\u2022 assertion incorrectly</li><li>\u2022 metabolite</li><li>\u2022 HFI.</li><li>\u2022 Option D.  A and R both are wrong: This option is incorrect because the reasoning statement about aldolase B deficiency is correct.</li><li>\u2022 Option D.  A and R both are wrong:</li><li>\u2022 incorrect</li><li>\u2022 reasoning statement</li><li>\u2022 aldolase B deficiency</li><li>\u2022 correct.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 During metabolism of fructose , fructose \u2192 fructose-1-phosphate (enzyme fructokinase) \u2192 glyceraldehyde and dihydroxyacetone phosphate (aldolase B enzyme). Deficiency of this aldolase B \u2192 accumulation of fructose-1-phosphate in various organs leading to organomegaly.</li><li>\u27a4 During metabolism of fructose , fructose \u2192 fructose-1-phosphate (enzyme fructokinase) \u2192 glyceraldehyde and dihydroxyacetone phosphate (aldolase B enzyme).</li><li>\u27a4 metabolism</li><li>\u27a4 fructose</li><li>\u27a4 fructose-1-phosphate</li><li>\u27a4 glyceraldehyde</li><li>\u27a4 dihydroxyacetone phosphate</li><li>\u27a4 Deficiency of this aldolase B \u2192 accumulation of fructose-1-phosphate in various organs leading to organomegaly.</li><li>\u27a4 Deficiency</li><li>\u27a4 aldolase B</li><li>\u27a4 accumulation of fructose-1-phosphate</li><li>\u27a4 organs</li><li>\u27a4 organomegaly.</li><li>\u27a4 Ref : Harper 30/e: p 202,205.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 202,205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c1dfebe3",
      "audio": ""
    },
    {
      "text": "A young woman presents with abdominal bloating and diarrhea after eating ice cream, alongside physical signs of dehydration but normal body temperature. She has a history of similar symptoms following the consumption of substantial amounts of dairy products. What enzyme deficiency is most likely responsible for her condition?",
      "options": [
        {
          "label": "A",
          "text": "Isomaltase",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u03b1-amylase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lactase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sucrase.",
          "correct": false
        }
      ],
      "correct_answer": "C. Lactase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Lactase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Isomaltose: Deficiency in isomaltase , part of the enzyme complex that also includes sucrase , leads to isomaltose intolerance. While it can cause similar symptoms of malabsorption, the specific reaction to dairy products is more indicative of lactose intolerance.</li><li>\u2022 Option A.  Isomaltose:</li><li>\u2022 Deficiency in isomaltase</li><li>\u2022 enzyme complex</li><li>\u2022 sucrase</li><li>\u2022 isomaltose</li><li>\u2022 intolerance.</li><li>\u2022 malabsorption,</li><li>\u2022 dairy products</li><li>\u2022 more</li><li>\u2022 lactose intolerance.</li><li>\u2022 Option B.  \u03b1-amylase: \u03b1-Amylase deficiency is exceedingly rare and would lead to a broader range of symptoms associated with the malabsorption of starches , not specifically dairy products.</li><li>\u2022 Option B.  \u03b1-amylase:</li><li>\u2022 \u03b1-Amylase deficiency</li><li>\u2022 rare</li><li>\u2022 broader range of symptoms</li><li>\u2022 malabsorption of starches</li><li>\u2022 not</li><li>\u2022 dairy products.</li><li>\u2022 Option D. Sucrase: Sucrase deficiency results in sucrase-isomaltase deficiency , which would lead to symptoms following the ingestion of sucrose and isomaltose-rich foods, not specifically lactose-containing foods like dairy products.</li><li>\u2022 Option D. Sucrase:</li><li>\u2022 Sucrase deficiency</li><li>\u2022 sucrase-isomaltase deficiency</li><li>\u2022 ingestion of sucrose and isomaltose-rich foods,</li><li>\u2022 not</li><li>\u2022 lactose-containing foods like dairy products.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lactose intolerance is a condition resulting from lactase deficiency , characterized by gastrointestinal symptoms such as bloating, diarrhea, and dehydration following the ingestion of lactose-containing foods like dairy products. Identifying the specific trigger (lactose) and connecting it to the deficient enzyme (lactase) is key in diagnosing and managing this condition effectively.</li><li>\u27a4 Lactose intolerance</li><li>\u27a4 lactase deficiency</li><li>\u27a4 gastrointestinal symptoms</li><li>\u27a4 bloating,</li><li>\u27a4 diarrhea, and dehydration</li><li>\u27a4 ingestion of lactose-containing</li><li>\u27a4 foods like dairy products.</li><li>\u27a4 specific trigger</li><li>\u27a4 deficient enzyme (lactase)</li><li>\u27a4 diagnosing and managing</li><li>\u27a4 effectively.</li><li>\u27a4 Ref : Harper 30/e: p 537-538.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 537-538.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61814bc8",
      "audio": ""
    },
    {
      "text": "A middle aged known alcoholic was found lying semiconscious at his residence and was taken to ER. Laboratory studies showed a large anion gap, elevated blood alcohol levels - 245 mg/dL and low blood glucose - 38 mg/dL. The patient\u2019s large anion gap and hypoglycemia can be explained by which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Decreased secretion of glucagon",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased secretion of insulin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inhibition of dehydrogenase enzymes by NADH",
          "correct": true
        },
        {
          "label": "D",
          "text": "Inhibition of glycogenolysis by ethanol",
          "correct": false
        }
      ],
      "correct_answer": "C. Inhibition of dehydrogenase enzymes by NADH",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)\u00a0 Inhibition of dehydrogenase enzymes by NADH</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Decreased secretion of glucagon: While glucagon secretion may be affected in chronic alcoholics due to pancreatic damage , it is not the primary cause of the large anion gap or hypoglycemia in acute ethanol intoxication.</li><li>\u2022 Option A. Decreased secretion of glucagon:</li><li>\u2022 chronic alcoholics</li><li>\u2022 pancreatic</li><li>\u2022 damage</li><li>\u2022 not</li><li>\u2022 large anion gap or hypoglycemia</li><li>\u2022 acute ethanol intoxication.</li><li>\u2022 Option B.  Increased secretion of insulin: Acute ethanol ingestion typically does not cause an increase in insulin secretion. In fact, hypoglycemia in this context is more related to the inhibition of gluconeogenesis and glycogenolysis rather than insulin-mediated glucose uptake.</li><li>\u2022 Option B.  Increased secretion of insulin:</li><li>\u2022 Acute ethanol ingestion</li><li>\u2022 does not</li><li>\u2022 increase in insulin secretion.</li><li>\u2022 hypoglycemia</li><li>\u2022 more</li><li>\u2022 inhibition of gluconeogenesis and glycogenolysis</li><li>\u2022 Option D. Inhibition of glycogenolysis by ethanol: While ethanol can impair glycogenolysis, the more significant impact on the anion gap and hypoglycaemia is through the inhibition of dehydrogenase enzymes by the increased NADH/NAD+ ratio, affecting gluconeogenesis and leading to the accumulation of organic acids.</li><li>\u2022 Option D. Inhibition of glycogenolysis by ethanol:</li><li>\u2022 ethanol</li><li>\u2022 impair glycogenolysis,</li><li>\u2022 more</li><li>\u2022 anion gap and hypoglycaemia</li><li>\u2022 inhibition of dehydrogenase enzymes</li><li>\u2022 increased NADH/NAD+ ratio,</li><li>\u2022 gluconeogenesis</li><li>\u2022 accumulation of organic acids.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alcoholics do not frequently eat while binge drinking \u2192 so most likely his liver glycogen stores become depleted and cannot increase his blood glucose levels. The metabolic stress in them leads to the increase in secretion of epinephrine and other hormones \u2192 mobilize fatty acids from stored triglycerides in adipose cells \u2192 undergo beta-oxidation \u2192 get converted to ketone bodies because of the inhibition of the TCA cycle by high levels of NADH (produced by the oxidation of ethanol first to acetaldehyde and acetate). Key gluconeogenic dehydrogenases are also inhibited by the elevated levels of NADH, including lactate dehydrogenase, glycerol 3-phosphate dehydrogenase, and malate dehydrogenase.</li><li>\u27a4 Alcoholics do not frequently eat while binge drinking \u2192 so most likely his liver glycogen stores become depleted and cannot increase his blood glucose levels.</li><li>\u27a4 Alcoholics do not</li><li>\u27a4 binge drinking \u2192</li><li>\u27a4 liver glycogen stores</li><li>\u27a4 depleted and</li><li>\u27a4 cannot increase</li><li>\u27a4 blood glucose levels.</li><li>\u27a4 The metabolic stress in them leads to the increase in secretion of epinephrine and other hormones \u2192 mobilize fatty acids from stored triglycerides in adipose cells \u2192 undergo beta-oxidation \u2192 get converted to ketone bodies because of the inhibition of the TCA cycle by high levels of NADH (produced by the oxidation of ethanol first to acetaldehyde and acetate).</li><li>\u27a4 metabolic stress</li><li>\u27a4 increase in secretion of epinephrine</li><li>\u27a4 hormones</li><li>\u27a4 mobilize fatty</li><li>\u27a4 acids</li><li>\u27a4 stored triglycerides in adipose cells</li><li>\u27a4 beta-oxidation</li><li>\u27a4 ketone bodies</li><li>\u27a4 inhibition of the TCA cycle</li><li>\u27a4 high levels of NADH</li><li>\u27a4 Key gluconeogenic dehydrogenases are also inhibited by the elevated levels of NADH, including lactate dehydrogenase, glycerol 3-phosphate dehydrogenase, and malate dehydrogenase.</li><li>\u27a4 gluconeogenic dehydrogenases</li><li>\u27a4 inhibited by the elevated levels of NADH,</li><li>\u27a4 lactate dehydrogenase, glycerol 3-phosphate dehydrogenase,</li><li>\u27a4 malate dehydrogenase.</li><li>\u27a4 Ref : Vasudevan 9/e: 140-141.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 140-141.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e590b67",
      "audio": ""
    },
    {
      "text": "A young woman with laboratory picture of normocytic anaemia and jaundice with splenomegaly was diagnosed to have RBC pyruvate kinase deficiency after a PBS showed spiculated cells. Due to the abnormal function of pyruvate kinase, less pyruvate is formed and the intermediates above pyruvate in the glycolytic pathway get accumulated. Which of the following products is not formed in appropriate amounts in the RBC due to the deficiency of pyruvate?",
      "options": [
        {
          "label": "A",
          "text": "Lactate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Oxaloacetate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetyl-CoA",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glucose",
          "correct": false
        }
      ],
      "correct_answer": "A. Lactate",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture3_vhplgH7.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture4_OJApgRI.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Lactate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This question tests understanding of RBC metabolism, particularly the consequences of pyruvate kinase deficiency. Pyruvate kinase deficiency is an inherited disorder that affects glycolysis in RBCs, leading to premature destruction of red blood cells (hemolytic anemia). The spiculated RBCs seen on peripheral blood smear are characteristic of this condition. The defect causes ATP depletion, accumulation of glycolytic intermediates upstream of the enzyme defect, and reduced production of downstream metabolites like lactate.</li><li>\u27a4 Ref : Harper 30/e:  p 170; Vasudevan 9/e: 111.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2ef41294",
      "audio": ""
    },
    {
      "text": "Can the acetyl CoA, derived from fatty acid oxidation, be converted back into glucose to maintain blood glucose levels? What is the correct response based on human metabolic pathways?",
      "options": [
        {
          "label": "A",
          "text": "True",
          "correct": false
        },
        {
          "label": "B",
          "text": "False",
          "correct": true
        },
        {
          "label": "C",
          "text": "Information Insufficient",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "B. False",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) False</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Acetyl CoA cannot be converted into glucose in humans because the reactions of the citric acid cycle are not reversible , and there is no pathway that can convert acetyl CoA back to pyruvate or any other gluconeogenic precursors. This underscores the importance of the concept that while glucose can be converted into acetyl CoA, the reverse is not true , marking a one-way route towards energy production.</li><li>\u2022 Acetyl CoA</li><li>\u2022 cannot</li><li>\u2022 glucose</li><li>\u2022 citric acid cycle are not reversible</li><li>\u2022 no pathway</li><li>\u2022 convert acetyl CoA back to pyruvate</li><li>\u2022 gluconeogenic precursors.</li><li>\u2022 underscores</li><li>\u2022 glucose can be converted into acetyl CoA,</li><li>\u2022 reverse is not true</li><li>\u2022 one-way route</li><li>\u2022 energy production.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fate of Acetyl CoA</li><li>\u27a4 Fate of Acetyl CoA</li><li>\u27a4 Fatty Acid Synthesis Ketone Body Synthesis Cholesterol Synthesis TCA Cycle</li><li>\u27a4 Fatty Acid Synthesis</li><li>\u27a4 Ketone Body Synthesis</li><li>\u27a4 Cholesterol Synthesis</li><li>\u27a4 TCA Cycle</li><li>\u27a4 Acetyl CoA cannot be converted to glucose as the link reaction is irreversible.</li><li>\u27a4 Acetyl CoA cannot be converted to glucose as the link reaction is irreversible.</li><li>\u27a4 Ref : Vasudevan 9/e p: 141.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e p: 141.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "239a03a9",
      "audio": ""
    },
    {
      "text": "In a remote clinic, a physician is treating a mountaineer for fatigue and muscle weakness after a prolonged trek. To understand the patient\u2019s condition, the physician reviews metabolic processes that could be affected by long-term physical exertion and caloric deficit. Considering the body's adaptive mechanisms, which functions does the glucose-alanine cycle serve in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Carries amino group to the Liver",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alanine as a substrate for Gluconeogenesis during starvation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both a and b",
          "correct": true
        },
        {
          "label": "D",
          "text": "Only b",
          "correct": false
        }
      ],
      "correct_answer": "C. Both a and b",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture22.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Both A and B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Carries amino group to the Liver: This is a correct function of the glucose-alanine cycle but does not fully capture the cycle's roles . It transports nitrogen to the liver, where it can be safely removed from the body.</li><li>\u2022 Option A. Carries amino group to the Liver:</li><li>\u2022 correct</li><li>\u2022 glucose-alanine cycle</li><li>\u2022 does not</li><li>\u2022 cycle's roles</li><li>\u2022 nitrogen to the liver,</li><li>\u2022 safely removed</li><li>\u2022 body.</li><li>\u2022 Option B. Alanine as a substrate for Gluconeogenesis during starvation: This is another correct function, highlighting the cycle's role in supporting glucose production from non-carbohydrate sources during periods of starvation or intense physical activity.</li><li>\u2022 Option B. Alanine as a substrate for Gluconeogenesis during starvation: This</li><li>\u2022 correct</li><li>\u2022 highlighting the cycle's role</li><li>\u2022 glucose production</li><li>\u2022 non-carbohydrate sources</li><li>\u2022 starvation or intense physical activity.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Uses of glucose-alanine (Cahill) cycle</li><li>\u27a4 Uses of glucose-alanine (Cahill) cycle</li><li>\u27a4 Carries amino group to the Liver. Alanine as a substrate for Gluconeogenesis during starvation. Amino acid increased in blood during starvation is Alanine.</li><li>\u27a4 Carries amino group to the Liver.</li><li>\u27a4 Carries amino group</li><li>\u27a4 Liver.</li><li>\u27a4 Alanine as a substrate for Gluconeogenesis during starvation.</li><li>\u27a4 Alanine</li><li>\u27a4 substrate</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 starvation.</li><li>\u27a4 Amino acid increased in blood during starvation is Alanine.</li><li>\u27a4 Amino acid increased</li><li>\u27a4 starvation is Alanine.</li><li>\u27a4 Ref : Vasudevan 9/e p:120.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e p:120.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a00ee83",
      "audio": ""
    },
    {
      "text": "A 25-year-old female, found comatose, was rushed to the emergency department from a campus chemistry lab. She exhibits a high fever (40.5\u00b0C or 105\u00b0F), tachycardia, tachypnea, and her arm is stained yellow. Blood pressure readings are unsuccessful. She experienced blurred vision, headaches, and tremors following an accidental exposure to metabolic inhibitors, leading to her current state. Based on these symptoms, which toxin is most likely responsible for her condition?",
      "options": [
        {
          "label": "A",
          "text": "Phenobarbital",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carboxin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dimercaprol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dinitrophenol",
          "correct": true
        }
      ],
      "correct_answer": "D. Dinitrophenol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Dinitrophenol</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical presentation of dinitrophenol poisoning , characterized by hyperthermia, rapid heart and respiratory rates, and yellow staining of the skin , highlighting the importance of understanding the effects of metabolic inhibitors in acute toxic exposures.</li><li>\u27a4 dinitrophenol poisoning</li><li>\u27a4 hyperthermia, rapid heart and respiratory rates, and yellow</li><li>\u27a4 staining of the skin</li><li>\u27a4 importance</li><li>\u27a4 effects of metabolic inhibitors</li><li>\u27a4 acute toxic exposures.</li><li>\u27a4 Ref : Harper 30/e: p 123</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 123</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c8dc0ed3",
      "audio": ""
    },
    {
      "text": "Which of the following statements accurately highlights a key difference between respiratory chain inhibitors and uncouplers?",
      "options": [
        {
          "label": "A",
          "text": "The effect of respiratory chain inhibitors cannot be characterized spectroscopically, whereas that of uncouplers can.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Uncouplers are toxic substances, but respiratory chain inhibitors are not.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Respiratory chain inhibitors allow leakage of protons across the membrane, but uncouplers do not.",
          "correct": false
        }
      ],
      "correct_answer": "B. Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Uncouplers such as 2, 4-dinitrophenol increase the permeability of the inner mitochondrial membrane to protons , reduce the electrochemical potential , and inhibit ATP synthase.</li><li>\u27a4 Uncouplers</li><li>\u27a4 2, 4-dinitrophenol increase</li><li>\u27a4 inner mitochondrial membrane to protons</li><li>\u27a4 reduce</li><li>\u27a4 electrochemical potential</li><li>\u27a4 inhibit</li><li>\u27a4 ATP synthase.</li><li>\u27a4 UNCOUPLERS</li><li>\u27a4 UNCOUPLERS</li><li>\u27a4 Thermogenin Thyroxine 2,4-dinitrophenol High dose Aspirin</li><li>\u27a4 Thermogenin</li><li>\u27a4 Thyroxine</li><li>\u27a4 2,4-dinitrophenol</li><li>\u27a4 High dose Aspirin</li><li>\u27a4 Ref : Harper Illustrated Biochemistry 31/e p 322.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper Illustrated Biochemistry 31/e p 322.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cb2c8e40",
      "audio": ""
    },
    {
      "text": "A clinical researcher is investigating a rare metabolic disorder characterized by defects in the mitochondrial electron transport chain. During her research, she examines the role and characteristics of various components within the chain, including Coenzyme Q (CoQ). She comes across some common misconceptions about CoQ among her colleagues. Which of the following statements about Coenzyme Q would she identify as FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Is a quinone derivative",
          "correct": false
        },
        {
          "label": "B",
          "text": "NADH is the only donor of pair of electrons to CoQ",
          "correct": true
        },
        {
          "label": "C",
          "text": "Have long isoprenoid tail",
          "correct": false
        },
        {
          "label": "D",
          "text": "It reduces two molecules of cytochrome c",
          "correct": false
        }
      ],
      "correct_answer": "B. NADH is the only donor of pair of electrons to CoQ",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) NADH is the only donor of pair of electrons to CoQ</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The ubiquinone (Q) is reduced to semiquinone (QH) and finally to quinol (QH2). It accepts a pair of electrons from NADH or FADH2 through complex-I or complex-II respectively Coenzyme Q is a quinone derivative having a long isoprenoid tail and the chain length of the tail is different in various species. Two molecules of cytochrome c are reduced. The Q cycle facilitates the switching from the two electron carrier ubiquinol to the single electron carrier cytochrome c.</li><li>\u27a4 The ubiquinone (Q) is reduced to semiquinone (QH) and finally to quinol (QH2).</li><li>\u27a4 ubiquinone (Q)</li><li>\u27a4 semiquinone (QH)</li><li>\u27a4 quinol (QH2).</li><li>\u27a4 It accepts a pair of electrons from NADH or FADH2 through complex-I or complex-II respectively</li><li>\u27a4 pair of electrons</li><li>\u27a4 NADH or FADH2</li><li>\u27a4 complex-I or complex-II</li><li>\u27a4 Coenzyme Q is a quinone derivative having a long isoprenoid tail and the chain length of the tail is different in various species.</li><li>\u27a4 Coenzyme Q</li><li>\u27a4 quinone derivative</li><li>\u27a4 isoprenoid tail</li><li>\u27a4 chain length of the tail</li><li>\u27a4 Two molecules of cytochrome c are reduced.</li><li>\u27a4 Two</li><li>\u27a4 cytochrome c</li><li>\u27a4 reduced.</li><li>\u27a4 The Q cycle facilitates the switching from the two electron carrier ubiquinol to the single electron carrier cytochrome c.</li><li>\u27a4 Q cycle</li><li>\u27a4 switching</li><li>\u27a4 two electron carrier ubiquinol</li><li>\u27a4 single electron carrier cytochrome c.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 261.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 261.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "86ac012b",
      "audio": ""
    },
    {
      "text": "A 28-year-old male patient with Mediterranean origin travels to Africa. During his trip, he develops symptoms of malaria and is subsequently treated with primaquine. Shortly after treatment, he presents with signs of hemolytic anemia. His medical history is significant for a specific enzyme deficiency that makes him susceptible to hemolysis when exposed to certain oxidative stressors, such as primaquine. The enzyme deficiency is involved in which of the following metabolic pathways?",
      "options": [
        {
          "label": "A",
          "text": "Glycolysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gluconeogenesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "HMP pathway",
          "correct": true
        },
        {
          "label": "D",
          "text": "Rapaport pathway",
          "correct": false
        }
      ],
      "correct_answer": "C. HMP pathway",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) HMP pathway</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glucose 6 Phosphate Dehydrogenase Deficiency \u2013</li><li>\u27a4 Glucose 6 Phosphate Dehydrogenase Deficiency \u2013</li><li>\u27a4 Most common enzyme deficiency in human beings. X-linked recessive Manifest as - Hemolytic Anaemia OR Methemoglobinemia</li><li>\u27a4 Most common enzyme deficiency in human beings.</li><li>\u27a4 Most common</li><li>\u27a4 deficiency</li><li>\u27a4 X-linked recessive</li><li>\u27a4 X-linked recessive</li><li>\u27a4 Manifest as - Hemolytic Anaemia OR Methemoglobinemia</li><li>\u27a4 Hemolytic Anaemia</li><li>\u27a4 Methemoglobinemia</li><li>\u27a4 DRUGS CAUSING HEMOLYSIS IN G6PD DEFICIENT INDIVIDUALS</li><li>\u27a4 DRUGS CAUSING HEMOLYSIS IN G6PD DEFICIENT INDIVIDUALS</li><li>\u27a4 Sulfonamides Chloroquine Quinine Primaquine Nitrofurantoin</li><li>\u27a4 Sulfonamides</li><li>\u27a4 Chloroquine</li><li>\u27a4 Quinine</li><li>\u27a4 Primaquine</li><li>\u27a4 Nitrofurantoin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7440943d",
      "audio": ""
    },
    {
      "text": "Which of the following statements about Fructosuria is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Deficiency of aldolase B",
          "correct": true
        },
        {
          "label": "B",
          "text": "Excretes fructose in urine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rare incidence",
          "correct": false
        },
        {
          "label": "D",
          "text": "Positive Benedict\u2019s test",
          "correct": false
        }
      ],
      "correct_answer": "A. Deficiency of aldolase B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Deficiency of aldolase B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B.  Excretes fructose in urine: This is true for fructosuria due to the inability to metabolize fructose effectively.</li><li>\u2022 Option B.  Excretes fructose in urine:</li><li>\u2022 true</li><li>\u2022 inability to metabolize fructose</li><li>\u2022 Option C. Rare incidence: Fructosuria is indeed a rare condition, given the specific enzyme deficiency required for its manifestation.</li><li>\u2022 Option C. Rare incidence:</li><li>\u2022 Fructosuria</li><li>\u2022 specific enzyme deficiency</li><li>\u2022 Option D. Positive Benedict\u2019s test: Fructose is a reducing sugar, which means it will react with Benedict\u2019s reagent to produce a color change , indicating a positive test result.</li><li>\u2022 Option D. Positive Benedict\u2019s test:</li><li>\u2022 reducing sugar,</li><li>\u2022 react with Benedict\u2019s reagent</li><li>\u2022 color</li><li>\u2022 change</li><li>\u2022 positive test result.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This is a benign metabolic defect due to defect/deficiency of fructokinase. Incidence is 1 in 130,000 births. There is excretion of fructose in urine. Urine gives positive Benedict\u2019s and Seliwanoff\u2019s tests.</li><li>\u27a4 This is a benign metabolic defect due to defect/deficiency of fructokinase.</li><li>\u27a4 benign metabolic defect</li><li>\u27a4 defect/deficiency of fructokinase.</li><li>\u27a4 Incidence is 1 in 130,000 births.</li><li>\u27a4 1 in 130,000 births.</li><li>\u27a4 There is excretion of fructose in urine.</li><li>\u27a4 excretion of fructose</li><li>\u27a4 Urine gives positive Benedict\u2019s and Seliwanoff\u2019s tests.</li><li>\u27a4 positive Benedict\u2019s and Seliwanoff\u2019s tests.</li><li>\u27a4 Ref : Vasudevan 9/e: P 138.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: P 138.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aee611d8",
      "audio": ""
    },
    {
      "text": "Oxidative phosphorylation process is known for its efficiency in generating ATP by utilizing a specific gradient. Which of the following best describes what oxidative phosphorylation couples with ATP generation?",
      "options": [
        {
          "label": "A",
          "text": "Proton translocation",
          "correct": true
        },
        {
          "label": "B",
          "text": "Substrate level phosphorylation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Electron flow through cytochromes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reduction of NADH",
          "correct": false
        }
      ],
      "correct_answer": "A. Proton translocation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Proton translocation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Substrate: level phosphorylation is a different mechanism of ATP production that occurs in the cytoplasm and mitochondrial matrix , not directly related to the proton gradient utilized in oxidative phosphorylation.</li><li>\u2022 Option B: Substrate:</li><li>\u2022 phosphorylation</li><li>\u2022 ATP production</li><li>\u2022 cytoplasm and</li><li>\u2022 mitochondrial matrix</li><li>\u2022 not</li><li>\u2022 proton gradient</li><li>\u2022 oxidative phosphorylation.</li><li>\u2022 Option C: While electron flow through cytochromes is essential for establishing the proton gradient, the direct coupling in oxidative phosphorylation involves the movement of protons , not just the electron flow.</li><li>\u2022 Option C:</li><li>\u2022 electron flow</li><li>\u2022 cytochromes</li><li>\u2022 proton gradient,</li><li>\u2022 direct</li><li>\u2022 oxidative</li><li>\u2022 phosphorylation</li><li>\u2022 movement of protons</li><li>\u2022 not</li><li>\u2022 electron flow.</li><li>\u2022 Option D: The reduction of NADH to NAD+ occurs upstream of ATP generation in oxidative phosphorylation , contributing to the electron transport chain that establishes the proton gradient but is not the direct coupling mechanism for ATP synthesis.</li><li>\u2022 Option D:</li><li>\u2022 reduction of NADH</li><li>\u2022 NAD+</li><li>\u2022 ATP generation</li><li>\u2022 oxidative phosphorylation</li><li>\u2022 electron transport chain</li><li>\u2022 proton gradient</li><li>\u2022 not</li><li>\u2022 direct</li><li>\u2022 ATP synthesis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Proton translocation across the mitochondrial membrane generates an electro- chemical potential difference composed of a pH gradient and an electrical potential. This electrochemical potential difference is used to drive ATP synthase to form ATP. During this process NADH is oxidized not reduced, by coupling with oxygen as the ultimate electron acceptor . Substrate level phosphorylation occurs during glycolysis and TCA . Electron flow through cytochromes is indirectly causing generation of proton gradient which is directly causing ATP generation, so the best answer to choose is A rather than C.</li><li>\u27a4 Proton translocation across the mitochondrial membrane generates an electro- chemical potential difference composed of a pH gradient and an electrical potential.</li><li>\u27a4 Proton</li><li>\u27a4 across</li><li>\u27a4 mitochondrial membrane</li><li>\u27a4 electro- chemical potential difference</li><li>\u27a4 pH gradient</li><li>\u27a4 electrical potential.</li><li>\u27a4 This electrochemical potential difference is used to drive ATP synthase to form ATP.</li><li>\u27a4 electrochemical potential</li><li>\u27a4 drive ATP synthase to form ATP.</li><li>\u27a4 During this process NADH is oxidized not reduced, by coupling with oxygen as the ultimate electron acceptor . Substrate level phosphorylation occurs during glycolysis and TCA . Electron flow through cytochromes is indirectly causing generation of proton gradient which is directly causing ATP generation, so the best answer to choose is A rather than C.</li><li>\u27a4 NADH is oxidized</li><li>\u27a4 coupling with oxygen</li><li>\u27a4 ultimate electron acceptor</li><li>\u27a4 Substrate</li><li>\u27a4 level phosphorylation</li><li>\u27a4 glycolysis and TCA</li><li>\u27a4 Electron flow</li><li>\u27a4 cytochromes</li><li>\u27a4 indirectly</li><li>\u27a4 generation of proton gradient</li><li>\u27a4 ATP generation,</li><li>\u27a4 choose is A</li><li>\u27a4 Ref : Harper Illustrated Biochemistry 31/e p 315.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper Illustrated Biochemistry 31/e p 315.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4bbac1b",
      "audio": ""
    },
    {
      "text": "A 32-year-old woman presents to the clinic with fatigue and muscle weakness. Further investigation reveals a mitochondrial DNA mutation leading to reduced complex I activity in her cells. Given the role of complex I in the electron transport chain, which of the following electron transfers would be most directly affected by this mutation?",
      "options": [
        {
          "label": "A",
          "text": "Succinate to complex III",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cytochrome C to complex IV",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coenzyme Q to complex III",
          "correct": false
        },
        {
          "label": "D",
          "text": "Malate to coenzyme Q",
          "correct": true
        }
      ],
      "correct_answer": "D. Malate to coenzyme Q",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Malate to coenzyme Q</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Complex I accepts electrons from NADH and will transfer them to coenzyme Q . Malate dehydrogenase will convert malate to oxaloacetate , generating NADH in the process. The NADH will then donate electrons to complex I to initiate electron transfer.</li><li>\u27a4 Complex I</li><li>\u27a4 electrons</li><li>\u27a4 NADH</li><li>\u27a4 coenzyme Q</li><li>\u27a4 Malate dehydrogenase</li><li>\u27a4 convert malate to</li><li>\u27a4 oxaloacetate</li><li>\u27a4 NADH</li><li>\u27a4 NADH</li><li>\u27a4 donate electrons</li><li>\u27a4 complex I</li><li>\u27a4 electron transfer.</li><li>\u27a4 Succinate donates electrons at complex II (Via succinate dehydrogenase, a component of complex II), which donates to coenzyme Q , thereby bypassing complex I. Cytochrome c transfers electrons from complex III to complex IV. Once electrons are carried by coenzyme Q , complex I is no longer required for electron transfer to oxygen.</li><li>\u27a4 Succinate donates electrons</li><li>\u27a4 complex II</li><li>\u27a4 succinate dehydrogenase,</li><li>\u27a4 donates to coenzyme</li><li>\u27a4 Q</li><li>\u27a4 bypassing complex I.</li><li>\u27a4 Cytochrome c</li><li>\u27a4 electrons</li><li>\u27a4 complex III to complex IV.</li><li>\u27a4 electrons</li><li>\u27a4 coenzyme Q</li><li>\u27a4 complex I</li><li>\u27a4 no</li><li>\u27a4 electron transfer to oxygen.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 260.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 260.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0e7ac2dd",
      "audio": ""
    },
    {
      "text": "Identify which of the following metabolites is not typically involved in the HMP shunt?",
      "options": [
        {
          "label": "A",
          "text": "Glycerol-3-phosphate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sedoheptulose-7-phosphate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glyceraldehyde-3-phosphate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Xylulose-5-phosphate",
          "correct": false
        }
      ],
      "correct_answer": "A. Glycerol-3-phosphate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Glycerol 3 Phosphate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Metabolites in HMP Shunt Pathway</li><li>\u27a4 Metabolites in HMP Shunt Pathway</li><li>\u27a4 Glucose-6-phosphate 6-Phosphogluconate Ribulose-5-Phosphate Xylulose-5-Phosphate Ribose-5-Phosphate Glyceraldehyde-3-Phosphate Sedoheptulose-7-Phosphate Fructose-6-phosphate Erythrose 4 Phosphate.</li><li>\u27a4 Glucose-6-phosphate</li><li>\u27a4 6-Phosphogluconate</li><li>\u27a4 Ribulose-5-Phosphate</li><li>\u27a4 Xylulose-5-Phosphate</li><li>\u27a4 Ribose-5-Phosphate</li><li>\u27a4 Glyceraldehyde-3-Phosphate</li><li>\u27a4 Sedoheptulose-7-Phosphate</li><li>\u27a4 Fructose-6-phosphate</li><li>\u27a4 Erythrose 4 Phosphate.</li><li>\u27a4 Ref : Harper 30/e: p197</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p197</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fba2e0b7",
      "audio": ""
    },
    {
      "text": "Which of the following enzymes is NOT directly involved in determining a cell's gluconeogenic capability?",
      "options": [
        {
          "label": "A",
          "text": "Pyruvate dehydrogenase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glucose-6-phosphatase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pyruvate carboxylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fructose 1,6- Bisphosphatase",
          "correct": false
        }
      ],
      "correct_answer": "A. Pyruvate dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Pyruvate dehydrogenase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gluconeogenesis is the process of synthesizing glucose or glycogen from non-carbohydrate precursors. Gluconeogenic capacity is determined by the presence of key enzymes of Gluconeogenesis. Pyruvate Dehydrogenase is not an enzyme of gluconeogenesis.</li><li>\u27a4 Gluconeogenesis is the process of synthesizing glucose or glycogen from non-carbohydrate precursors.</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 synthesizing glucose or glycogen</li><li>\u27a4 non-carbohydrate precursors.</li><li>\u27a4 Gluconeogenic capacity is determined by the presence of key enzymes of Gluconeogenesis.</li><li>\u27a4 Gluconeogenic</li><li>\u27a4 presence of key enzymes</li><li>\u27a4 Gluconeogenesis.</li><li>\u27a4 Pyruvate Dehydrogenase is not an enzyme of gluconeogenesis.</li><li>\u27a4 Pyruvate Dehydrogenase</li><li>\u27a4 not</li><li>\u27a4 gluconeogenesis.</li><li>\u27a4 Ref : Harper 30/e p188, 189.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p188, 189.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "773c2082",
      "audio": ""
    },
    {
      "text": "During a clinical rotation in endocrinology, a resident encounters a patient with a rare metabolic disorder that affects glucose production. Through discussions with the attending physician, the resident learns that the patient's condition involves a unique metabolic pathway that operates across two distinct cellular compartments, which is unusual compared to other pathways involved in glucose metabolism. Intrigued, the resident decides to research this further. Which metabolic pathway, relevant to the patient's condition, is known to occur across two different cellular compartments?",
      "options": [
        {
          "label": "A",
          "text": "Gluconeogenesis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glycolysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycogenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glycogenolysis",
          "correct": false
        }
      ],
      "correct_answer": "A. Gluconeogenesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Gluconeogenesis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gluconeogenesis takes place in both cytosol and mitochondria . The Mitochondrial step is Pyruvate Carboxylase reaction.</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 both cytosol and mitochondria</li><li>\u27a4 Mitochondrial</li><li>\u27a4 Pyruvate Carboxylase reaction.</li><li>\u27a4 Pathways taking place in two compartments are \u2013</li><li>\u27a4 Pathways taking place in two compartments are \u2013</li><li>\u27a4 Heme Synthesis Urea Cycle Gluconeogenesis</li><li>\u27a4 Heme Synthesis</li><li>\u27a4 Heme Synthesis</li><li>\u27a4 Urea Cycle</li><li>\u27a4 Urea Cycle</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 Ref : Harper 30/e p188, 189</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p188, 189</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b644a07",
      "audio": ""
    },
    {
      "text": "Which of the following metabolic pathways is not directly involved in the generation of ATP?",
      "options": [
        {
          "label": "A",
          "text": "Glycolysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "TCA Cycle",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fatty Acid Oxidation",
          "correct": false
        },
        {
          "label": "D",
          "text": "HMP Pathway",
          "correct": true
        }
      ],
      "correct_answer": "D. HMP Pathway",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture11.jpg"
      ],
      "explanation": "<p><strong>Ans. D) HMP Pathway.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Glycolysis: Glycolysis is a fundamental metabolic pathway that converts glucose to pyruvate, generating a net gain of 2 ATP molecules per glucose molecule.</li><li>\u2022 Option A. Glycolysis:</li><li>\u2022 fundamental metabolic pathway</li><li>\u2022 glucose to pyruvate,</li><li>\u2022 net gain</li><li>\u2022 2</li><li>\u2022 ATP molecules</li><li>\u2022 glucose molecule.</li><li>\u2022 Option B. TCA Cycle: The TCA Cycle, or Krebs cycle , occurs in the mitochondrial matrix and produces GTP, which is equivalent to ATP, along with NADH and FADH2 , which are used in oxidative phosphorylation to generate further ATP.</li><li>\u2022 Option B. TCA Cycle:</li><li>\u2022 Krebs cycle</li><li>\u2022 mitochondrial matrix</li><li>\u2022 GTP,</li><li>\u2022 ATP,</li><li>\u2022 NADH and FADH2</li><li>\u2022 oxidative phosphorylation</li><li>\u2022 further ATP.</li><li>\u2022 Option C. Fatty Acid Oxidation: Fatty acid oxidation, or \u03b2-oxidation, takes place in the mitochondria, breaking down fatty acids to acetyl-CoA and generating NADH and FADH2, which are then used in the TCA cycle and oxidative phosphorylation to produce ATP.</li><li>\u2022 Option C. Fatty Acid Oxidation:</li><li>\u2022 \u03b2-oxidation,</li><li>\u2022 mitochondria,</li><li>\u2022 fatty acids</li><li>\u2022 acetyl-CoA</li><li>\u2022 NADH and FADH2,</li><li>\u2022 TCA cycle</li><li>\u2022 oxidative phosphorylation</li><li>\u2022 ATP.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Harper 30/e: p200.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p200.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "91454438",
      "audio": ""
    },
    {
      "text": "Which of the following options correctly represents the diagnostic criteria for Diabetes Mellitus?",
      "options": [
        {
          "label": "A",
          "text": "If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion",
          "correct": false
        },
        {
          "label": "B",
          "text": "If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion).",
          "correct": false
        },
        {
          "label": "C",
          "text": "If the random plasma sugar level is more than 200 mg/dl, on more than one occasion.",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All the above",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture5_cgQTuPi.jpg"
      ],
      "explanation": "<p><strong>Ans. D) All the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fasting plasma sugar more than 126 mg/dl, on more than one occasion: This is one of the criteria for diagnosing diabetes but not the only one.</li><li>\u2022 Option A. Fasting plasma sugar more than 126 mg/dl, on more than one occasion:</li><li>\u2022 Option B.  2-hour post-glucose load value of GTT more than 200 mg/dl: This too is a valid criterion for diagnosing diabetes, even if observed on just one occasion, provided there are classic symptoms of hyperglycemia.</li><li>\u2022 Option B.  2-hour post-glucose load value of GTT more than 200 mg/dl:</li><li>\u2022 Option C. Random plasma sugar level more than 200 mg/dl, on more than one occasion: While a single measurement with classic symptoms can be sufficient, additional confirmation enhances the diagnostic certainty, especially in asymptomatic individuals.</li><li>\u2022 Option C. Random plasma sugar level more than 200 mg/dl, on more than one occasion:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion). If the random plasma sugar level is more than 200 mg/dl , on more than one occasion. Glycated haemoglobin (Glyco -Hb) or HbA1c level more than 6.5% at any occasion</li><li>\u27a4 If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion</li><li>\u27a4 fasting plasma sugar</li><li>\u27a4 more than 126 mg /dl,</li><li>\u27a4 more</li><li>\u27a4 If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion).</li><li>\u27a4 2-hr post-glucose</li><li>\u27a4 GTT is more than 200 mg /dl</li><li>\u27a4 If the random plasma sugar level is more than 200 mg/dl , on more than one occasion.</li><li>\u27a4 random plasma sugar level</li><li>\u27a4 more than 200 mg/dl</li><li>\u27a4 more than one occasion.</li><li>\u27a4 Glycated haemoglobin (Glyco -Hb) or HbA1c level more than 6.5% at any occasion</li><li>\u27a4 Glycated haemoglobin (Glyco -Hb)</li><li>\u27a4 HbA1c</li><li>\u27a4 more than 6.5%</li><li>\u27a4 any occasion</li><li>\u27a4 Ref : Vasudevan 9/e: 314.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 314.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "688088cd",
      "audio": ""
    },
    {
      "text": "During a review of laboratory practices, a medical student is presented with a case study. A 55-year-old woman underwent routine blood work at 8 am in plain Vacutainer, but her blood glucose level was not processed until 11 am, with results reported at noon showing a blood glucose level of 48 mg/dl, despite all other tests being normal. Sample for blood glucose should be taken in Vacutainer containing NaF because it inhibit the following enzyme:",
      "options": [
        {
          "label": "A",
          "text": "Glucokinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hexokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "PFK",
          "correct": false
        },
        {
          "label": "D",
          "text": "Enolase",
          "correct": true
        }
      ],
      "correct_answer": "D. Enolase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This question highlights the importance of proper pre-analytical handling of blood samples for glucose testing. Blood samples should either be processed immediately or collected in tubes containing glycolysis inhibitors (such as sodium fluoride) to prevent falsely lowered glucose results due to continued cellular metabolism. The case demonstrates how delayed processing can lead to clinically significant errors in laboratory results, potentially misleading diagnosis and treatment decisions.</li><li>\u27a4 Ref : Vasudevan 9/e: 111.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6c7ecda0",
      "audio": ""
    },
    {
      "text": "Assertion (A): After overnight fasting, levels of glucose transporters are reduced in adipocytes. Reasoning (R): Adipocytes are insulin-sensitive tissues and as an early response to the hormone, the glucose transporters are externalized.",
      "options": [
        {
          "label": "A",
          "text": "A as well as R are right, and R is a correct explanation of A",
          "correct": true
        },
        {
          "label": "B",
          "text": "A is right but R is a wrong statement",
          "correct": false
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": false
        }
      ],
      "correct_answer": "A. A as well as R are right, and R is a correct explanation of A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) A as well as R are right, and R is a correct explanation of A</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 After overnight fasting, insulin levels in the body are low . In insulin-sensitive tissues like adipocytes, low insulin levels lead to a decrease in the number of glucose transporters (such as GLUT4) present on the cell membrane because insulin is required to stimulate the translocation of these transporters from the intracellular stores to the cell surface.</li><li>\u27a4 overnight fasting, insulin</li><li>\u27a4 low</li><li>\u27a4 insulin-sensitive tissues</li><li>\u27a4 adipocytes, low insulin levels</li><li>\u27a4 decrease</li><li>\u27a4 glucose transporters (such as GLUT4)</li><li>\u27a4 cell membrane</li><li>\u27a4 insulin</li><li>\u27a4 translocation</li><li>\u27a4 transporters</li><li>\u27a4 intracellular stores to the cell surface.</li><li>\u27a4 Ref : Harper 30/e p192.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p192.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "16709286",
      "audio": ""
    },
    {
      "text": "A 35-year-old male presented with hypoglycaemia and altered sensorium and his MRI features are suggestive of neuroglycopenic coma. He was intervened early and life saving measures were done. So, Neurons takes up blood glucose predominantly by:",
      "options": [
        {
          "label": "A",
          "text": "SGLT-2",
          "correct": false
        },
        {
          "label": "B",
          "text": "GLUT-4",
          "correct": false
        },
        {
          "label": "C",
          "text": "GLUT-3",
          "correct": true
        },
        {
          "label": "D",
          "text": "GLUT-1",
          "correct": false
        }
      ],
      "correct_answer": "C. GLUT-3",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture17.jpg"
      ],
      "explanation": "<p><strong>Ans. C) GLUT-3</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. SGLT-2: Distributed in Kidney.</li><li>\u2022 Option A. SGLT-2:</li><li>\u2022 Kidney.</li><li>\u2022 Option B. GLUT-4: Distributed in Skeletal muscle, Cardiac muscle, and Adipose Tissue.</li><li>\u2022 Option B. GLUT-4:</li><li>\u2022 Skeletal muscle, Cardiac muscle, and Adipose Tissue.</li><li>\u2022 Option D. GLUT-1: Distributed in RBC, brain, kidney, placenta.</li><li>\u2022 Option D. GLUT-1:</li><li>\u2022 RBC, brain, kidney, placenta.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Various types of glucose transporters with their tissue distribution are:</li><li>\u27a4 Ref : Harper 30/e: p 191,192.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 191,192.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "237f7d42",
      "audio": ""
    },
    {
      "text": "Evaluate the following mentioned assertion (A) and reasoning (R) regarding aldolase and its role in the metabolic pathway Assertion (A): Aldolase is the most common example of hydrolases class of enzyme under IUBMB system of nomenclature of enzymes: Reasoning (R): Aldolase catalyses the step 4 of glycolysis, cleaves the bond in the fructose-1,6-bisphosphate to form glyceraldehyde-3-phosphate and (DHAP) dihydroxyacetone phosphate and water is not required for this reversible reaction:",
      "options": [
        {
          "label": "A",
          "text": "A and R both are right, but R is not the correct explanation of A",
          "correct": false
        },
        {
          "label": "B",
          "text": "A as well as R are right, and R is a correct explanation of A",
          "correct": false
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": true
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": false
        }
      ],
      "correct_answer": "C. A is wrong but R is a right statement",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture20_CkxXXG8.jpg"
      ],
      "explanation": "<p><strong>Ans. C) A is wrong, but R is a right statement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Aldolase is an example of lyase group of enzymes, which cleaves the bond without the need of water molecule. Other enzymes include HMG CoA lyase and ATP Citrate lyase.</li><li>\u2022 Aldolase is an example of lyase group of enzymes, which cleaves the bond without the need of water molecule. Other enzymes include HMG CoA lyase and ATP Citrate lyase.</li><li>\u2022 Aldolase</li><li>\u2022 lyase group of enzymes,</li><li>\u2022 cleaves the bond</li><li>\u2022 without</li><li>\u2022 water</li><li>\u2022 HMG CoA lyase and ATP Citrate lyase.</li><li>\u2022 STEP 4 OF GLYCOLYSIS; REVERSIBLE</li><li>\u2022 STEP 4 OF GLYCOLYSIS; REVERSIBLE</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Aldolase is actually classified under the lyases class of enzymes , not hydrolases. Lyases are enzymes that cleave bonds without the addition of water and without the transfer of electrons. The aldolase reaction in glycolysis cleaves fructose-1,6-bisphosphate into glyceraldehyde-3-phosphate and DHAP without the use of water, fitting the definition of a lyase.</li><li>\u27a4 Aldolase</li><li>\u27a4 lyases class of enzymes</li><li>\u27a4 not</li><li>\u27a4 Lyases</li><li>\u27a4 cleave bonds</li><li>\u27a4 addition of water</li><li>\u27a4 without</li><li>\u27a4 electrons.</li><li>\u27a4 cleaves fructose-1,6-bisphosphate into</li><li>\u27a4 glyceraldehyde-3-phosphate</li><li>\u27a4 DHAP without</li><li>\u27a4 use of water,</li><li>\u27a4 Ref : Harper 30/e:  p 170.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 170.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a06285f0",
      "audio": ""
    },
    {
      "text": "A third-year medical student is shadowing in the metabolic diseases unit and encounters a patient being evaluated for a disorder affecting energy production. The patient's symptoms are suggestive of a defect in the complete oxidation of glucose. Intrigued, the student reviews biochemistry notes to understand where in the cell this process might be impaired. To aid in diagnosing and managing the patient's condition, the student seeks to identify the cellular compartment responsible for the full catabolism of glucose into carbon dioxide and water. Where are the enzymes located that facilitate this complete metabolic breakdown?",
      "options": [
        {
          "label": "A",
          "text": "Cytosol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mitochondria",
          "correct": true
        },
        {
          "label": "C",
          "text": "Lysosomes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endoplasmic reticulum",
          "correct": false
        }
      ],
      "correct_answer": "B. Mitochondria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Mitochondria</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cytosol: Only hosts glycolysis , the first stage of glucose metabolism, not its complete oxidation.</li><li>\u2022 Option A. Cytosol:</li><li>\u2022 glycolysis</li><li>\u2022 first</li><li>\u2022 glucose metabolism, not</li><li>\u2022 oxidation.</li><li>\u2022 Option C. Lysosomes: Involved in degrading and recycling cellular waste , not in energy metabolism.</li><li>\u2022 Option C. Lysosomes:</li><li>\u2022 degrading and recycling cellular waste</li><li>\u2022 not</li><li>\u2022 energy metabolism.</li><li>\u2022 Option D. Endoplasmic reticulum: Plays a key role in protein and lipid synthesis , but not in the oxidation of glucose.</li><li>\u2022 Option D. Endoplasmic reticulum:</li><li>\u2022 protein and lipid synthesis</li><li>\u2022 not</li><li>\u2022 oxidation of glucose.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Under aerobic conditions , pyruvate is taken up into mitochondria and after oxidative decarboxylation to Acetyl-CoA is oxidized to CO2 by the citric acid cycle Under anaerobic conditions , pyruvate is reduced by the NADH to lactate, catalyzed by lactate dehydrogenase.</li><li>\u27a4 Under aerobic conditions , pyruvate is taken up into mitochondria and after oxidative decarboxylation to Acetyl-CoA is oxidized to CO2 by the citric acid cycle</li><li>\u27a4 aerobic conditions</li><li>\u27a4 pyruvate</li><li>\u27a4 mitochondria and after oxidative decarboxylation</li><li>\u27a4 Acetyl-CoA</li><li>\u27a4 CO2</li><li>\u27a4 citric acid cycle</li><li>\u27a4 Under anaerobic conditions , pyruvate is reduced by the NADH to lactate, catalyzed by lactate dehydrogenase.</li><li>\u27a4 anaerobic conditions</li><li>\u27a4 pyruvate</li><li>\u27a4 NADH to lactate,</li><li>\u27a4 lactate dehydrogenase.</li><li>\u27a4 Ref : Harper 30/e p: 172</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p: 172</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "787dc5b2",
      "audio": ""
    },
    {
      "text": "During a marathon, an endurance athlete experiences a significant drop in blood glucose levels, triggering a series of metabolic adjustments. A sports medicine specialist explaining these changes to the athlete highlights how the body responds to maintain energy balance. Which of the following responses to decreased blood glucose levels is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of PFK-II",
          "correct": false
        },
        {
          "label": "B",
          "text": "Activation of Fructose 2,6 Bisphosphatase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase in glucagon",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increase in Fructose 2,6 Bisphosphate",
          "correct": true
        }
      ],
      "correct_answer": "D. Increase in Fructose 2,6 Bisphosphate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Increase in Fructose 2, 6 Bisphosphate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Inhibition of PFK-II: This is a correct response to low blood glucose levels , leading to decreased fructose 2,6-bisphosphate production and reduced glycolysis.</li><li>\u2022 Option A. Inhibition of PFK-II:</li><li>\u2022 correct</li><li>\u2022 low blood glucose levels</li><li>\u2022 decreased fructose 2,6-bisphosphate</li><li>\u2022 reduced glycolysis.</li><li>\u2022 Option B. Activation of Fructose 2,6 Bisphosphatase: This also accurately reflects the body's response to low blood glucose, promoting th e lowering of fructose 2,6-bisphosphate levels and encouraging gluconeogenesis.</li><li>\u2022 Option B. Activation of Fructose 2,6 Bisphosphatase:</li><li>\u2022 reflects</li><li>\u2022 low blood glucose,</li><li>\u2022 e lowering of fructose 2,6-bisphosphate levels</li><li>\u2022 gluconeogenesis.</li><li>\u2022 Option C. Increase in glucagon: Glucagon levels increase in response to low blood glucose to stimulate gluconeogenesis and glycogenolysis , raising blood glucose levels.</li><li>\u2022 Option C. Increase in glucagon:</li><li>\u2022 response</li><li>\u2022 low blood glucose</li><li>\u2022 stimulate gluconeogenesis</li><li>\u2022 glycogenolysis</li><li>\u2022 raising blood glucose levels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Increase Blood Glucose Level :</li><li>\u27a4 Increase Blood Glucose Level</li><li>\u27a4 Inhibition of Glycolysis By phosphorylating the key enzymes of Glycolysis (option a) By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II</li><li>\u27a4 Inhibition of Glycolysis By phosphorylating the key enzymes of Glycolysis (option a) By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II</li><li>\u27a4 Inhibition of Glycolysis</li><li>\u27a4 By phosphorylating the key enzymes of Glycolysis (option a) By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II</li><li>\u27a4 By phosphorylating the key enzymes of Glycolysis (option a)</li><li>\u27a4 By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II</li><li>\u27a4 Favour Gluconeogenesis By phosphorylating Key enzymes of Gluconeogenesis By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.</li><li>\u27a4 Favour Gluconeogenesis By phosphorylating Key enzymes of Gluconeogenesis By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.</li><li>\u27a4 Favour Gluconeogenesis</li><li>\u27a4 By phosphorylating Key enzymes of Gluconeogenesis By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.</li><li>\u27a4 By phosphorylating Key enzymes of Gluconeogenesis</li><li>\u27a4 By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.</li><li>\u27a4 Ref : Harper 30/e p191</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p191</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "132e6254",
      "audio": ""
    },
    {
      "text": "A post-operative patient develops angular stomatitis and shows low riboflavin excretion, indicative of a deficiency. Riboflavin is essential for FAD, a coenzyme in the TCA cycle. Which TCA cycle enzyme, dependent on FAD, would be affected by this deficiency?",
      "options": [
        {
          "label": "A",
          "text": "Isocitrate dehydrogenase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fumarase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Malate dehydrogenase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Succinate dehydrogenase",
          "correct": true
        }
      ],
      "correct_answer": "D. Succinate dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Succinate dehydrogenase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Isocitrate dehydrogenase: Forms Alpha Keto Glutarate in TCA cycle with NADH generation, which is later oxidized in ETC to generate ATPs.</li><li>\u2022 Option A. Isocitrate dehydrogenase:</li><li>\u2022 Alpha Keto Glutarate</li><li>\u2022 NADH</li><li>\u2022 generation,</li><li>\u2022 later oxidized</li><li>\u2022 ETC</li><li>\u2022 ATPs.</li><li>\u2022 Option B.  Fumarase: In TCA cycle, it helps in formation of malate from fumarate and the reaction involves addition of a water molecule.</li><li>\u2022 Option B.  Fumarase:</li><li>\u2022 malate from fumarate</li><li>\u2022 addition of a water molecule.</li><li>\u2022 Option C. Malate dehydrogenase: In TCA cycle , malate is oxidized to oxaloacetate by this enzyme and the coenzyme is NAD+.</li><li>\u2022 Option C. Malate dehydrogenase:</li><li>\u2022 TCA cycle</li><li>\u2022 malate</li><li>\u2022 oxidized to oxaloacetate</li><li>\u2022 enzyme</li><li>\u2022 coenzyme is NAD+.</li><li>\u2022 Note - None of the above 3 enzymes are dependent on FAD.</li><li>\u2022 None of the above 3 enzymes</li><li>\u2022 dependent on FAD.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Succinate dehydrogenase is the TCA cycle enzyme directly impacted by riboflavin deficiency, as it uses FAD, derived from riboflavin, as a coenzyme. This enzyme catalyzes the oxidation of succinate to fumarate, with FAD being reduced to FADH2 in the process. A deficiency in riboflavin would impair the function of succinate dehydrogenase, affecting the efficiency of the TCA cycle and overall energy production.</li><li>\u27a4 Succinate dehydrogenase</li><li>\u27a4 TCA cycle</li><li>\u27a4 riboflavin deficiency,</li><li>\u27a4 FAD,</li><li>\u27a4 riboflavin, as a coenzyme.</li><li>\u27a4 oxidation of</li><li>\u27a4 succinate to fumarate,</li><li>\u27a4 FAD</li><li>\u27a4 reduced to FADH2</li><li>\u27a4 deficiency</li><li>\u27a4 riboflavin</li><li>\u27a4 impair the function of succinate dehydrogenase,</li><li>\u27a4 efficiency</li><li>\u27a4 TCA cycle</li><li>\u27a4 energy production.</li><li>\u27a4 Ref : Harper 30/e:  p 556; Vasudevan 9/e: 479.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 556; Vasudevan 9/e: 479.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d9ead413",
      "audio": ""
    },
    {
      "text": "During the conversion of \u03b1-ketoglutarate to succinate in the TCA cycle, several reactions occur, leading to the production of energy-rich molecules. This conversion involves the decarboxylation of \u03b1-ketoglutarate, the generation of Succinyl CoA, and the subsequent formation of succinate. how many ATP molecules are typically produced through this series of reactions?",
      "options": [
        {
          "label": "A",
          "text": "1.5",
          "correct": false
        },
        {
          "label": "B",
          "text": "2.5",
          "correct": false
        },
        {
          "label": "C",
          "text": "3.5",
          "correct": true
        },
        {
          "label": "D",
          "text": "10",
          "correct": false
        }
      ],
      "correct_answer": "C. 3.5",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1.jpg"
      ],
      "explanation": "<p><strong>Ans. C. 3.5</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The conversion of \u03b1-ketoglutarate to succinate in the TCA cycle involves two key steps:</li><li>\u2022 First, \u03b1-ketoglutarate dehydrogenase complex catalyzes the oxidative decarboxylation of \u03b1-ketoglutarate to form succinyl-CoA, CO\u2082, and NADH. The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain. Second, succinyl-CoA synthetase (also called succinate thiokinase) catalyzes the conversion of succinyl-CoA to succinate with the generation of GTP (which is energetically equivalent to ATP. This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.</li><li>\u2022 First, \u03b1-ketoglutarate dehydrogenase complex catalyzes the oxidative decarboxylation of \u03b1-ketoglutarate to form succinyl-CoA, CO\u2082, and NADH. The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain.</li><li>\u2022 The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain.</li><li>\u2022 The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain.</li><li>\u2022 Second, succinyl-CoA synthetase (also called succinate thiokinase) catalyzes the conversion of succinyl-CoA to succinate with the generation of GTP (which is energetically equivalent to ATP. This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.</li><li>\u2022 This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.</li><li>\u2022 This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.</li><li>\u2022 Therefore, the total ATP yield from converting \u03b1-ketoglutarate to succinate is:</li><li>\u2022 2.5 ATP from NADH oxidation in the electron transport chain 1 ATP from substrate-level phosphorylation (GTP formation) Total: 3.5 ATP molecules</li><li>\u2022 2.5 ATP from NADH oxidation in the electron transport chain</li><li>\u2022 1 ATP from substrate-level phosphorylation (GTP formation)</li><li>\u2022 Total: 3.5 ATP molecules</li><li>\u2022 This makes option C (3.5) the correct answer.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understanding the energetics of the TCA cycle reactions, specifically:</li><li>\u27a4 The \u03b1-ketoglutarate dehydrogenase complex reaction produces NADH The succinyl-CoA synthetase reaction produces GTP/ATP via substrate-level phosphorylation NADH yields approximately 2.5 ATP when oxidized through the electron transport chain Together, these reactions yield 3.5 ATP molecules from the conversion of \u03b1-ketoglutarate to succinate</li><li>\u27a4 The \u03b1-ketoglutarate dehydrogenase complex reaction produces NADH</li><li>\u27a4 The succinyl-CoA synthetase reaction produces GTP/ATP via substrate-level phosphorylation</li><li>\u27a4 NADH yields approximately 2.5 ATP when oxidized through the electron transport chain</li><li>\u27a4 Together, these reactions yield 3.5 ATP molecules from the conversion of \u03b1-ketoglutarate to succinate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e8d426a9",
      "audio": ""
    },
    {
      "text": "Among the following, which is NOT a function or significance of the TCA cycle?",
      "options": [
        {
          "label": "A",
          "text": "Complete oxidation of acetyl CoA",
          "correct": false
        },
        {
          "label": "B",
          "text": "ATP generation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Synthesis of NADPH",
          "correct": true
        },
        {
          "label": "D",
          "text": "Amphibolic pathway",
          "correct": false
        }
      ],
      "correct_answer": "C. Synthesis of NADPH",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The synthesis of NADPH is NOT a function of the TCA cycle. The TCA cycle (tricarboxylic acid cycle, also known as the Krebs cycle or citric acid cycle) produces NADH, not NADPH. This is a key distinction because NADH and NADPH have different roles in metabolism:</li><li>\u2022 NADH primarily serves as an electron carrier for energy production in the electron transport chain NADPH serves as a reducing agent for biosynthetic reactions and antioxidant defense</li><li>\u2022 NADH primarily serves as an electron carrier for energy production in the electron transport chain</li><li>\u2022 NADPH serves as a reducing agent for biosynthetic reactions and antioxidant defense</li><li>\u2022 The TCA cycle specifically generates reduced electron carriers in the form of NADH (three molecules per acetyl-CoA) and FADH\u2082 (one molecule per acetyl-CoA), but not NADPH. NADPH is primarily produced by other pathways such as:</li><li>\u2022 The pentose phosphate pathway The malic enzyme reaction Isocitrate dehydrogenase in the cytosol (not the mitochondrial form involved in the TCA cycle) NADP\u207a-dependent glutamate dehydrogenase NADP\u207a-dependent malate dehydrogenase (malic enzyme)</li><li>\u2022 The pentose phosphate pathway</li><li>\u2022 The malic enzyme reaction</li><li>\u2022 Isocitrate dehydrogenase in the cytosol (not the mitochondrial form involved in the TCA cycle)</li><li>\u2022 NADP\u207a-dependent glutamate dehydrogenase</li><li>\u2022 NADP\u207a-dependent malate dehydrogenase (malic enzyme)</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Complete oxidation of acetyl CoA - This IS a function of the TCA cycle. The cycle completely oxidizes the two-carbon acetyl group of acetyl-CoA to two molecules of CO\u2082. This oxidation is coupled with the reduction of electron carriers (NAD\u207a to NADH and FAD to FADH\u2082).</li><li>\u2022 Option A. Complete oxidation of acetyl CoA</li><li>\u2022 Option B. ATP generation - This IS a function of the TCA cycle. The cycle directly generates one GTP (equivalent to one ATP) per turn through substrate-level phosphorylation catalyzed by succinyl-CoA synthetase. More importantly, it indirectly enables substantial ATP production by providing NADH and FADH\u2082 to the electron transport chain for oxidative phosphorylation.</li><li>\u2022 Option B. ATP generation</li><li>\u2022 Option D. Amphibolic pathway - This IS a characteristic of the TCA cycle. The term \"amphibolic\" means the pathway serves both catabolic (breakdown) and anabolic (biosynthetic) functions. While the TCA cycle primarily functions in catabolism to generate energy, several of its intermediates serve as precursors for biosynthetic pathways, including:</li><li>\u2022 Option D. Amphibolic pathway</li><li>\u2022 Oxaloacetate and \u03b1-ketoglutarate for amino acid synthesis Succinyl-CoA for heme synthesis Citrate for fatty acid synthesis (after transport to the cytosol)</li><li>\u2022 Oxaloacetate and \u03b1-ketoglutarate for amino acid synthesis</li><li>\u2022 Succinyl-CoA for heme synthesis</li><li>\u2022 Citrate for fatty acid synthesis (after transport to the cytosol)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Key functions and significance of the TCA cycle include:</li><li>\u27a4 Complete oxidation of acetyl-CoA to CO\u2082 Energy production through substrate-level phosphorylation (GTP) and generation of reducing equivalents (NADH, FADH\u2082) Serving as a final common oxidative pathway for carbohydrates, proteins, and fats Acting as an amphibolic pathway (both catabolic and anabolic functions)</li><li>\u27a4 Complete oxidation of acetyl-CoA to CO\u2082</li><li>\u27a4 Energy production through substrate-level phosphorylation (GTP) and generation of reducing equivalents (NADH, FADH\u2082)</li><li>\u27a4 Serving as a final common oxidative pathway for carbohydrates, proteins, and fats</li><li>\u27a4 Acting as an amphibolic pathway (both catabolic and anabolic functions)</li><li>\u27a4 Ref : Harper 30/e p161-167.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "430a2680",
      "audio": ""
    },
    {
      "text": "In managing individuals with respiratory chain disorders, supplements like riboflavin and coenzyme Q (ubiquinone) are commonly used. Understanding the role of these supplements in mitochondrial function is crucial. What is the specific function of coenzyme Q in the respiratory chain?",
      "options": [
        {
          "label": "A",
          "text": "It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.",
          "correct": true
        },
        {
          "label": "B",
          "text": "It links NAD-dependent dehydrogenases to cytochrome c.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It links each of the cytochromes in the respiratory chain to one another.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is the first step in the respiratory chain.",
          "correct": false
        }
      ],
      "correct_answer": "A. It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: While coenzyme Q does transfer electrons to components that eventually lead to cytochrome c, its direct link is with cytochrome b in Complex III, not cytochrome c.</li><li>\u2022 Option B:</li><li>\u2022 coenzyme Q</li><li>\u2022 electrons to components</li><li>\u2022 lead to cytochrome c,</li><li>\u2022 direct link</li><li>\u2022 cytochrome b in Complex III,</li><li>\u2022 not</li><li>\u2022 Option C: Coenzyme Q does not directly link all cytochromes but plays a pivotal role in transferring electrons from flavoproteins to cytochrome b in Complex III.</li><li>\u2022 Option C:</li><li>\u2022 Coenzyme Q</li><li>\u2022 does not</li><li>\u2022 all cytochromes</li><li>\u2022 electrons from flavoproteins</li><li>\u2022 cytochrome b</li><li>\u2022 Complex III.</li><li>\u2022 Option D: Coenzyme Q is not the initial electron acceptor; it accepts electrons from Complex I and II, which are upstream in the electron transport chain.</li><li>\u2022 Option D:</li><li>\u2022 Coenzyme Q</li><li>\u2022 not</li><li>\u2022 Complex I and II,</li><li>\u2022 upstream</li><li>\u2022 electron transport chain.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Coenzyme Q (ubiquinone) is a critical component in the mitochondrial electron transport chain, acting as a mobile electron carrier. It primarily accepts electrons from various flavoproteins , including those in Complex I (NADH dehydrogenase) and Complex II ( succinate dehydrogenase ), and transfers them to cytochrome b within Complex III (cytochrome bc1 complex). This transfer is vital for maintaining the flow of electrons through the chain , essential for the generation of a proton gradient used in ATP synthesis .</li><li>\u27a4 Coenzyme Q (ubiquinone)</li><li>\u27a4 mitochondrial electron transport chain,</li><li>\u27a4 mobile electron carrier.</li><li>\u27a4 primarily</li><li>\u27a4 electrons</li><li>\u27a4 flavoproteins</li><li>\u27a4 Complex I (NADH dehydrogenase)</li><li>\u27a4 Complex II</li><li>\u27a4 succinate dehydrogenase</li><li>\u27a4 cytochrome b within Complex III (cytochrome bc1 complex).</li><li>\u27a4 flow of electrons through</li><li>\u27a4 chain</li><li>\u27a4 generation of a proton gradient</li><li>\u27a4 ATP synthesis</li><li>\u27a4 Ref : Harper 31/e p: 315.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 31/e p: 315.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "be8ded06",
      "audio": ""
    },
    {
      "text": "One specialized organ in mammals has a unique adaptation that allows it to utilize fuel oxidation not primarily for ATP production but for the generation of heat, aiding in thermoregulation. Which of the following is this specialized organ?",
      "options": [
        {
          "label": "A",
          "text": "Adrenal gland",
          "correct": false
        },
        {
          "label": "B",
          "text": "Skeletal music",
          "correct": false
        },
        {
          "label": "C",
          "text": "Brown adipose tissue",
          "correct": true
        },
        {
          "label": "D",
          "text": "Heart",
          "correct": false
        }
      ],
      "correct_answer": "C. Brown adipose tissue",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Brown adipose tissue</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Brown adipose tissue is the specialized organ in mammals designed for heat production through non-shivering thermogenesis, emphasizing its role in thermoregulation and energy metabolism.</li><li>\u27a4 Brown adipose tissue</li><li>\u27a4 mammals designed</li><li>\u27a4 heat production</li><li>\u27a4 non-shivering thermogenesis,</li><li>\u27a4 thermoregulation and energy metabolism.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 162, 267.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 162, 267.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dfc11cec",
      "audio": ""
    },
    {
      "text": "Which of the following pairs of trace elements are essential for the proper functioning of the electron transport chain within the mitochondria?",
      "options": [
        {
          "label": "A",
          "text": "Iron and copper",
          "correct": true
        },
        {
          "label": "B",
          "text": "Iodine and zinc",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chromium and selenium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fluoride",
          "correct": false
        }
      ],
      "correct_answer": "A. Iron and copper",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Iron and copper</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Iodine and Zinc: Iodine is primarily involved in thyroid hormone synthesis , and zinc serves as a cofactor for numerous enzymes but neither are directly involved in the ETC.</li><li>\u2022 Option B. Iodine and Zinc:</li><li>\u2022 Iodine</li><li>\u2022 thyroid hormone synthesis</li><li>\u2022 zinc</li><li>\u2022 cofactor</li><li>\u2022 numerous</li><li>\u2022 enzymes</li><li>\u2022 neither</li><li>\u2022 ETC.</li><li>\u2022 Option C. Chromium and Selenium: Chromium is involved in glucose metabolism, and selenium is a component of certain antioxidant enzymes . They do not have a direct role in the ETC.</li><li>\u2022 Option C. Chromium and Selenium:</li><li>\u2022 Chromium</li><li>\u2022 glucose metabolism,</li><li>\u2022 selenium</li><li>\u2022 antioxidant enzymes</li><li>\u2022 do not</li><li>\u2022 ETC.</li><li>\u2022 Option D. Fluoride: Fluoride is known to inhibit certain enzymes but is not a component of the ETC.</li><li>\u2022 Option D. Fluoride:</li><li>\u2022 Fluoride</li><li>\u2022 inhibit</li><li>\u2022 not</li><li>\u2022 ETC.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Complex I NADH Coenzyme Q Oxidoreductase : Contain FMN and Fe-S (Iron- Sulfur) Complex Complex IV Cytochrome c Oxidase : Contain Cyt a and a3 (also known as Heme a a3 ) and has Copper A and Copper B centre.</li><li>\u27a4 Complex I NADH Coenzyme Q Oxidoreductase : Contain FMN and Fe-S (Iron- Sulfur) Complex</li><li>\u27a4 Complex I NADH Coenzyme Q Oxidoreductase</li><li>\u27a4 FMN and Fe-S (Iron- Sulfur) Complex</li><li>\u27a4 Complex IV Cytochrome c Oxidase : Contain Cyt a and a3 (also known as Heme a a3 ) and has Copper A and Copper B centre.</li><li>\u27a4 Complex IV Cytochrome c Oxidase</li><li>\u27a4 Cyt a and a3</li><li>\u27a4 Heme a a3</li><li>\u27a4 Copper A and Copper B</li><li>\u27a4 centre.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 261.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 261.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd94c87c",
      "audio": ""
    },
    {
      "text": "Two farmers were applying a locally sourced pesticide to cotton crops when they began exhibiting severe symptoms, including intense breathing difficulties, high fever, and eventual unconsciousness. Given the agricultural practices, the pesticide is suspected to contain a compound that disrupts oxidative phosphorylation within the cells. Which of the following substances, known to interfere with oxidative phosphorylation, would most likely mimic the effects of the agent in the pesticide?",
      "options": [
        {
          "label": "A",
          "text": "Oligomycin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atractyloside",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rotenone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dinitrophenol",
          "correct": true
        }
      ],
      "correct_answer": "D. Dinitrophenol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Dinitrophenol</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The impact of uncoupling agents like dinitrophenol on oxidative phosphorylation , particularly how they can lead to increased heat production and oxygen consumption , resulting in symptoms such as high fever, heavy breathing, and loss of consciousness.</li><li>\u27a4 uncoupling agents</li><li>\u27a4 dinitrophenol</li><li>\u27a4 oxidative phosphorylation</li><li>\u27a4 increased heat</li><li>\u27a4 production</li><li>\u27a4 oxygen consumption</li><li>\u27a4 high fever, heavy breathing, and loss of consciousness.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 266.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 266.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbb023dd",
      "audio": ""
    },
    {
      "text": "A pediatrician evaluates a child presenting with recurrent episodes of hypoglycemia, particularly noted during fasting periods. Further investigation reveals that the child has a metabolic condition impairing both glycogenolysis and gluconeogenesis. Which enzyme deficiency is most likely responsible for these metabolic disturbances in the child?",
      "options": [
        {
          "label": "A",
          "text": "Fructokinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucose 6 Phosphatase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transketolase",
          "correct": false
        }
      ],
      "correct_answer": "C. Glucose 6 Phosphatase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Glucose 6 Phosphatase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glucose 6-phosphatase deficiency is a cause of impaired glycogenolysis and gluconeogenesis, leading to hypoglycemia</li><li>\u27a4 Glucose 6-phosphatase deficiency</li><li>\u27a4 impaired glycogenolysis and gluconeogenesis,</li><li>\u27a4 hypoglycemia</li><li>\u27a4 Ref : Harper 30/e: p177.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p177.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "803d5e62",
      "audio": ""
    },
    {
      "text": "Identify which of the following statements about gluconeogenesis is incorrect:",
      "options": [
        {
          "label": "A",
          "text": "Prevent hypoglycaemia during prolonged fasting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Occur in both muscle and liver",
          "correct": true
        },
        {
          "label": "C",
          "text": "Excess of acetyl CoA stimulate it",
          "correct": false
        },
        {
          "label": "D",
          "text": "Carbon skeleton of amino acid is involved",
          "correct": false
        }
      ],
      "correct_answer": "B. Occur in both muscle and liver",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)\u00a0 Occur in both muscle and liver</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gluconeogenesis occur in liver and kidney not in the muscle Gluconeogenesis prevents hypoglycaemia in prolonged fasting Excess Acetyl CoA is an allosteric activator of Pyruvate Carboxylase, a key enzyme of Gluconeogenesis Carbon skeletons of gluconeogenic amino acids are involved in gluconeogenesis.</li><li>\u27a4 Gluconeogenesis occur in liver and kidney not in the muscle</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 liver and kidney</li><li>\u27a4 Gluconeogenesis prevents hypoglycaemia in prolonged fasting</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 prevents hypoglycaemia</li><li>\u27a4 prolonged fasting</li><li>\u27a4 Excess Acetyl CoA is an allosteric activator of Pyruvate Carboxylase, a key enzyme of Gluconeogenesis</li><li>\u27a4 Acetyl CoA</li><li>\u27a4 allosteric activator of Pyruvate Carboxylase,</li><li>\u27a4 Gluconeogenesis</li><li>\u27a4 Carbon skeletons of gluconeogenic amino acids are involved in gluconeogenesis.</li><li>\u27a4 Carbon</li><li>\u27a4 gluconeogenic amino</li><li>\u27a4 acids</li><li>\u27a4 gluconeogenesis.</li><li>\u27a4 Ref : Harper 30/e: p187</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p187</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e0ac074",
      "audio": ""
    },
    {
      "text": "Which of the following glycogen storage diseases typically spares the muscles from involvement?",
      "options": [
        {
          "label": "A",
          "text": "Type I",
          "correct": true
        },
        {
          "label": "B",
          "text": "Type II",
          "correct": false
        },
        {
          "label": "C",
          "text": "Type V",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type VII",
          "correct": false
        }
      ],
      "correct_answer": "A. Type I",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture2.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Type I</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Type II: Type II, or Pompe disease , involves lysosomal alpha-1,4-glucosidase deficiency and affects cardiac and skeletal muscles, leading to progressive muscle weakness.</li><li>\u2022 Option B. Type II:</li><li>\u2022 Pompe disease</li><li>\u2022 lysosomal alpha-1,4-glucosidase deficiency</li><li>\u2022 cardiac and skeletal</li><li>\u2022 muscles,</li><li>\u2022 progressive muscle weakness.</li><li>\u2022 Option C. Type V: Type V, known as McArdle disease , specifically affects muscle phosphorylase and is characterized by muscle cramps and exercise intolerance , indicating direct muscle involvement.</li><li>\u2022 Option C. Type V:</li><li>\u2022 McArdle disease</li><li>\u2022 muscle phosphorylase</li><li>\u2022 muscle</li><li>\u2022 cramps and exercise intolerance</li><li>\u2022 direct muscle involvement.</li><li>\u2022 Option D. Type VII: Type VII, or Tarui disease, involves phosphofructokinase deficiency in muscle cells, leading to exercise intolerance and myopathy, hence directly affecting muscles .</li><li>\u2022 Option D. Type VII:</li><li>\u2022 Tarui disease,</li><li>\u2022 phosphofructokinase deficiency</li><li>\u2022 exercise</li><li>\u2022 intolerance and myopathy,</li><li>\u2022 directly affecting muscles</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Von Gierke disease (Ia) is due to Glucose 6 phosphatase deficiency Clinical features include glycogen accumulation in liver and renal tubule cells , hypoglycaemia, lactic acidemia, ketosis and hyperlipidemia . ( No muscle weakness ).</li><li>\u27a4 Von Gierke disease (Ia) is due to Glucose 6 phosphatase deficiency</li><li>\u27a4 Von Gierke disease (Ia)</li><li>\u27a4 Glucose 6 phosphatase deficiency</li><li>\u27a4 Clinical features include glycogen accumulation in liver and renal tubule cells , hypoglycaemia, lactic acidemia, ketosis and hyperlipidemia . ( No muscle weakness ).</li><li>\u27a4 glycogen</li><li>\u27a4 liver and renal tubule cells</li><li>\u27a4 hypoglycaemia, lactic acidemia, ketosis</li><li>\u27a4 hyperlipidemia</li><li>\u27a4 No muscle weakness</li><li>\u27a4 Muscle Glycogen Storage Disorders:</li><li>\u27a4 Muscle Glycogen Storage Disorders:</li><li>\u27a4 Ref : Nelson 20/e Defects in the metabolism of Carbohydrates</li><li>\u27a4 Ref</li><li>\u27a4 : Nelson 20/e Defects in the metabolism of Carbohydrates</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b57b7e46",
      "audio": ""
    },
    {
      "text": "Considering the physiological adaptations in chronic anemia, assess the following assertion (A) and reasoning (R): Assertion (A): Level of 2,3-BPG is elevated in chronic anaemia. Reasoning (R): High 2,3-BPG levels lowers the oxygen affinity of hemoglobin, permitting unloading of oxygen in tissues.",
      "options": [
        {
          "label": "A",
          "text": "A is right but R is a wrong statement",
          "correct": false
        },
        {
          "label": "B",
          "text": "A as well as R are right, and R is a correct explanation of A",
          "correct": true
        },
        {
          "label": "C",
          "text": "A is wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "D",
          "text": "A and R both are wrong",
          "correct": false
        }
      ],
      "correct_answer": "B. A as well as R are right, and R is a correct explanation of A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) A as well as R are right, and R is a correct explanation of A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The concentration of 2,3-BPG in the RBC increases in response to chronic hypoxia , such as in COPD like emphysema, or at high altitudes, where circulating haemoglobin may have difficulty receiving sufficient oxygen. Intra cellular levels of 2,3-BPG are also elevated in chronic anaemia, in which fewer than normal RBCs are available to supply the body\u2019s oxygen needs. Elevated 2,3-BPG levels lower the oxygen affinity of haemoglobin , permitting greater unloading of oxygen in the capillaries of the tissues Hb F has low affinity towards 2, 3 BPG.</li><li>\u2022 The concentration of 2,3-BPG in the RBC increases in response to chronic hypoxia , such as in COPD like emphysema, or at high altitudes, where circulating haemoglobin may have difficulty receiving sufficient oxygen.</li><li>\u2022 2,3-BPG in the RBC increases</li><li>\u2022 chronic hypoxia</li><li>\u2022 COPD</li><li>\u2022 emphysema,</li><li>\u2022 high altitudes,</li><li>\u2022 circulating haemoglobin</li><li>\u2022 difficulty</li><li>\u2022 sufficient oxygen.</li><li>\u2022 Intra cellular levels of 2,3-BPG are also elevated in chronic anaemia, in which fewer than normal RBCs are available to supply the body\u2019s oxygen needs.</li><li>\u2022 Intra cellular levels</li><li>\u2022 2,3-BPG</li><li>\u2022 elevated in chronic anaemia,</li><li>\u2022 fewer</li><li>\u2022 normal RBCs</li><li>\u2022 body\u2019s oxygen needs.</li><li>\u2022 Elevated 2,3-BPG levels lower the oxygen affinity of haemoglobin , permitting greater unloading of oxygen in the capillaries of the tissues</li><li>\u2022 Elevated 2,3-BPG levels lower</li><li>\u2022 oxygen affinity</li><li>\u2022 haemoglobin</li><li>\u2022 greater</li><li>\u2022 oxygen</li><li>\u2022 capillaries of the tissues</li><li>\u2022 Hb F has low affinity towards 2, 3 BPG.</li><li>\u2022 Hb F</li><li>\u2022 low affinity</li><li>\u2022 2, 3 BPG.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In chronic anemia , the body compensates by increasing 2,3-BPG levels in red blood cells to enhance the release of oxygen from hemoglobin to the tissues . This biochemical response is crucial for improving oxygen delivery despite a reduced number of erythrocytes.</li><li>\u27a4 chronic anemia</li><li>\u27a4 increasing 2,3-BPG levels in red blood cells</li><li>\u27a4 release of oxygen</li><li>\u27a4 hemoglobin to the tissues</li><li>\u27a4 improving oxygen delivery</li><li>\u27a4 despite</li><li>\u27a4 reduced number</li><li>\u27a4 erythrocytes.</li><li>\u27a4 Ref : Harper 30/e: p 57, Lippincott 6/e: p 31, 32.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 57, Lippincott 6/e: p 31, 32.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f3e17c6",
      "audio": ""
    },
    {
      "text": "Which of the following statements accurately reflects a metabolic characteristic of the well-fed state",
      "options": [
        {
          "label": "A",
          "text": "NADPH production by the hexose monophosphate shunt is decreased.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acetoacetate is the major fuel for muscle.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucose transport into adipose tissue is decreased.",
          "correct": false
        },
        {
          "label": "D",
          "text": "The major fuel used by the brain is glucose.",
          "correct": true
        }
      ],
      "correct_answer": "D. The major fuel used by the brain is glucose.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) \u00a0\u00a0The major fuel used by the brain is glucose.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. NADPH production by the hexose monophosphate shunt is decreased: Liver production of NADPH is at a high level because it is needed for fatty acid synthesis.</li><li>\u2022 Option A. NADPH production by the hexose monophosphate shunt is decreased:</li><li>\u2022 NADPH</li><li>\u2022 high level</li><li>\u2022 fatty acid synthesis.</li><li>\u2022 Option B.  Acetoacetate is the major fuel for muscle: During the absorptive phase , ketone bodies such as acetoacetate and 3-hydroxybutyrate are low with glucose rather than these ketones used by muscle.</li><li>\u2022 Option B.  Acetoacetate is the major fuel for muscle:</li><li>\u2022 absorptive phase</li><li>\u2022 ketone bodies</li><li>\u2022 acetoacetate and 3-hydroxybutyrate are low</li><li>\u2022 glucose</li><li>\u2022 Option C.  Glucose transport into adipose tissue is decreased: Glucose is actively transported into all cells , including adipocytes, which require it to form glycerol-3-phosphate for esterification of fatty acids into triacylglycerides.</li><li>\u2022 Option C.  Glucose transport into adipose tissue is decreased:</li><li>\u2022 Glucose</li><li>\u2022 actively</li><li>\u2022 all cells</li><li>\u2022 adipocytes,</li><li>\u2022 glycerol-3-phosphate</li><li>\u2022 esterification of fatty acids</li><li>\u2022 triacylglycerides.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a well-fed state, the brain continues to use glucose as its primary energy source. The blood glucose levels are sufficient , and insulin facilitates glucose uptake into the brain cells.</li><li>\u27a4 well-fed state,</li><li>\u27a4 brain</li><li>\u27a4 continues</li><li>\u27a4 use glucose</li><li>\u27a4 its primary energy</li><li>\u27a4 blood glucose levels</li><li>\u27a4 sufficient</li><li>\u27a4 insulin facilitates glucose uptake</li><li>\u27a4 brain cells.</li><li>\u27a4 Ref : Vasudevan 9/e: 101.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 101.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "79fff575",
      "audio": ""
    },
    {
      "text": "During a pediatric rotation, a medical student observes the management of a child presenting with acute gastroenteritis and signs of dehydration. The attending physician prescribes oral rehydration solution (ORS). The student learns that the efficacy of ORS is partly due to its facilitation of glucose absorption, which in turn enhances electrolyte and water uptake in the intestines. Which glucose transporter is primarily responsible for the glucose absorption facilitated by ORS in the intestinal mucosa?",
      "options": [
        {
          "label": "A",
          "text": "SGLT 1",
          "correct": true
        },
        {
          "label": "B",
          "text": "SGLT 2",
          "correct": false
        },
        {
          "label": "C",
          "text": "GLUT 4",
          "correct": false
        },
        {
          "label": "D",
          "text": "GLUT 2",
          "correct": false
        }
      ],
      "correct_answer": "A. SGLT 1",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture1.jpg"
      ],
      "explanation": "<p><strong>Ans. A) SGLT-1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B.  SGLT-2: SGLT-2 is defective in congenital renal glycosuria</li><li>\u2022 Option B.  SGLT-2:</li><li>\u2022 defective</li><li>\u2022 congenital renal glycosuria</li><li>\u2022 Option C. GLUT 4: Insulin-mediated glucose uptake. Involved in Type 2 diabetes mellitus</li><li>\u2022 Option C. GLUT 4:</li><li>\u2022 Insulin-mediated glucose uptake.</li><li>\u2022 Type 2 diabetes mellitus</li><li>\u2022 Option D.  GLUT 2: Enables the pancreas to monitor the glucose level, thereby adjusts the rate of insulin secretion.</li><li>\u2022 Option D.  GLUT 2:</li><li>\u2022 Enables the pancreas</li><li>\u2022 monitor the glucose level,</li><li>\u2022 rate of insulin secretion.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 SGLT 1 ( sodium-glucose cotransporter 1 ) is responsible for the absorption of glucose in the small intestine. It cotransports sodium and glucose from the intestinal lumen into enterocytes , thereby facilitating the absorption of water and electrolytes, which is the principle behind the effectiveness of ORS.</li><li>\u27a4 SGLT 1</li><li>\u27a4 sodium-glucose cotransporter 1</li><li>\u27a4 absorption of glucose</li><li>\u27a4 small intestine.</li><li>\u27a4 cotransports sodium</li><li>\u27a4 glucose from the intestinal lumen</li><li>\u27a4 enterocytes</li><li>\u27a4 facilitating the absorption of water and electrolytes,</li><li>\u27a4 effectiveness of ORS.</li><li>\u27a4 Ref : Vasudevan 9/e: 106.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 106.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96affdee",
      "audio": ""
    },
    {
      "text": "A patient with chronic obstructive pulmonary disease (COPD) has been receiving supplemental oxygen therapy for several years, leading to an improvement in symptoms. However, concerns arise regarding potential lung injury from prolonged oxygen exposure, known as oxygen toxicity. This condition can lead to a decrease in the rate of glycolysis due to high oxygen levels. What is the phenomenon called where elevated oxygen levels decrease the glycolysis rate?",
      "options": [
        {
          "label": "A",
          "text": "Crabtree Effect",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pasteur Effect",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chemiosmotic effect",
          "correct": false
        },
        {
          "label": "D",
          "text": "Feedback inhibition",
          "correct": false
        }
      ],
      "correct_answer": "B. Pasteur Effect",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pasteur Effect.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Pasteur effect describes the inhibition of glycolysis by high concentrations of oxygen. In the presence of oxygen, cells preferentially utilize aerobic metabolism , which is more efficient in terms of ATP production, leading to a reduced need for glycolysis.</li><li>\u27a4 Pasteur effect</li><li>\u27a4 inhibition of glycolysis</li><li>\u27a4 high concentrations of oxygen.</li><li>\u27a4 presence of oxygen,</li><li>\u27a4 cells</li><li>\u27a4 utilize aerobic metabolism</li><li>\u27a4 more</li><li>\u27a4 ATP production,</li><li>\u27a4 leading</li><li>\u27a4 reduced</li><li>\u27a4 glycolysis.</li><li>\u27a4 Ref : Vasudevan 9/e: p 285-287.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: p 285-287.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6cb7bafe",
      "audio": ""
    },
    {
      "text": "In a research project focusing on glucose metabolism, a group of medical students observe that ATP is produced in the cytosol before the breakdown products of glucose enter the mitochondria. This finding highlights an important step in the glycolytic pathway. Which enzyme involved in glucose metabolism is responsible for this early ATP generation in the cytosol?",
      "options": [
        {
          "label": "A",
          "text": "Hexokinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phosphofructokinase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pyruvate kinase",
          "correct": true
        }
      ],
      "correct_answer": "D. Pyruvate kinase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture19_T9tgs1j.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Pyruvate kinase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hexokinase: Catalyzes the first step of glycolysis, phosphorylating glucose to glucose-6-phosphate , but does not directly result in ATP generation.</li><li>\u2022 Option A. Hexokinase:</li><li>\u2022 first step</li><li>\u2022 glycolysis, phosphorylating glucose to glucose-6-phosphate</li><li>\u2022 not</li><li>\u2022 ATP generation.</li><li>\u2022 Option B. Glucokinase: Functions similarly to hexokinase but is specific to the liver and pancreatic \u03b2-cells, also not directly involved in ATP generation.</li><li>\u2022 Option B. Glucokinase:</li><li>\u2022 specific to the liver and pancreatic \u03b2-cells,</li><li>\u2022 not</li><li>\u2022 ATP generation.</li><li>\u2022 Option C. Phosphofructokinase: A key regulatory enzyme in glycolysis that catalyzes the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate, not directly involved in ATP generation.</li><li>\u2022 Option C. Phosphofructokinase:</li><li>\u2022 regulatory enzyme</li><li>\u2022 catalyzes</li><li>\u2022 fructose-6-phosphate to</li><li>\u2022 fructose-1,6-bisphosphate,</li><li>\u2022 not</li><li>\u2022 ATP generation.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pyruvate kinase is involved in the last step of the glycolytic pathway, where it catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate , generating ATP in the process. This occurs in the cytosol and is one of the steps in glycolysis that produces ATP before the metabolites enter the mitochondria for further energy production processes like the citric acid cycle and oxidative phosphorylation.</li><li>\u27a4 Pyruvate kinase</li><li>\u27a4 last step</li><li>\u27a4 glycolytic pathway,</li><li>\u27a4 conversion of phosphoenolpyruvate</li><li>\u27a4 to pyruvate</li><li>\u27a4 ATP</li><li>\u27a4 occurs</li><li>\u27a4 cytosol</li><li>\u27a4 one</li><li>\u27a4 steps in glycolysis</li><li>\u27a4 ATP</li><li>\u27a4 before the metabolites</li><li>\u27a4 enter</li><li>\u27a4 mitochondria</li><li>\u27a4 energy</li><li>\u27a4 production</li><li>\u27a4 citric acid cycle</li><li>\u27a4 oxidative</li><li>\u27a4 phosphorylation.</li><li>\u27a4 Ref : Harper 30/e: p 168-172.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 168-172.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ad5e08e",
      "audio": ""
    },
    {
      "text": "While conducting a research study on the efficiency of various diets on long-distance runners, a team of exercise physiologists focuses on the metabolic pathways that are most active during extended periods of physical activity. They are particularly interested in quantifying the energy output from different substrates. The team debates the number of ATP molecules generated from the complete oxidation of one molecule of acetyl CoA through the TCA cycle. What is the correct ATP yield from this process?",
      "options": [
        {
          "label": "A",
          "text": "9 ATP",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 ATP",
          "correct": true
        },
        {
          "label": "C",
          "text": "13 ATP",
          "correct": false
        },
        {
          "label": "D",
          "text": "12 ATP",
          "correct": false
        }
      ],
      "correct_answer": "B. 10 ATP",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture24.jpg"
      ],
      "explanation": "<p><strong>Ans. B)\u00a0 10 ATP</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The oxidation of one molecule of acetyl CoA in the TCA cycle produces 3 NADH, 1 FADH2, and 1 GTP. With the assumption that 1 NADH generates 2.5 ATP and 1 FADH2 yields 1.5 ATP through oxidative phosphorylation, the total ATP produced is calculated as follows:</li><li>\u2022 oxidation of one molecule of acetyl CoA</li><li>\u2022 3 NADH, 1 FADH2, and 1 GTP.</li><li>\u2022 1</li><li>\u2022 NADH generates 2.5 ATP</li><li>\u2022 1 FADH2 yields 1.5 ATP</li><li>\u2022 oxidative phosphorylation,</li><li>\u2022 total ATP</li><li>\u2022 3 NADH x 2.5 ATP/NADH = 7.5 ATP</li><li>\u2022 3 NADH x 2.5 ATP/NADH</li><li>\u2022 7.5 ATP</li><li>\u2022 1 FADH2 x 1.5 ATP/FADH2 = 1.5 ATP</li><li>\u2022 1 FADH2 x 1.5 ATP/FADH2 = 1.5 ATP</li><li>\u2022 1 GTP = 1 ATP</li><li>\u2022 1 GTP = 1 ATP</li><li>\u2022 The sum of these yields a total of 10 ATP per molecule of acetyl CoA oxidized through the TCA cycle, making option B the most accurate answer.</li><li>\u2022 10 ATP</li><li>\u2022 acetyl CoA</li><li>\u2022 TCA cycle,</li><li>\u2022 option B</li><li>\u2022 accurate answer.</li><li>\u2022 Note - Three molecules of NADH and one of FADH2 are produced for each molecule of acetyl-CoA catabolized in one turn of the cycle.</li><li>\u2022 Three molecules of NADH</li><li>\u2022 one of FADH2</li><li>\u2022 each molecule of acetyl-CoA</li><li>\u2022 one</li><li>\u2022 cycle.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Ref : Vasudevan 9/e: 253.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/e: 253.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4d32b110",
      "audio": ""
    },
    {
      "text": "In conditions of low oxygen levels (low pO2), the body must adapt its metabolic pathways to ensure energy production continues. One such adaptation involves an enzyme that compensates for reduced Tricarboxylic Acid (TCA) cycle activity under hypoxic conditions. This enzyme facilitates a key step in an alternative pathway, allowing cells to generate ATP anaerobically. Which enzyme is responsible for this compensatory mechanism?",
      "options": [
        {
          "label": "A",
          "text": "Phosphofructokinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lactate dehydrogenase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pyruvate dehydrogenase",
          "correct": false
        }
      ],
      "correct_answer": "C. Lactate dehydrogenase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture25.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Lactate dehydrogenase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the absence of mitochondria (Eg: RBC) and in hypoxic conditions , anaerobic glycolysis will be turned on where lactate dehydrogenase (LDH) will convert pyruvate to lactate.</li><li>\u27a4 absence of mitochondria (Eg: RBC)</li><li>\u27a4 hypoxic conditions</li><li>\u27a4 anaerobic glycolysis</li><li>\u27a4 lactate dehydrogenase (LDH)</li><li>\u27a4 pyruvate to lactate.</li><li>\u27a4 Ref : Harper 30/e: p 168-169.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 168-169.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f0c3a44",
      "audio": ""
    },
    {
      "text": "Many compounds poison the respiratory chain by inhibiting various steps of oxidation or phosphorylation. Which of the following steps is inhibited by carbon monoxide and cyanide?",
      "options": [
        {
          "label": "A",
          "text": "Oxidation step between cytochrome and coenzyme Q and distal cytochromes",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oxidation step involving direct reduction of oxygen",
          "correct": true
        },
        {
          "label": "C",
          "text": "Uncoupling of oxidation from phosphorylation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxidation step between cytochromes c and b",
          "correct": false
        }
      ],
      "correct_answer": "B. Oxidation step involving direct reduction of oxygen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Oxidation step involving direct reduction of oxygen)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Carbon monoxide and cyanide inhibit cytochrome oxidase , the terminal step of the respiratory chain that is driven by oxygen reduction to water Barbiturates block transfer from cytochrome to coenzyme Q, antimycin A, and dimercaprol, the step between cytochromes c and b, and dinitrophenol is an uncoupler that releases the respiratory chain from regulation by energy (phosphorylation) needs. Oligomycin blocks phosphorylation by inhibiting ATP synthase , thus shutting down its coupled oxidation .</li><li>\u27a4 Carbon monoxide and cyanide inhibit cytochrome oxidase , the terminal step of the respiratory chain that is driven by oxygen reduction to water</li><li>\u27a4 Carbon monoxide</li><li>\u27a4 cyanide</li><li>\u27a4 cytochrome oxidase</li><li>\u27a4 respiratory chain</li><li>\u27a4 oxygen reduction to water</li><li>\u27a4 Barbiturates block transfer from cytochrome to coenzyme Q, antimycin A, and dimercaprol, the step between cytochromes c and b, and dinitrophenol is an uncoupler that releases the respiratory chain from regulation by energy (phosphorylation) needs. Oligomycin blocks phosphorylation by inhibiting ATP synthase , thus shutting down its coupled oxidation .</li><li>\u27a4 Barbiturates block</li><li>\u27a4 cytochrome to coenzyme Q, antimycin A, and dimercaprol,</li><li>\u27a4 cytochromes c and b,</li><li>\u27a4 dinitrophenol</li><li>\u27a4 uncoupler</li><li>\u27a4 respiratory chain</li><li>\u27a4 energy</li><li>\u27a4 Oligomycin blocks phosphorylation</li><li>\u27a4 inhibiting ATP synthase</li><li>\u27a4 shutting down</li><li>\u27a4 coupled oxidation</li><li>\u27a4 Ref : Harper Illustrated Biochemistry 31/e p 321-22.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper Illustrated Biochemistry 31/e p 321-22.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8cf00df",
      "audio": ""
    },
    {
      "text": "The electron transport chain (ETC) plays a critical role in the final stages of energy production within mitochondria. This complex system involves a series of electron carriers that facilitate the transfer of electrons, culminating in ATP synthesis. Among the list below, which component is not involved in the mitochondrial electron transport chain?",
      "options": [
        {
          "label": "A",
          "text": "NADP",
          "correct": true
        },
        {
          "label": "B",
          "text": "NAD",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coenzyme Q",
          "correct": false
        },
        {
          "label": "D",
          "text": "FAD",
          "correct": false
        }
      ],
      "correct_answer": "A. NADP",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Image88667.PNG"
      ],
      "explanation": "<p><strong>Ans. A) NADP</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The main components of the ETC includes:</li><li>\u27a4 Complex I (NADH: ubiquinone oxidoreductase) Complex II (Succinate dehydrogenase) Coenzyme Q (Ubiquinone) Complex III (Cytochrome bc1 complex): Cytochrome C Complex IV (Cytochrome c oxidase) ATP Synthase (Complex V)</li><li>\u27a4 Complex I (NADH: ubiquinone oxidoreductase)</li><li>\u27a4 Complex II (Succinate dehydrogenase)</li><li>\u27a4 Coenzyme Q (Ubiquinone)</li><li>\u27a4 Complex III (Cytochrome bc1 complex):</li><li>\u27a4 Cytochrome C</li><li>\u27a4 Complex IV (Cytochrome c oxidase)</li><li>\u27a4 ATP Synthase (Complex V)</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 262.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56bf7d1e",
      "audio": ""
    },
    {
      "text": "Which of the following statements about the malate-aspartate shuttle is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "It is used to transport NADH from Cytosol to Mitochondria.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is used to transport NADPH from Cytoplasm to Mitochondria.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Malate get converted to Oxaloacetate and release NADH",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxaloacetate is reconstituted from Aspartate and \u03b1 Ketoglutarate",
          "correct": false
        }
      ],
      "correct_answer": "B. It is used to transport NADPH from Cytoplasm to Mitochondria.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The malate-aspartate shuttle is a key biochemical system that allows the transfer of reducing equivalents (NADH) from the cytosol into the mitochondrial matrix, because the inner mitochondrial membrane is impermeable to NADH itself.</li><li>\u2022 How it works:</li><li>\u2022 How it works:</li><li>\u2022 In the cytosol: Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH. Malate is transported into the mitochondria. In the mitochondria: Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria. OAA is transaminated to aspartate, which can travel back to the cytosol to complete the cycle.</li><li>\u2022 In the cytosol: Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.</li><li>\u2022 Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.</li><li>\u2022 Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.</li><li>\u2022 Malate is transported into the mitochondria.</li><li>\u2022 In the mitochondria: Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.</li><li>\u2022 Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.</li><li>\u2022 Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.</li><li>\u2022 OAA is transaminated to aspartate, which can travel back to the cytosol to complete the cycle.</li><li>\u2022 Other Option:</li><li>\u2022 Other Option:</li><li>\u2022 Option A. It is used to transport NADH from Cytosol to Mitochondria : True. This is the core purpose of the shuttle. Option B. It is used to transport NADPH from Cytoplasm to Mitochondria : False. The shuttle transports NADH equivalents, not NADPH. NADPH is involved mainly in biosynthesis and antioxidant defenses, not in this shuttle system. Option C. Malate gets converted to Oxaloacetate and releases NADH : True. Inside mitochondria, malate \u2192 OAA + NADH (via malate dehydrogenase). Option D. Oxaloacetate is reconstituted from Aspartate and \u03b1-Ketoglutarate : True. Aspartate + \u03b1-KG \u2194 OAA + glutamate (via transamination).</li><li>\u2022 Option A. It is used to transport NADH from Cytosol to Mitochondria : True. This is the core purpose of the shuttle.</li><li>\u2022 Option A. It is used to transport NADH from Cytosol to Mitochondria</li><li>\u2022 Option B. It is used to transport NADPH from Cytoplasm to Mitochondria : False. The shuttle transports NADH equivalents, not NADPH. NADPH is involved mainly in biosynthesis and antioxidant defenses, not in this shuttle system.</li><li>\u2022 Option B. It is used to transport NADPH from Cytoplasm to Mitochondria</li><li>\u2022 Option C. Malate gets converted to Oxaloacetate and releases NADH : True. Inside mitochondria, malate \u2192 OAA + NADH (via malate dehydrogenase).</li><li>\u2022 Option C. Malate gets converted to Oxaloacetate and releases NADH</li><li>\u2022 Option D. Oxaloacetate is reconstituted from Aspartate and \u03b1-Ketoglutarate : True. Aspartate + \u03b1-KG \u2194 OAA + glutamate (via transamination).</li><li>\u2022 Option D. Oxaloacetate is reconstituted from Aspartate and \u03b1-Ketoglutarate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 The malate-aspartate shuttle transfers cytosolic NADH equivalents into the mitochondria for oxidative phosphorylation . It operates via a series of reversible reactions , involving: Oxaloacetate \u2192 Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate \u2192 Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 The malate-aspartate shuttle transfers cytosolic NADH equivalents into the mitochondria for oxidative phosphorylation .</li><li>\u27a4 malate-aspartate shuttle</li><li>\u27a4 cytosolic NADH equivalents</li><li>\u27a4 oxidative phosphorylation</li><li>\u27a4 It operates via a series of reversible reactions , involving: Oxaloacetate \u2192 Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate \u2192 Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 series of reversible reactions</li><li>\u27a4 Oxaloacetate \u2192 Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate \u2192 Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 Oxaloacetate \u2192 Malate (reduced by cytosolic NADH)</li><li>\u27a4 Oxaloacetate \u2192 Malate</li><li>\u27a4 Malate transport into mitochondria</li><li>\u27a4 Malate transport</li><li>\u27a4 Malate \u2192 Oxaloacetate (regenerates NADH in matrix)</li><li>\u27a4 Malate \u2192 Oxaloacetate</li><li>\u27a4 Transamination of oxaloacetate+ Glutamate  \u2194 aspartate + \u03b1-ketoglutarate</li><li>\u27a4 Transamination</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 219.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1e0ff609",
      "audio": ""
    }
  ]
}